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LTD . . . . . . . . . . . . . . . . . . . . . . . . . . . .  long term depression 
mAB . . . . . . . . . . . . . . . . . . . . . . . . . . . .  monoclonal antibody 
MBP . . . . . . . . . . . . . . . . . . . . . . . . . . . .  myelin basic protein 
MOI . . . . . . . . . . . . . . . . . . . . . . . . . . . .  multiplicity of infection 
mRNA . . . . . . . . . . . . . . . . . . . . . . . . . .  messenger RNA 
NAc . . . . . . . . . . . . . . . . . . . . . . . . . . . .  nucleus accumbens 
NMDA . . . . . . . . . . . . . . . . . . . . . . . . . .  n-methyl-d-aspartic acid 
NT . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  neurotrophin factor 
pAB . . . . . . . . . . . . . . . . . . . . . . . . . . . .  polyclonal antibody 
PFC . . . . . . . . . . . . . . . . . . . . . . . . . . . .  prefrontal cortex 
PDT . . . . . . . . . . . . . . . . . . . . . . . . . . . .  percent distance traveled 
PNS . . . . . . . . . . . . . . . . . . .  . . . . . . .  peripheral nervous system 
PSD95 . . . . . . . . . . . . . . . . . . . . . . . . . .  postsynaptic density protein 95 
PTM . . . . . . . . . . . . . . . . . . . . . . . . . . . .  pavlidis template matching 
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PTS . . . . . . . . . . . . . . . . . . . . . . . . . . . .  percent time spent 
QHCl . . . . . . . . . . . . . . . . . . . . . . . . . . .  quinine hydrochloride 
qRT-PCR . . . . . . . . . . . . . . . . . . . . . . . . quantitative reverse transcription 
polymerase chain reaction 
RBP . . . . . . . . . . . . . . . . . . . . . . . . . . . .  RNA binding protein 
RI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . recombinant inbred 
RNA . . . . . . . . . . . . . . . . . . .  . . . . . . . .  ribonucleic acid 
RNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . ribonucleoprotein 
RQI . . . . . . . . . . . . . . . . . . . . . . . . . . . .  RNA quality index 
SYT . . . . . . . . . . . . . . . . . . . . . . . . . . . .  synaptotagmin 
TB . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  terrific broth 
TBST . . . . . . . . . . . . . . . . . . . . . . . . . . .  tris buffered saline with Tween 20 
TEM . . . . . . . . . . . . . . . . . . . . . . . . . . . .  transmission electron microscopy 
UTR . . . . . . . . . . . . . . . . . . . . .  . . . . . .  untranslated region 
Vd . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  volume of distribution 
 
VTA . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ventral tegmental area 
WH . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  whole homogenate 
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Alcoholism is a complex neurological disorder characterized by loss of control in 
limiting intake, compulsion to seek and imbibe ethanol, and chronic craving and relapse. 
It is suggested that the characteristic behaviors associated with the escalation of drug 
use are caused by long-term molecular adaptations precipitated by the drug’s continual 
 administration. These lasting activity-dependent changes that underlie addiction-
associated behavior are thought, in part, to depend on new protein synthesis and 
remodeling at the synapses. It is well established that mRNA can be transported to 
neuronal distal processes, where it can undergo localized translation that is regulated in 
a spatially restricted manner in response to stimulation. Through two avenues of 
investigation, the research herein demonstrates that behavioral responses to ethanol 
result, at least in part, from alterations in the synaptic transcriptome which contribute to 
synaptic remodeling and plasticity. The synaptoneurosome preparation was utilized to 
enrich for RNAs trafficked to the synapse. Two complementary methods of genomic 
profiling, microarrays and RNA-Seq, were used to survey the synaptic transcriptome of 
DBA/2J mice subjected to ethanol-induced behavioral sensitization. A habituating 
expression profile, characteristic of glucocorticoid-responsive genes, was observed for a 
portion of synaptically targeted genes determined to be sensitive to repeated ethanol 
exposure. Other ethanol-responsive genes significantly enriched for at the synapse 
were related to biological functions such as protein folding and extra-cellular matrix 
components, suggesting a role for local regulation of synaptic functioning by ethanol. In 
a separate series of experiments, it was shown that altered trafficking of Bdnf, an 
ethanol-responsive gene, resulted in aberrant ethanol behavioral phenotypes. In 
particular, mice lacking dendritically targeted Bdnf mRNA exhibited enhanced sensitivity 
to low, activating doses and high, sedating doses of ethanol. Together these 
experiments suggest that ethanol has local regulatory effects at the synapse and lays 
the foundation for further investigations into the role of the synaptic transcriptome in 
ethanol-responsive behaviors. Supported by NIAA grants R01AA014717, U01 
 AA016667 and P20AA017828 to MFM, F31AA021035 to MAO, and NIDA 
T32DA007027 to WLD. 
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Chapter 1 – Introduction 
 
 
 
Alcohol use disorder (AUD) is a medical condition that is characterized by 
uncontrolled, compulsive alcohol seeking and consumption, undeterred by adverse 
consequences. The 5th edition of the Diagnostics and Statistical Manual of Mental 
Disorders categorizes the disorder into mild, moderate, and severe sub-classifications. 
The more serious of the conditions, colloquially known as alcoholism, is a disease that 
includes symptoms of craving, loss of control in the amount consumed, dependence, 
and tolerance. Alcoholism is a world-wide public health problem, but in the United 
States alone, it is estimated that 18 million Americans can be classified as having AUD 
(NIAAA, 2012). Each year in the United States, 88,000 people die from alcohol-related 
causes, making it the third leading preventable cause of death in the country (CDC, 
2014b). The economic impact of AUD is staggering, as it’s estimated that in 2006 
alcohol use problems cost the United States approximately 224 billion dollars (CDC, 
2014a). Despite the overwhelming presence and burden AUD has on society, the exact 
molecular actions of ethanol in the brain are not entirely understood, as ethanol acts on 
diverse array of receptor signaling systems, across many different brain regions 
(Spanagel, 2009), and produces a spectrum of behavioral disorders. A better 
understanding of the neurobiology of ethanol-related disorders is needed in order to 
identify novel therapeutic treatments.   
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  Alcoholism is a complex, multifactorial disease and the risk for developing 
addiction is determined by an interplay between an individual’s genetic makeup, 
environmental factors, and neuroadaptations that occur following acute and repeated 
drug exposure (Spanagel, 2009). A major directive of the alcohol research field is to 
delineate the pathological progression to alcohol dependence. With initial exposure, 
changes in neurotransmission lead to intoxication, anxiolysis, and a sense of reward 
(Spanagel, 2009). After repeated exposure, alterations in cell signaling can generate 
changes in gene expression and synaptic function, thought to contribute to the 
development of tolerance, dependence and sensitization to ethanol (Gilpin & Koob, 
2008). As drug administration continues, allostasis is established which may account for 
the essentially permanent changes in behavior associated with addiction (Koob, 2003).  
A consequence of the interaction of ethanol with its molecular targets is altered 
synaptic functioning, otherwise known as synaptic plasticity. Previous research from our 
laboratory that examined ethanol regulation of gene expression across a variety of 
mouse strains has found significant enrichment of genes involved with synaptic 
plasticity, reproducibly amongst several brain regions (Kerns et al., 2005; Wolen et al., 
2012). There is also evidence to support that adaptive responses underlying ethanol 
tolerance and dependence are synaptic in nature, in part involving changes in glutamate 
neurotransmission (Tsai & Coyle, 1998). Ethanol administration has been shown to 
induce structural synaptic plasticity as well. Alcohol-preferring rats exposed to 14 weeks 
of continuous access or subjected to repeated deprivations of ethanol exhibited 
decreased density and increased size of spines in a subpopulation of neurons in the 
nucleus accumbens (Zhou et al., 2007). Cortical neurons exposed to chronic 
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intermittent ethanol administration had significant increases in NMDA receptor surface 
expression (Qiang et al., 2007) and hippocampal cultures receiving prolonged ethanol 
exposures exhibited increased co-localization of PSD95 and f-actin (Carpenter-Hyland 
& Chandler, 2006) leading to enlargement of spine heads. Together these data suggest 
that dendritic spines may be an important target for the adaptive actions of ethanol.  
 The morphological specialization of neurons, where synapses appear to be 
regulated in an individual manner, advocates the need for local regulation. Local protein 
synthesis in dendrites is supported by the presence of synthesis machinery and mRNAs 
for a subset of genes (Steward & Levy, 1982; Steward & Reeves, 1988; Poon et al., 
2006; Matsumoto et al., 2007). This complement of RNAs, known as the synaptic 
transcriptome, has been shown to be regulated by neuronal activation (Tongiorgi et al., 
1997; Steward & Worley, 2001; Grooms et al., 2006). Yet, there are no known published 
studies that investigate the role the synaptic transcriptome plays in the expression of 
ethanol-induced behaviors. Therefore, since ethanol is known to induce widespread 
changes in gene expression (Miles et al., 1992; Morrow et al., 1992; Treadwell & Singh, 
2004; Kerns et al., 2005; Bell et al., 2009), which can contribute to synaptic plasticity, 
and because local protein synthesis from synaptic mRNA populations is important for 
spatially restricted plasticity to occur (Steward & Levy, 1982),  I set out to examine the 
function of the synaptic transcriptome in ethanol-induced behaviors. It is my hypothesis 
that behavioral responses to ethanol result, at least in part, from alterations in the 
synaptic transcriptome which contribute to synaptic remodeling and plasticity.  
This investigation was approached in two ways. First, we observed the effect of 
repeated intermittent ethanol exposure on the profile of the synaptic transcriptome. 
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Behavioral sensitization is a process that occurs following repeated drug exposure, 
proposed as a result of neuroadaptations in the brain reward systems that contribute to 
such behaviors as drug craving and relapse in alcoholics (Piazza et al., 1990; Robinson 
& Berridge, 1993). Not much is known about the exact molecular mechanisms that 
underlie ethanol sensitization, but evidence has indicated a potential involvement of the 
hypothalamic-pituitary-adrenal (HPA) axis and glucocorticoid receptors (Phillips et al., 
1997; Costin et al., 2013a). Nonetheless, ethanol sensitization provides a model of 
neuroplasticity with a measureable behavioral endpoint. Selective analysis of the 
synaptic transcriptome through utilization of a synaptoneurosomal preparation allowed 
us to detect changes in synaptic mRNA profiles as a result of repeated ethanol 
exposure. In the second approach, we employed a transgenic mouse strain with altered 
dendritic trafficking of an ethanol-responsive gene, Bdnf, and determined that proper 
transcript localization is necessary for normal ethanol behavioral responses. Together, 
these results suggest an important function of the synaptic transcriptome in mediating 
the effects of ethanol. Future studies will continue to utilize the synaptoneurosomal 
model with the objective of potentially identifying molecular mechanisms that contribute 
to the actions of ethanol, which would otherwise go undetected when studying the entire 
transcriptome.  
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Chapter 2 – Background and Significance 
 
 
Role of mRNA trafficking and local protein synthesis in synaptic plasticity  
 Neuroplasticity refers to the brain’s ability to undergo structural and functional 
changes as a result of experience. This umbrella term describes the capability for neural 
pathway reorganization as well as the capacity for individual synaptic connections to be 
strengthened or weakened in response to activity. Repeated administration of drugs of 
abuse can lead to long-lasting adaptive changes that manifest as behaviors associated 
with addiction (Nestler, 2001a; Russo et al., 2010). These modifications can be both 
structural (Robinson & Kolb, 1997) and molecular in nature (Nestler, 2001a). 
Development of long-lasting forms of behavioral and synaptic plasticity has been shown 
to require new protein synthesis (Davis & Squire, 1984; Kang & Schuman, 1996). These 
newly formed proteins are thought to be utilized specifically by activated synapses to 
stabilize modifications in synaptic strength (Kelleher et al., 2004).  
 The prevailing theory had been that the soma represented the primary site of 
protein synthesis and synapses were dependent upon this synthesis for their function. 
This view was challenged by the work of Steward and others in the 1980’s. The 
observation of dendritic polyribosomes localized near postsynaptic sites suggested the 
means for local protein synthesis (Steward & Levy, 1982; Steward, 1983). Quantitative 
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assessment of serial electron micrographs found approximately 70% of dendritic 
polyribosomes localized to structures positively identified as spine bases or membrane 
mounds that were highly probable to be spine bases (Steward & Levy, 1982). 
Subsequent work documented the presence of tRNA, translation factors, endoplasmic 
reticulum and golgi-like apparatus at postsynaptic sites (Steward & Reeves, 1988; 
Tiedge & Brosius, 1996; Gardiol et al., 1999). Translocation of translational machinery 
into spines during hippocampal long term potentiation (LTP) has also been observed 
(Ostroff et al., 2002). Soma-free synapse preparations retain the ability to translate 
proteins (Rao & Steward, 1991; Eberwine et al., 2001), and this dendritic synthesis is 
crucial for some forms of synaptic plasticity (Huber et al., 2000). 
 Local protein synthesis makes the prospect of regulating synapses on an 
individual basis a more efficient process (Steward & Levy, 1982). For instance, local 
translation is an effective way to obtain high protein concentrations at a particular 
synapse. Transport of relatively few mRNA molecules that can be translated multiple 
times as opposed to transporting each individual protein is more economical for the cell 
(Wilhelm & Vale, 1993). Local synthesis also allows for the spatial regulation of 
macromolecular assembly reactions and prevents expression of proteins in 
inappropriate locations which could have deleterious effects. For example, myelin basic 
protein (MBP) has high affinity for membranous structures. Binding of this protein to 
membranes causes compaction (St Johnston, 1995). On-site synthesis of MBP 
prevents harmful interactions that could occur during transport of the protein. 
Furthermore, efficiency in response to synaptic activation could be optimized by having 
a ready pool of transcripts available. Local translation to produce the proteins needed 
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for synaptic modification would conceivably be faster than excitation-transcription 
coupling. Another particularly attractive concept allows for locally transcribed proteins to 
have distinct functions as compared to somatic variants. It has been shown that 
dendritically localized Bdnf transcripts, but not somatic, are necessary for proper 
dendritic spine pruning in mice (An et al., 2008). Hypotheses for how localization could 
dictate function include 1) temporal activation that would allow interaction with activity-
initiated signaling cascades and 2) cis- or trans-acting regulatory elements associated 
with localized transcripts that could control conditions under which translation is 
initiated. Both provide thought-provoking avenues for investigation.  
 Supporting local protein synthesis, mRNA has been identified in the distal 
processes and is referred to as the synaptic transcriptome. In situ hybridization of 
hippocampal lamina (Lyford et al., 1995; Tongiorgi et al., 1997) as well as 
characterizations of synapse-enriched subcellular fractions (Chicurel et al., 1993; Rao & 
Steward, 1993; Poon et al., 2006; Matsumoto et al., 2007) have confirmed the presence 
of specific transcripts in dendrites. The occurrence and functionality of mRNA in axons 
remains controversial. Local protein synthesis has clearly been detected in axons of 
invertebrate systems (Twiss & Fainzilber, 2009), however initial ultrastructural studies 
failed to detect ribosomes in mature mammalian CNS axons (Steward & Levy, 1982). 
Despite the apparent absence of ribosomes, some vertebrate axons were reported to 
contain mRNAs. For example, axons of hypothalamic neurons projecting to the 
posterior pituitary were shown to contain transcripts for vasopressin and oxytocin (Mohr 
et al., 1991; Mohr & Richter, 1992). Additionally, message for the kappa-opioid receptor 
revealed axonal distribution in the dorsal root ganglia of rodents (Bi et al., 2006). The 
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presence of peri-axoplasmic ribosome plaques (PARPs) have been identified 
intermittently along myelinated peripheral nerves (Koenig et al., 2000), suggesting an 
inherent ability for axonal protein synthesis in the PNS. This may correlate with the 
capacity for spontaneous regeneration in peripheral nerves, not typically observed in the 
mature CNS (Twiss & Fainzilber, 2009). It has also been suggested that neuronal cell 
bodies are not the only source for translational machinery and message in distal axons, 
and that ribosomes and mRNA may be transferred from glia sources (Court et al., 2008; 
Sotelo et al., 2014). Regulated trafficking of mRNA in granules that also contain 
ribosomes and other translational factors has been detected in astrocytes and 
oligodendrocytes as well (Barbarese et al., 1995; Gerstner et al., 2012). Together these 
data suggest an important and varied role for local protein synthesis throughout the 
nervous system. 
 Transport of mRNA to distal processes has been shown to occur in an activity-
dependent manner. For example, potassium depolarization of hippocampal neurons in 
culture resulted in anterograde movement of Camk2a, Bdnf, and Ntrk2 mRNA along 
dendrites (Tongiorgi et al., 1997; Rook et al., 2000). Quantitative fluorescent in situ 
hybridization revealed bidirectional regulation of AMPA receptor mRNA localization as a 
result of NMDA and metabotropic glutamate receptor activation (Grooms et al., 2006). 
In vivo synaptic stimulation of the dentate gyrus delivered Arc mRNA to the 
corresponding projection lamina and was found to be dependent upon NMDAR 
signaling (Steward et al., 1998; Steward & Worley, 2001). A model for mRNA transport 
as a component of large ribonucleoprotein (RNP) granules has been described 
(Bramham & Wells, 2007). RNA binding proteins (RBPs) in the nucleus are thought to 
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stabilize the newly transcribed RNA and provide sequestration from translation during 
transport. Dendritic mRNA encoding fragile-X mental retardation protein (FMRP) and 
ARC remain associated with the translation initiation factor, eIF4AIII, indicating 
translation does not occur en route (Giorgi et al., 2007). The speed of RNP movement 
along dendrites and the sensitivity of RNPs to microtubule (MT) depolymerizing drugs 
have implicated the MT cytoskeletal system in RNP granule transport (Kiebler & 
Bassell, 2006). Furthermore, characterization of affinity isolated RNP granules using the 
kinesin motor protein, KIF5, revealed a diverse composition (Kanai et al., 2004). 
Constituents included multiple mRNA species and 42 different proteins involved in 
transport, stabilization, and translation. The observation of bidirectional transport of 
mRNAs within dendrites (Knowles et al., 1996) suggests that activated synapses 
capture RNPs from a pool of patrolling granules (Doyle & Kiebler, 2011). The exact 
physical nature of the synaptic tag that marks an activated synapse has not been 
absolutely defined. Candidate molecular tags that have been proposed include post-
translation modifications to existing synaptic proteins, alterations to protein 
conformational states, initiation of localized translation or proteolysis, and reorganization 
of the local cytoskeleton (Martin & Kosik, 2002; Kelleher et al., 2004; Doyle & Kiebler, 
2011). Following synaptic activation, granule localization into spines employs actin 
cytoskeleton myosin motor proteins, repressive RNA binding proteins are neutralized, 
and translation can occur (Bramham & Wells, 2007). Trafficking and local translation are 
regulated by particular cis-acting elements of both the transcript and proteins that bind 
them (Wells, 2006). mRNA localization elements that are typically, but not exclusively, 
located in 3’untranslated regions (UTR), help to distribute RNAs to their proper 
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subcellular location. These “zip codes” are heterogeneous in nature and range from 
short nucleotide sequences to complex secondary structure recognized by trans-acting 
RBPs (Doyle & Kiebler, 2011). The model of mRNA transport and local translation 
presented here exposes several regulatory mechanisms. Modulation by drugs of abuse 
at any point along the process would result in alterations to the synaptic transcriptome, 
potentially contributing to the development of behavioral plasticity.  
 
Utilization of the synaptoneurosome preparation in neurogenomic research 
Research into synaptic functioning, which includes local protein synthesis, has 
been advanced by the development of subcellular fractionation techniques that provide 
samples enriched for synaptic entities. A variety of preparations have been published in 
the literature (Whittaker et al., 1964; Hollingsworth et al., 1985; Rao & Steward, 1993). 
Each preparation differs slightly in protocol and consequently in the structure of 
enriched synaptic elements, retained molecular constituents, and functional capacity. 
Synaptosomes were first described by Gray and Whittaker (1960, 1964), who also 
showed that disruption of these particles by hypo-osmotic media and subsequent 
gradient filtration of the components would result in sub-fractions that corresponded to 
separate synaptic localizations (Whittaker et al., 1964). Synaptosomes are typically 
defined as a subcellular particle that is derived from resealed axonal termini prepared 
from brain issue homogenized in iso-osmotic buffer followed by density-gradient 
fractionation. Initial centrifugation, usually at around 1000 x g, removes the nuclear 
pellet, the supernatant of which is then spun again at 17,000 x g to yield a mitochondrial 
pellet, which is then re-suspended and applied to a sucrose density gradient, 
 11 
 
centrifuged at 50,000 x g to separate mitochondria from synaptosomes (Gray & 
Whittaker, 1960). This results in a fraction mainly composed of presynaptic elements 
which often retain part of the postsynaptic membrane. Synaptodendrosomes (Rao & 
Steward, 1993) and synaptoneurosomes (Hollingsworth et al., 1985) are preparations 
that have been shown to retain a greater portion of the postsynaptic compartment, often 
in the form of a re-sealed portion of the dendritic spine. Synaptoneurosomes were first 
named as such in Hollingsworth et al. (1985), where a low centrifugation, size-filtration 
scheme was used to produce synaptosomal structures attached to resealed 
postsynaptic entities (neurosomes). The typical sizes of the identified particles were 
approximately 0.6 µm for the synaptosomes and 1.1 µm for the neurosomes 
(Hollingsworth et al., 1985).  
Together these subcellular fractionation procedures have been used in myriad 
studies that have aided the characterization of synapses as discrete biochemical units. 
It was demonstrated that depolarization of the synaptosomal membranes increased 
polysomal association of Camk2a mRNA and subsequent increase in protein (Bagni et 
al., 2000). Synaptosomes prepared from striatum of rats injected with a single dose of 
2.0 g/kg ethanol revealed a time-dependent initial increase followed by a decrease in 
the ability to synthesize dopamine (DA) (Pohorecky & Newman, 1977). Barbiturates 
were shown to increase Cl- efflux from rat cerebral cortical synaptoneurosomes 
(Schwartz et al., 1985). The observed differences in structure between synaptosomes 
and synaptoneurosomes may make them uniquely adept for particular types of 
experiments. While synaptosomes have been utilized more frequently, it can be 
surmised that synaptoneurosomes would be the more appropriate model to examine 
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postsynaptic functioning. For instance, the accumulation of cyclic AMP elicited by 
incubation of the preparations with adenosine, norepinephrine and histamine was 
significantly greater in the synaptoneurosomes as compared to the synaptosomes 
(Hollingsworth et al., 1985). This is most likely explained by the neurosome being the 
functional entity that contains most of the receptors linked to the adenylyl cyclase 
(Hollingsworth et al., 1985). Theoretically synaptoneurosomes should also provide the 
most complete complement of RNA present in the synapse. In fact, synaptoneurosomes 
have been used to identify the presence and activity-dependent modulation of Dicer and 
RNA-induced silencing complex (RISC) component, eIF2c, at the synapse (Lugli et al., 
2005). They have also been used to examine the synaptic transcriptome in the 
prefrontal cortex (PFC) of humans that were afflicted with Alzheimer’s disease (Williams 
et al., 2009). We therefore hypothesized that synaptoneurosomes could be used to 
survey the synaptic transcriptome for changes resulting from repeated administration of 
ethanol in an in vivo model.   
 
Behavioral sensitization as a model of neuronal plasticity  
Behavioral sensitization is the phenomenon defined by escalation of behavioral 
responses to repeated exposure of stimulus. Often measured as a long-lasting 
augmentation in psychomotor stimulating effects, behavioral sensitization is observed 
across different classes of drugs with abuse liability (Shuster et al., 1975; Masur & 
Boerngen, 1980; Hirabayashi & Alam, 1981; Crabbe et al., 1982). Sensitization is 
proposed to occur as the result of progressive neuroadaptations in brain regions that 
mediate reinforcement and reward resulting in incentive salience of the drug (Robinson 
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& Berridge, 1993). This is evidenced by studies with amphetamine and cocaine showing 
animals with an increased propensity for self-administration after sensitization (Horger 
et al., 1990; Piazza et al., 1990). Repeated pre-exposure to amphetamine, cocaine, and 
morphine can also enhance reward as measured by conditioned place preference 
(CPP) (Lett, 1989). The effect of sensitizing ethanol treatments on the rewarding 
properties of the drug is slightly convoluted. In a paper by Camarini and Hodge (2004), 
intermittent repeated ethanol exposure of 1.0 g/kg and 2.0 g/kg administered every 
other day resulted in increased two-bottle choice ethanol self-administration in B6 and 
D2 mice. However, the ethanol pretreatment in this study did not actually manifest as a 
significant sensitizing locomotor response in either genotype (Camarini & Hodge, 2004). 
In another study looking at the effect of ethanol sensitization on ethanol consumption in 
B6 and D2 mice, it was found that the ethanol preferring mice (B6) exhibited an 
increase in ethanol intake following induction of locomotor sensitization using 2.5 g/kg 
ethanol, that was elicited following a bout of pre-sensitized drinking (Lessov et al., 
2001). This increase was not observed in B6 mice that had been exposed to ethanol in 
the pre-sensitized drinking phase but only received repeated saline injections. Non-
ethanol preferring mice (D2) did not increase their consumption subsequent to 
sensitization in this series of experiments. In another study that used Swiss Webster 
mice subjected to daily injections of 1.8 g/kg ethanol for 21 days, it was shown that mice 
that sensitized exhibited increased drinking of 20% ethanol, but not 10% ethanol, in a 
limited access, voluntary choice model compared to non-sensitized and saline control 
mice (Abrahao et al., 2013). However, the genetic heterogeneity present in this outbred 
strain cannot be eliminated as the source for susceptibility to both sensitization and 
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increased ethanol consumption. Together these data suggest that the ability to 
modulate ethanol intake by sensitizing pretreatment is highly dependent upon mouse 
strain and schedule of administration. 
Sensitization to specific effects of addictive drugs has also been observed in 
humans (Newlin & Thomson, 1991; Strakowski et al., 1996; Schenk & Davidson, 1998; 
Sax & Strakowski, 2001). Clinical presentation of psychostimulant-induced psychosis 
that occurs with repeated dosing of stimulant drugs has been suggested to be the result 
of changes to the central nervous system, producing a form of ‘kindling’, that results in 
symptoms similar to schizophrenia (Ellinwood & Kilbey, 1980). Human experimental 
studies investigating sensitization are few due to ethical considerations, but one double-
blind, placebo-controlled study (Strakowski et al., 1996) showed significantly greater 
eye-blink rates, a process controlled by dopaminergic mechanisms (Karson, 1983), 
following a second dose of d-amphetamine. Newlin and Thompson (1991) found that 
sensitization to finger pulse amplitude was observed across ethanol sessions in sons of 
alcoholics, a group with increased propensity for development of alcoholism. In contrast, 
participants that reported no parental history of alcoholism, and whom were therefore 
deemed low-risk, tended to demonstrate tolerance. These results, where high-risk 
individuals seem to derive greater response to acute administration of alcohol than low-
risk participants appears to contradict Schuckit’s seminal work showing low level of 
response to an alcohol challenge in high-risk subjects (Schuckit, 1994). The former 
study is the only examination of response to equivalent doses of alcohol across multiple 
sessions (Newlin & Thomson, 1991).  
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The concurrence among different drug classes for development of sensitization, 
along with the observation of cross-sensitization, where pretreatment with one drug 
results in a sensitized response to another, suggests common neural substrates may 
mediate these effects (Wise & Bozarth, 1987; Robinson & Berridge, 1993). The 
mesocorticolimbic system is a major substrate for motivated behavior and responses to 
natural reinforcers and is suggested to mediate the rewarding properties of drugs. This 
pathway primarily consists of dopaminergic projections from the ventral tegmental area 
(VTA) to the nucleus accumbens (NAc), prefrontal cortex (PFC), amygdala, and 
hippocampus. The system is also innervated with reciprocal glutamatergic connections 
and GABAergic interneurons. Studies involving mesocorticolimbic lesions caused by 6-
hydroxydopamine determined that the A10 dopamine neurons that project from the VTA 
to the NAc are important in mediating spontaneous and psychostimulant-induced 
locomotion (Fink & Smith, 1980; Koob et al., 1981). Most drugs of abuse, including 
ethanol, cause a release of dopamine in the NAc, dorsal striatum (DS), and PFC (Di 
Chiara & Imperato, 1988; Maisonneuve et al., 1990), and this is thought to be a major 
mediator of the positive reinforcing effects of addictive substances (Koob, 2000). 
Repeated intermittent treatment of psychostimulants results in augmented extracellular 
release of dopamine upon subsequent administrations. This molecular adaptation 
correlates with the observed enhanced motor stimulation (Kalivas & Duffy, 1990; 
Paulson & Robinson, 1995).  
There are conflicting reports in the literature as to whether ethanol sensitization 
elicits an augmented DA response in the NAc (Rossetti et al., 1993; Szumlinski et al., 
2005; Zapata et al., 2006), but there are other lines of evidence that suggest that DA 
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does play a role in development of the behavior. D1 and D3 receptor knockout (KO) mice 
do not show a sensitized response to the locomotor-activating effects of ethanol 
(Harrison & Nobrega, 2009). while sensitization was potentiated in dopamine active 
transport (DAT) knockout mice on a D2 background (Morice et al., 2010). In addition, 
neuroimaging studies of alcoholics during craving and relapse reveal altered dopamine 
transmission (George et al., 2001). Overall the current data indicate that the mechanism 
of ethanol sensitization is complex, and requires investigation into the role of other 
neurotransmitters and signaling systems (Broadbent & Harless, 1999; Carrara-
Nascimento et al., 2011; Pastor et al., 2012). 
Various other neurochemical adaptations have been found in occur in response 
to sensitizing treatments of drugs of abuse including, but not limited, to dopamine 
autoreceptor subsensitivity (White & Wang, 1984; Ackerman & White, 1990), decreases 
in G protein subunits (Nestler et al., 1990; Striplin & Kalivas, 1993), and increases in 
calmodulin message and protein (Gnegy et al., 1991; Shimizu et al., 1997). However 
many of these subcellular neurochemical adaptations are relatively transient, 
suggesting that they are not involved in the long-term expression of sensitization but are 
possibly necessary to trigger more lasting plastic changes required for maintenance of 
the behavior (White & Kalivas, 1998). Anatomical changes to dendritic spine 
morphology in response to sensitizing treatments of amphetamine and cocaine in rats 
have been shown to persist for longer periods of time (Robinson & Kolb, 1999), and 
other studies have focused on more enduring rearrangements of neural networks and 
circuitry to explain the long-lasting effects of repeated drug exposure (Ujike et al., 2002). 
Together, these studies implicate behavioral sensitization as a valid, testable model to 
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study the neural plasticity that mediates drug related behavior and potentially 
contributes to development of addiction. 
 
Application of microarrays and RNA-Seq to ethanol-related behaviors 
Long-term cellular and molecular changes in the brain as a result of chronic drug 
exposure are believed to be crucial in the development of drug addiction (Nestler & 
Aghajanian, 1997). Alterations in gene expression caused by repeated administration of 
ethanol or other drugs of abuse are a proposed mechanism contributing to the 
neuroadaptations leading to addiction (Nestler & Aghajanian, 1997). Moreover, gene 
expression has been used as a surrogate measure of signaling mechanisms evoked by 
acute ethanol that contribute to a behavioral response (Kerns et al., 2005; Farris & 
Miles, 2013). Genome-wide expression analysis allows for a non-biased, parallel 
examination of the entire transcriptome. The utility of expression profiling not only lies in 
its ability to identify individual genes that are associated with a particular phenotype, but 
also to provide insight into the inter-related nature of genes and their functions (Lockhart 
& Winzeler, 2000; Lockhart & Barlow, 2001). Gene networks can be defined and 
populated based on functional interactions or common regulatory mechanisms that 
manifest as highly correlated expression patterns. Investigating the response of the 
network, as opposed to single genes, may be more apt to explain a complex trait, like 
alcoholism (Farris & Miles, 2012).  
In order to investigate the complex traits of alcohol abuse and dependence, 
genome-wide analysis has been applied to the study of various animal models, 
treatment paradigms, and tissues. Transcriptomic comparisons of inbred strains of mice 
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that differ in their response to ethanol have been important in elucidating genes and 
pathways that underlie divergent ethanol phenotypes (Xu et al., 2001; Kerns et al., 
2005). These strains are frequently used as the progenitors for recombinant inbred (RI) 
lines which often exhibit a distribution in behavioral response to ethanol as a result of 
recombinational events between genomes. Genomic analysis combined with genetic 
mapping in these RI lines allow for the identification of genes that contribute to the 
variation in the behavioral response (Jansen & Nap, 2001). Gene profiling studies have 
also revealed brain regional differences in expression that are often greater than those 
induced by selective breeding (Kimpel et al., 2007) or binge drinking (Mulligan et al., 
2011). Characterization of basal and ethanol-responsive differences in the VTA, NAc, 
and PFC between B6 and D2 mice uncovered region-specific expression profiles (Kerns 
et al., 2005). This study found region-specific functional involvement for retinoic acid 
and development in the VTA, Bdnf signaling and neuropeptide expression in the NAc, 
and glucocorticoid signaling and myelination in the PFC (Kerns et al., 2005). Expression 
profiling has also been instrumental in investigating various ethanol treatment 
paradigms (Rimondini et al., 2002; Rodd et al., 2008; McBride et al., 2010), ethanol 
regulation of chromatin remodeling (Wolstenholme et al., 2011; Zhou et al., 2011; 
Ponomarev et al., 2012) and the role of miRNAs in post-translation regulation (Lewohl 
et al., 2011). 
Most of ethanol transcriptomic studies to date have used microarray technology. 
Although there are differences among the various platforms, microarrays work 
according to the same molecular principle: complementary base pairing between 
fluorescently labeled target (either RNA or DNA based) and short probes attached to a 
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solid-phase support. After hybridization, the fluorescent signal detected correlates to 
mRNA abundance (Chee et al., 1996). However, as next-generation sequencing 
technologies advance and decrease in cost, the use of high-throughput RNA 
sequencing (RNA-Seq) for expression profiling becomes an attractive option. Once 
again, the exact methodology depends on the platform being utilized, but the general 
approach involves creation of a sequencing library, typically in the form of cDNA. 
Following sequencing, the resulting short reads can either be aligned against a 
reference genome or assembled without the use of a reference genome to allow for 
identification of novel transcripts and splicing sites (Cloonan & Grimmond, 2008; 
Mortazavi et al., 2008). Alignment provides structure to the transcriptome and the 
number of reads from each exon, splicing event, transcript, or gene can be determined 
and correlated to expression levels (Mortazavi et al., 2008). RNA-Seq is currently 
believed to have distinct advantages to prior methods of quantifying the transcriptome, 
such as a larger dynamic range, determination of expression without the need for probe 
design, and detection of polymorphisms, novel splicing events, and transcriptional 
boundaries (Cloonan & Grimmond, 2008; Mortazavi et al., 2008; Wang et al., 2009; 
Zhou, 2014). Despite the promise of RNA-Seq, practical application is currently 
hindered by lack of consensus and support for analytical methodology, making 
microarrays still a viable and incredibility useful tool. 
 
Activity-dependent regulation of BDNF and its role in alcoholism 
Brain-derived neurotrophin factor (BDNF) is the most prevalent growth factor in 
the CNS and is a member of the neurotrophins (NTs) family of proteins. These 
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molecules are primarily associated with neuronal survival and differentiation in the 
developing nervous system. However, NTs have also been extensively investigated for 
their role in modulating synaptic transmission and facilitating plasticity in mature 
neurons (Poo, 2001). BDNF serves critical functions in the processes of learning and 
memory (Lu et al., 2008), and the disruption of its proper functioning has been linked to 
numerous pathologies including Alzheimer’s disease, Parkinson’s disease, depression, 
obesity, schizophrenia, and addiction (Autry & Monteggia, 2012). 
Every aspect of BDNF regulation is facilitated by neuronal activity, including 
transcription. The rodent Bdnf gene (Figure 2.1) contains nine promoters, each of which 
initiates transcription of a different exon (I – IX) (Aid et al., 2007). A heterogeneous 
population of Bdnf transcripts is created by alternative splicing of each of the non-coding 
5’ exons onto the common 3’ exon (IX) that contains the entire open reading frame for 
the protein. Expression profiles for the various splicing variants are developmental 
stage, tissue, and brain region-specific (Liu et al., 2006b; Aid et al., 2007). The 
transcription start sites are also differentially activated by neuronal activity. For example, 
transcription of exons I, IV, V, VII, VIII, and IX was enhanced in the hippocampus by 
kainic acid-induced seizures (Aid et al., 2007). Furthermore, acute, but not chronic, 
administration of cocaine enhanced transcription of exon IV in the striatum and frontal 
cortex, but not hippocampus (Liu et al., 2006b). The mRNAs for Bdnf are also 
polyadenylated at one of two alternative sites (Timmusk et al., 1993). This creates two 
distinctive populations of mRNAs: those with short 3’ untranslated regions (UTR) and 
those with long 3’ UTR. Both long and short Bdnf mRNAs were expressed in all brain 
regions examined, however the ratio between long and short varied greatly between  
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Figure 2.1 – Exon/intron structure and alternative transcripts of rodent Bdnf. 
Schematic representation of Bdnf transcripts in relation to the gene. Protein coding 
region is shown as filled box and untranslated regions are shown as open boxes. Each 
of the eight 5’ untranslated exons splice to the common 3’ protein coding exon IX. 
Transcription can also be initiated in the intron before the protein coding exon. The two 
alternative polyadenylation signals in the 3’ untranslated region are marked by arrows. 
Exon II can generate three different transcript variants, IIA, IIB, and IIC, from the use of 
alternative splice-donor sites. Image reproduced with permission © 2006 Wiley-Liss, 
Inc. (Aid et al., 2007).  
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brain regions (An et al., 2008). The ratio of long to short isoforms also was significantly 
different depending on the promoter usage, within the single brain region (An et al., 
2008). 
The redundancy that arises from two populations of Bdnf mRNAs that encode the 
exact same protein was hypothesized to allow for regulation of BDNF function in 
different subcellular locations. Bdnf mRNA has been shown to be targeted to dendrites  
under physiological conditions (An et al., 2008). Bdnf mRNA also accumulates in the 
dendrites of cultured hippocampal neurons in a glutamate, Ca2+, and TrkB receptor-
dependent manner (Tongiorgi et al., 1997; Tongiorgi et al., 2004). An et al. (2008) 
concluded that it was long 3’ UTR containing Bdnf transcripts that were preferentially 
targeted to synapses. Quantitative PCR was performed on RNA isolated from separated 
cell bodies and synaptic compartments of cultured rat cortical neurons, revealing a 
relative 7-fold enrichment of long 3’ UTR in synaptic samples (An et al., 2008). This was 
corroborated by fluorescent in situ hybridization (FISH) analysis of cultured cortical 
neurons as well as hippocampal neurons that had been transfected with constructs 
containing the Bdnf coding region attached to the short 3’ UTR, the long 3’ UTR, or just 
the portion between the two polyadenylation sites (An et al., 2008). Alternatively, it has 
been suggested that the dendritic targeting element of Bdnf resides within the coding 
sequence (CDS), and can be overridden by inclusion of specific 5’ UTR exons 
(Chiaruttini et al., 2009). This was determined by FISH analysis of cultured hippocampal 
neurons transfected with constructs that contained Bdnf CDS preceded by 5’ UTR 
sequences, yet missing the 3’ UTR in its entirety (Chiaruttini et al., 2009). They also 
determined that the RNA-binding protein, translin, bound the Bdnf CDS and that this 
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binding was blocked by the G196A mutation, which they showed impaired dendritic 
targeting of Bdnf mRNA. A model was proposed that suggested the CDS dendritic 
targeting element is specifically involved in constitutive trafficking of transcript to 
synapses while the 3’ UTR acts as a inducible targeting signal (Chiaruttini et al., 2009). 
The results of these two papers appear to contradict each other, but both conclude that 
cis-acting elements in the Bdnf mRNA are responsible for the synaptic targeting of 
transcript.  
BDNF, like all neurotrophins, is synthesized as a prepro-BDNF precursor (Figure 
2.2).  Cleavage of the signal peptide after sequestration to the ER produces pro-BDNF, 
which can then form homo- and heterodimers with other pro-NTs (Lessmann et al., 
2003). The protein is then transferred to the golgi-network where it is packaged into 
both constitutive and regulated secretory vesicles. Cleavage of pro-BDNF to mature 
BDNF is catalyzed by furin-like enzymes and pro-hormone convertases that are 
associated with the golgi network and secretory vesicles (Lu, 2003). It has also been 
shown that pro-BDNF can be secreted and cleaved extracellularly by plasmin and 
metalloproteinases (Lee et al., 2001). Recently it has been suggested that specific 
modes of neuronal activation can result in the concurrent secretion of pro-BDNF and 
tissue plasminogen activator, shifting the extracellular balance to mature-BDNF 
(Waterhouse & Xu, 2009). BDNF is released from presynaptic and postsynaptic sites. 
However it is believed that activity-dependent secretion occurs primarily from dendritic 
spines (Lu, 2003), and transfection experiments using BDNF-GFP constructs have 
indicated that postsynaptic release of BDNF upon presynaptic high frequency  
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Figure 2.2 – Structural organization of prepro-BDNF. Schematic representation of 
the BDNF precursor protein. Bdnf mRNA encodes a 247 amino acid residue precursor 
protein. Following cleavage of the 18 amino acid signal peptide, pro-BDNF is 
transported to the Golgi for sorting into either the constitutive or regulated secretory 
granules. Pro-BDNF can be converted to the 119 amino acid mature BDNF by Golgi-
associated furin, secretory granule prohormone convertases, or by extracellular matrix 
plasmin and metalloproteinases (Greenberg et al., 2009).  
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stimulation depends on activation of postsynaptic glutamate receptors (Hartmann et al., 
2001). 
Following secretion, the biological functions of BDNF are mediated by binding of 
two cell surface receptors. Tropomyosin related kinase B (TrkB) is a high affinity 
tyrosine kinase receptor that appears to mediate the cell survival and synaptic effects of 
BDNF. Truncated forms of TrkB have been identified on cultured astrocytes and appear 
to sequester BDNF, acting as a molecular sponge to remove the ligand from the 
extracellular environment, and inhibiting axonal regeneration following axonal injury 
(Fryer et al., 1997). When BDNF binds TrkB, it induces dimerization and 
autophosphorylation of the receptor, leading to activation of three main signaling 
transduction pathways: phospholipase C (PLC)/protein kinase C (PKC), 
phosphatidylinositol 3-kinase (PI3K)/AKT, and mitogen-activated protein kinase (MAPK) 
pathways. Binding of BDNF to TrkB also results in receptor internalization followed by 
retrograde or anterograde transport, depending on the subcellular site of activation, to 
the axon where it activates cell survival signaling pathways (Lessmann et al., 2003). 
The second receptor responsible for mediating the effects of BDNF is the low-affinity 
nerve growth factor receptor (LNGFR), also known as p75. The exact downstream 
signaling mechanism activated by the p75 receptor is unknown. However, it is thought 
to act in two ways. As a Trk co-receptor, p75 can enhance or suppress neurotrophin-Trk 
activity (Roux & Barker, 2002). Alternatively, data suggests that pro-BDNF can bind 
autonomous p75 resulting in the induction of apoptosis (Roux & Barker, 2002; 
Lessmann et al., 2003).  
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BDNF signaling is able to modulate synaptic transmission through either 
presynaptic or postsynaptic mechanisms. Presynaptically, BDNF has been shown to 
cause phosphorylation of synapsin I and RIM1α via MAPK signaling, subsequently 
increasing synaptic vesicle exocytosis and glutamate efflux, respectively (Jovanovic et 
al., 1996; Simsek-Duran & Lonart, 2008). In the postsynaptic cell, BDNF-induced 
phosphorylation of NR1 and NR2B subunits was shown to potentiate NMDA currents 
(Wang & Salter, 1994). It has also been suggested that BDNF may modulate synaptic 
plasticity by regulating local protein synthesis in dendrites (Waterhouse & Xu, 2009). 
Application of BDNF to cultured hippocampal neurons in the presence of transcriptional 
inhibitor, actinomycin, was able to increase levels of dendritic Bdnf and Ntrk2  mRNA 
(Righi et al., 2000). Facilitation of translation of existing dendritic Arc mRNA by BDNF 
was shown to be dependent upon a synergism between TrkB and NMDA receptors, as 
this function was blocked by both the NMDAR antagonist, MK-801, and the tyrosine 
kinase inhibitor, K252a, as well by inhibition of mammalian target of rapamycin (mTOR) 
(Takei et al., 2004; Waterhouse & Xu, 2009).  
The ability of BDNF to mediate synaptic plasticity and regulate 
neurotransmission, particularly of dopamine and serotonin release (Goggi et al., 2002), 
would suggest that BDNF may be involved in the neuroadaptations that underlie the 
development of addiction. Human studies have indicated an association between BDNF 
and susceptibility to addiction (Uhl et al., 2001; Matsushita et al., 2004) along with lower 
plasma levels of BDNF in alcoholics, particularly in those with a family history of the 
disease (Joe et al., 2007). Preclinically, alterations in Bdnf have been shown to 
modulate several behaviors associated with drugs of abuse (Horger et al., 1999; Hall et 
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al., 2003; Hensler et al., 2003). While studies of Bdnf homozygous knockout mice would 
be highly informative about the potential influences the neurotrophic factor has on the 
response to various drugs of abuse, these mice display substantial nervous system 
abnormalities and often die by their third postnatal week (Ernfors et al., 1994; Conover 
& Yancopoulos, 1997). In contrast, Bdnf heterozygotes are viable and possess mRNA 
and protein levels that are half that of wildtype mice (Kolbeck et al., 1999; Lyons et al., 
1999). As such, Bdnf heterozygous mice have been the primary reagent for studying the 
genetic impact on behavioral responses to a variety of drugs of abuse. On a mixed 
J129ftm/1Jae/C57BL/6 background, heterozygous mice exhibited increased ethanol 
consumption as well as augmented ethanol-induced sensitization and conditioned place 
preference as compared to their wildtype littermates (McGough et al., 2004). It has also 
been reported that Bdnf mRNA is significantly augmented by single acute ethanol 
injection or voluntary self-administration (McGough et al., 2004; Logrip et al., 2009). 
Interestingly, Loprig et al. (2009) was able to show that escalating consumption of 
ethanol over 6 weeks resulted in the loss of ethanol’s ability to increase Bdnf transcript 
levels, and that this was not recovered with a 2 week withdrawal period. The work of Dr. 
Dorit Ron and colleagues has suggested that BDNF signaling works as a parallel 
protective mechanism that prevents the neuroadaptations that lead to phenotypes 
associated with alcohol addiction and that a dysregulation of this protective mechanism 
can permit these adaptive responses to occur (McGough et al., 2004). Therefore, due to 
BDNF's implicated function in ethanol-induced synaptic plasticity as well as the fact that 
Bdnf mRNA is targeted to the synapse where it can be translated and secreted in an 
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activity-dependent manner, BDNF is an excellent candidate for studying the effects of 
modulated dendritic trafficking on ethanol-induced behaviors.  
 
Bdnfklox/klox mouse as a model for altered synaptic transcript trafficking 
To examine the role of dendritically targeted Bdnf mRNA in response to ethanol 
administration, experiments here utilized an existing transgenic mouse model. This 
strain, referred to as Bdnfklox/klox, was initially created as a mating partner for a cre-
recombinase expressing mouse to produce brain region-restricted Bdnf mutants (Gorski 
et al., 2003). The endogenous Bdnf allele was replaced with the gene diagramed in 
Figure 2.3. LoxP sites were inserted into the 5’ UTR of the coding exon and 3’ to the 
first polyadenylation site in the 3’ UTR. In addition, three tandem SV40 polyadenylation 
signal sequences were inserted immediately upstream of the second loxP site, followed 
by a lacZ gene (An et al., 2008). The insertion of the exogenous tandem 
polyadenylation sites resulted in truncation of the long Bdnf 3’ UTR, creating a new 
species of mRNA. The short 3’ UTR isoform was found to be unaffected in Bdnfklox/klox 
mice, however the long isoform was found to be absent (An et al., 2008).  The total 
amount of Bdnf mRNA was determined to be equivalent between Bdnfklox/klox and 
wildtype animals, however in situ hybridization revealed marked reduction of dendritic 
localization of Bdnf in both the dendrites of cortical and CA1 neurons (An et al., 2008). 
This corresponded with elevated transcript levels in the soma of both cortical and 
hippocampal regions. Immunoblotting detected no alterations in global levels of either 
pro-BDNF or total-BDNF in the cortex, hippocampus, or striatum of Bdnfklox/klox mice, 
however dendritic targeting of BDNF protein was significantly reduced (An et al., 2008).   
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Figure 2.3 – Diagram of the Bdnfklox allele. The Bdnfklox allele contains one lox P site 
inserted into the 5’ UTR within exon 9 and a sequence containing three tandem SV40 
polyadenylation signals, a lox P site, and a LacZ gene inserted at a site 3’ to the first 
Bdnf polyadenylation site. Image reproduced with permission © Nature Medicine (Liao 
et al., 2012). 
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Immunostaining of cultured hippocampal neurons found that while BDNF protein could 
be detected in distal dendrites of wildtype mice, it was only detectable in proximal 
dendrites of Bdnfklox/klox mice. In addition, BDNF immunofluorescence in cell bodies was 
44% higher in Bdnfklox/klox neurons as compared to wildtype neurons. Secretion of BDNF 
by cultured hippocampal neurons in response to KCl depolarization was impaired in 
Bdnfklox/klox mice (An et al., 2008). Lastly, these mice were backcrossed and maintained 
on a C57BL/6J (B6) genome for 10 generations; a strain often utilized in ethanol 
research due to its proclivity for ethanol consumption. Therefore, these mice provided a 
unique genetic resource where the dendritic localization of an ethanol-responsive gene 
was significantly altered without affecting total transcript or protein levels. Administering 
ethanol and testing the resultant behavioral phenotypes in Bdnfklox/klox mice would 
provide insight to the role of proper transcript targeting in ethanol’s neuronal effects. 
The Bdnfklox/klox mice have been used to investigate certain physiological 
outcomes of reduced dendritic trafficking of Bdnf mRNA. The exhibited phenotypes 
either directly affected the design of experiments presented here, or were considered 
when interpreting the data. Cytoarchitecture and dendritic arborization in the cortex and 
hippocampus of 2 month old Bdnfklox/klox mice was no different from wildtype animals (An 
et al., 2008). However, the dendritic spines of 2 month old Bdnfklox/klox mice were thinner 
and more numerous in CA1 pyramidal neurons. A 20% reduction in spine head 
diameter and a 54% increase in density was observed compared to wildtype neurons 
(An et al., 2008). This altered morphology was confirmed to be the result of reduced 
dendritic BDNF synthesis and not due to increased levels of BDNF in cell bodies by 
using another transgenic mouse, BTg (Huang et al., 1999). BTg mice expressed 2-3 
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fold higher levels of Bdnf mRNA in the dorsal forebrain, which remained restricted to the 
soma (An et al., 2008). BTg mice exhibited average spine head diameter comparable to 
wildtype mice and spine density that was slightly increased, but significantly lower than 
Bdnfklox/klox mice. Further examination of Bdnfklox/klox mice at postnatal day 21 showed no 
difference in spine density as compared to wildtype mice, suggesting that the difference 
observed at 2 months resulted from a deficit in spine pruning, which occurs after the 
third postnatal week in mice (An et al., 2008). Not unexpectedly, Bdnfklox/klox mice 
demonstrated impaired LTP at hippocampal CA1 synapses upon tetanic stimulation of 
the Schaeffer collaterals (An et al., 2008). However Bdnfklox/klox mice exhibited normal 
paired pulse facilitation and synaptic responses to high frequency stimulation, 
phenotypes abnormal in conventional Bdnf knockout mice. There was also no difference 
in LTP recorded in cell bodies of neurons from Bdnfklox/klox mice. 
 Truncation of the long Bdnf 3’ UTR was also found to cause severe obesity. Not 
only were Bdnfklox/klox male mice 171% heavier than sex-matched wildtype mice, they 
also showed longer linear growth, hyperleptinemia, enlarged adipose tissues, and 
impaired glucose homeostasis as a result of marked hyperphagia (Liao et al., 2012). It 
was also shown that young (5-6 weeks), non-obese Bdnfklox/klox mice, which maintained 
similar serum leptin concentration as compared to wildtype, did not respond to a 
repeated dosing regimen of leptin (Liao et al., 2012). Three doses of 3 µg/g of leptin 
over a 24 hour period significantly reduced food intake by wildtype, but had no effect on 
Bdnfklox/klox mice. This was not the result of impaired leptin receptor (LepR) activation, 
but in the ability for leptin-sensing neurons to communicate properly with non-LepR 
expressing cells (Liao et al., 2012). Together, the studies utilizing Bdnfklox/klox mice 
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demonstrated a selective and distinctive function for the long 3’ UTR Bdnf transcript 
preferentially trafficked to the synapse. 
 
Behavioral models for assessing phenotypic responses to ethanol 
Ethanol-induced locomotor activation 
 As mentioned previously, the mesolimbic dopamine pathway has been implicated 
in mediating drug-induced locomotor stimulation (Koob, 1992; Hooks & Kalivas, 1995). 
This system has also been implicated in reward perception, appetitive motivated 
behaviors, novelty/sensation seeking, and impulsivity (Alcaro et al., 2007). Therefore, 
measurement of locomotor activity can be used as a surrogate for phenotypes more 
difficult to assess (Curzon et al., 2009). In human studies, an individual’s initial 
sensitivity to the drug has been shown to be predictive of susceptibility to develop 
alcoholism (Schuckit, 1994), and that this phenotype has a strong genetic influence 
(Heath et al., 1999). Acute administration of ethanol reveals a dose-dependent biphasic 
effect. Low doses of ethanol during the rising phase of the blood ethanol curve cause a 
locomotor activation and higher doses can result in a sedative and even hypnotic 
response. Thus, testing transgenic animals in an acute locomotor dose response 
experiment will evaluate initial sensitivity to a range of ethanol doses. The results of 
which could increase understanding of acute ethanol-mediated signaling events that 
may lead to the genesis of behaviors associated with addition.    
 
 
.  
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Loss of Righting Reflex (LORR) 
Another model of acute sensitivity to ethanol is loss of righting reflex (LORR). 
Rodents administered a hypnotic dose of ethanol, when placed supine, are unable to 
return themselves to a prone position. The amount of time until an animal loses its 
LORR is referred to as latency and the length of “sleep time” is termed duration. 
Duration of LORR is a complex phenotype that is thought to depend on a combination 
of metabolic rate, initial brain sensitivity, and rapid development of functional tolerance 
(Tabakoff & Ritzmann, 1979). Functional tolerance is defined as the brain’s ability to 
adapt in order to compensate for the disruption caused by alcohol (Tabakoff et al., 
1986). When this tolerance develops within a single session, it is referred to as acute 
functional tolerance (Tabakoff et al., 1986). The molecular mechanism of ethanol acute 
functional tolerance is not completely elucidated. However, evidence suggests that 
compensatory adaptation of NMDA receptor function is important for mediating the 
behavior. Acute ethanol is a potent inhibitor of NMDA receptor function (Lovinger et al., 
1989). Nevertheless, administration of ethanol has been shown to increase 
phosphorylation of the NMDA receptor subunit, NR2B, which enhances channel 
function (Miyakawa et al., 1997; Yaka et al., 2002; Yaka et al., 2003a). This modification 
is mediated by the Src family protein tyrosine kinase, FYN. Mice that are homozygous 
null for the Fyn gene (Fyn-/-) have an increased duration of LORR (Miyakawa et al., 
1997). Excitatory postsynaptic potentials (EPSPs) measured in hippocampal slices from 
Fyn-/- mice did not recover from ethanol suppression over time as observed in control 
mice (Miyakawa et al., 1997). It was also shown that administration of the NMDA 
antagonist, ifenprodil, abolished the difference in duration of LORR between the Fyn-/- 
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and control mice (Yaka et al., 2003b) and overexpression of FYN kinase resulted in 
shorter duration of LORR (Boehm et al., 2004). Furthermore, previous work in our lab 
defined a Fyn-LORR gene network from genome-wide basal expression profiling of Fyn-
/- mice PFC that was correlated to Fyn gene expression across the recombinant inbred 
strains, BXD and LXS, along with LORR data across BXDs (Farris & Miles, 2013). 
Functional over-representation analysis of this network identified enrichment of genes 
involved in ion channel activity and localization to the postsynaptic density (Farris & 
Miles, 2013). While the network was populated with genes that had potential roles in 
modulating NMDA receptor activity, there were also genes associated with other 
glutamate-related ion channels and white matter. This suggested additional 
mechanisms that contribute to the high-dose ethanol response that still need to be 
investigated (Farris & Miles, 2013). 
 
Voluntary two-bottle choice paradigm 
Free-choice ethanol consumption is a frequently employed test for general avidity 
of the drug in which animals are presented with one bottle of ethanol and one bottle of 
water for a prescribed amount of time. In the classic paradigm, animals have ad libitum 
access to the two bottles for 24 hours per day. However, manipulations designed to 
obtain high ethanol intake and consequently pharmacologically meaningful blood 
ethanol concentrations have been implemented throughout the literature (Melendez et 
al., 2006; Melendez, 2011; Thiele et al., 2014). These experiments are often used to 
study the genetic and neurobiological mechanisms underlying high ethanol drinking 
behavior through the use of animals models such as selectively bred, inbred, 
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recombinant inbred, and transgenic rodent lines (Crabbe et al., 1992; Li et al., 1993). 
While the paradigm does not inherently test for the rewarding properties of ethanol, it 
has been suggested that there is a positive correlation between ethanol drinking and the 
more formal assessment of reinforcement, operant self-administration (Green & 
Grahame, 2008). Strengthening the argument for validity, the µ-opioid receptor 
antagonist, naltrexone, which is used clinically to treat alcoholism and has been shown 
to decrease cue-induced cravings in alcoholics (Monti et al., 1999), was able to reduce 
ethanol consumption in the two-bottle choice model (Franck et al., 1998; Middaugh & 
Bandy, 2000; Ciccocioppo et al., 2014). However, the effect is often transient, as 
tolerance to naltrexone develops. Acamprosate, another drug used clinically for treating 
alcohol dependence, was also able to diminish voluntary ethanol drinking (Zalewska-
Kaszubska et al., 2008; Oka et al., 2013). Therefore, two-bottle choice drinking provides 
a useful screening test for genetic influences on ethanol consumption.  
  
Conditioned Placed Preference (CPP) 
Perception of the rewarding properties of drugs of abuse can be modeled though 
a Pavlovian conditioned stimulus test known as conditioned place preference (CPP). 
The premise behind CPP is that a learned association is formed between the rewarding 
drug (unconditioned stimulus) and the contextual environment in which it was 
administered (conditioned stimulus). The result of the association is that the conditioned 
stimulus is able to evoke a conditioned motivational response in the absence of the 
unconditioned stimulus, and consequently animals exhibit an increased preference for 
the drug-paired environment. The advantages of this model are that animals are tested 
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in a drug-free state, simultaneous measurement of reward and locomotor activity, 
sensitivity to reward and aversion, simplicity in execution (no need for surgical 
procedures), and utility for probing neural pathways involved in reward (Bardo & Bevins, 
2000; Cunningham et al., 2006). Limitations in the procedure include the confounding 
variables of novelty-seeking, apparatus bias, and general memory impairment (Bardo & 
Bevins, 2000). Additionally, validity of the CPP model for the motivational effects of 
abused drugs is not as robust as with self-administration protocols (Bardo & Bevins, 
2000; Cunningham et al., 2006). However, CPP can yield information regarding the 
rewarding effect of contextual cues associated with a drug stimulus (Bardo & Bevins, 
2000).   
 
Light-Dark Box (LDB) model of anxiety 
The light-dark box (LDB) assay is based upon the spontaneous exploratory 
behavior of rodents which is offset by their natural averseness to novel environments 
and bright light (Crawley & Goodwin, 1980). When placed in an apparatus that provides 
choice between a light or dark compartment, rodents will spend more time and have 
greater locomotor activity in the dark side (Costall et al., 1989; Onaivi & Martin, 1989). 
Clinically-prescribed anxiolytic drugs, such as benzodiazepines, will increase 
locomotion and time spent in the light and decrease latency to transition into the light, 
whereas anxiogenics have the opposite effects (Costall et al., 1989; Imaizumi et al., 
1994a; Imaizumi et al., 1994b).  Therefore, preference for the light side is interpreted as 
an anxiolytic-like phenotype. Ethanol, a drug known to have anxiolytic effects in 
humans, when administered to mice predictably and significantly increases percent time 
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spent (PTS) and percent distance traveled (PDT) in the light. Thus, ethanol-induced 
anxiolytic-like activity provides an additional behavioral measurement of initial response 
to acute ethanol.   
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Chapter 3 – Characterization of the Synaptoneurosome Preparation 
 
 
 
Introduction 
Ever since the pioneering work of Cajal, the morphological polarity of neurons 
has been a major tenet of neuroscience. This specialized structure allows for 
compartmentalized functioning to occur in restricted subcellular domains, such as 
dendritic spines, which are able to respond individually to afferent signals (Holt & 
Schuman, 2013). This spatially limited response advocates the need for local regulation. 
Local synaptic protein synthesis is supported by the finding of synthesis machinery, 
including ribosomes, tRNA, translation factors, endoplasmic reticulum, and Golgi 
apparatus, at postsynaptic sites (Steward & Levy, 1982; Steward & Reeves, 1988). 
Furthermore, through hippocampal in situ hybridization (Lyford et al., 1995; Poon et al., 
2006) and studies characterizing synapse-enriched subcellular fractions (Chicurel et al., 
1993; Rao & Steward, 1993; Poon et al., 2006; Matsumoto et al., 2007) and micro-
dissected neuropil (Cajigas et al., 2012), a number of mRNA species have been 
identified at synapses. Studies using protein synthesis inhibitors have shown that 
protein synthesis is required for behavioral and synaptic plasticity, assumedly for 
establishing enduring modifications (Kang & Schuman, 1996; Steward & Schuman, 
2001). Thus, targeting of specific RNAs to dendrites may be an efficient way of 
localizing proteins involved in synaptic function by establishing local sites for their 
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synthesis and alterations in mRNA transport, stability, or translation could mediate 
synaptic plasticity (Steward & Banker, 1992; Chicurel et al., 1993).  
Synaptoneurosomes which retain resealed postsynaptic elements attached to 
isolated presynaptic terminals theoretically should provide a useful system to investigate 
regulation of the synaptic transcriptome in an in vivo model. Synaptoneurosomes, and 
preparations that enrich for similar synaptic entities, have been used previously to 
identify and evaluate dendritic RNA (Rao & Steward, 1993; Williams et al., 2009). For 
the present study, we adapted a synaptoneurosome preparation from Williams, et al. 
(2009), which had been previously used in a genomic analysis of the synaptic 
transcriptome in PFC of Alzheimer’s patients (Williams et al., 2009). Characterization 
studies to ensure enrichment of synaptic elements that contain synaptically localized 
mRNA were necessary before proceeding with subsequent genomic profiling to 
examine the effect of repeated ethanol exposure on the synaptic transcriptome. 
Through molecular and transcriptomic analyses, we determined that an evaluation of 
transcripts within the synaptoneurosomal P2 fraction and its complementary 
supernatant, S2 would permit a comparison of synaptic and somatic transcriptomes in 
response to exogenous stimuli. 
 
Materials and Methods 
Animals. Characterization of the synaptoneurosome protocol utilized DBA/2J 
(D2) mice purchased from Jackson Laboratories (Bar Harbor, ME) at 8-9 weeks of age. 
All mice were housed 4-5 per cage and had ad libitum access to Teklad standard rodent 
chow (7912, Harlan, Madison, WI) and tap water in a 12-hour light/dark cycle (6 am on, 
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6 pm off). Mice were housed with Teklad corn cob bedding (7092, Harlan, Madison, 
WI)).  All animal procedures were approved by the Institutional Animal Care and Use 
Committee of Virginia Commonwealth University (AM10332) and followed the NIH 
Guide for the Care and Use of Laboratory Animals. 
Synaptoneurosome Preparation. The protocol for preparation of 
synaptoneurosomes was adapted from Williams et al. (2009) (Figure 3.1). Fresh tissue 
from 4 animals was pooled (approximately 0.45 g), manually homogenized utilizing a 
Potter-Elvehjem Safe-Grind® tissue grinder (Wheaton, Millville, NJ), and diluted 1:10 in 
synaptoneurosome homogenization buffer. The buffer consisted of 0.35 M nuclease 
free sucrose (Acros Organics, NJ), 10 mM HEPES (Life Technologies, Carlsbad, CA), 
and 1 mM EDTA (Ambion, Carlsbad, CA), which was brought to a pH of 7.4 and filter 
sterilized. Immediately before use, 0.25 mM DTT (Fisher Scientific, Waltham, MA), 30 
U/ml RNase Out (Invitrogen, Carlsbad, CA), and 1x protease inhibitor cocktail 
containing AEBSF, Aprotinin, Bestatin, E64, Leupeptin, and Pepstatin A (Halt, Thermo 
Scientific, Rockford, IL), was added to the buffer. Centrifugation of whole homogenate 
(WH) at 500 x g for 10 minutes at 4˚C removed nuclei and cellular debris, yielding pellet, 
P1 and supernatant, S1. The S1 fraction was passed through a series of nylon filters 
with successively decreasing pore sizes of 70, 35, and 10 µm (SEFAR, Buffalo, NY). 
The filtrate was then re-suspended with 3 volumes of homogenization buffer, and 
centrifuged at 2000 x g for 15 minutes at 4˚C to yield the synaptoneurosome enriched 
pellet, P2 and supernatant, S2. Fractions were frozen on dry ice and then stored at -
80˚C until further processing. 
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Figure 3.1 – Schematic depicting synaptoneurosome preparation. Whole 
homogenate (WH) processed from pooled frontal pole tissue of 4 mice was used in the 
centrifugation/filtration scheme depicted here. The initial pellet (P1) contained cellular 
debris and nuclei. The supernatant from the initial centrifugation (S1) was filtered and 
subjected to a second centrifugation. The pellet, P2, was enriched for synaptic elements 
and dendritically targeted RNA as compared to the supernatant, S2, which contained 
the remainder of the somatodendritic RNA.   
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Transmission Electron Microscopy (TEM). Morphological integrity of 
synaptoneurosomes was confirmed by transmission electron microscopy (TEM) 
performed by Dr. John Bigbee. A 1 ml aliquot of S1 supernatant was centrifuged at 
2000 x g for 15 minutes to produce a pellet. P1, P2, and the pelleted S1 fractions were 
washed in PBS and centrifuged at 2000 x g for 8 minutes. The supernatant was 
decanted and pellet was fixed with 2% glutaraldhehyde in 0.1 M sodium cacodylate 
buffer at room temperature. After initial fixation, the sample was rinsed in 0.1 M 
cacodylate buffer for 5-10 minutes and then post-fixed in 1% osmium tetroxide in 0.1 M 
cacodylate buffer for 1 hour, followed by another 5-10 minutes rise in 0.1 M cacodylate 
buffer. Preparation continued with a serial dehydration with ethanol: 50%, 70%, 80%, 
95% - for 5-10 minutes each, followed by 100% ethanol for 10-15 minutes (3x), and 
incubation in propylene oxide for 10-15 minutes (3x). The sample was then infiltrated 
with a 50/50 mix of propylene oxide and PolyBed 812 resin (Polysciences, Inc., 
Warrington, PA) overnight, which was then replaced with pure resin once again 
overnight. The sample was embedded in a mold, placed in a 60˚C oven overnight, and 
then sectioned with a Leica EM UC6i Ultramicrome (Leica Microsystems, Wetzlar, 
Germany), stained with 5% Uranyl acetate and Reynold’s Lead Citrate, and examined 
on JEOL JEM-1230 transmission electron microscope (JEOL USA, Inc., Peabody, MA). 
Images of various magnifications (2,000x – 10,000x) were captured with the Gatan 
Ultrascan 4000 digital camera (Gatan, Inc., Pleasanton, CA). 
DAPI Staining. Aliquots from each fraction of the synaptoneurosomal preparation 
were examined for the presence of contaminating nuclei using 4’, 6-diamidino-2-
phenylindole (DAPI) staining. 5 µl of WH, S1, and reconstituted P1 and P2 were 
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smeared onto microscope slides, allowed to air dry for 10 minutes, and were fixed in 
ice-cold acetone for 5 minutes. Specimens were mounted using DAPI containing media 
(Vectasheild, Burlingame, CA) and a cover slip. Ultraviolet light was used for DAPI 
excitation and emission was detected by Olympus IX-70 fluorescent microscope 
(Olympus America Inc., Tokyo, Japan) at 461 nm. Representative fields at 20x 
magnification were assessed for nuclear content. 
Immunoblotting. Pellets (P1 and P2) and liquid aliquots (WH, S1, and S2) from 
synaptoneurosomal preparations were used to perform semi-quantitative 
immunoblotting. Pellets were triturated with NuPAGE lithium dodecyl sulfate (LDS) 
sample buffer (Life Technologies, Carlsbad, CA) diluted to 1x and containing 1x 
proteinase inhibitor cocktail (Halt, Thermo Scientific, Rockford, IL), while liquid aliquots 
were lysed directly with 4x LDS with added proteinase inhibitor. Samples were 
sonicated on ice water until samples were no longer viscous. Protein concentrations 
were determined using the bicinchoninic acid (BCA) assay (Thermo Scientific, Rockford, 
IL). Sample concentrations were balanced using 1x LDS, 10x NuPAGE reducing agent 
(Life Technologies, Carlsbad, CA) and boiled for 10 minutes. For each 
synaptoneurosome fraction, 10 µg of protein was loaded per lane on a 10% and on a 
4% - 12% gradient NuPAGE bis-tris gel (Life Technologies, Carlsbad, CA). 
Electrophoresis was performed at 150V followed by transfer to 0.45 µm nitrocellulose 
membrane for 1.5 hours at 30V on ice. Membranes were incubated with Ponceau S for 
10 minutes, and densitometric analysis of staining was performed using ImageJ 
processing and analysis software (National Institutes of Health). Prior to primary 
antibody incubation, the membranes were blocked with 5% non-fat dried milk in 1x Tris-
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Buffered Saline with Tween 20 (TBST) for 45 minutes. Primary and secondary antibody 
catalog numbers, dilutions, and incubation times are provided in Table 3.1. Immunoblots 
were visualized on GeneMate Blue Autoradiography film (BioExpress, Kaysville, UT) 
using the Amersham ECLWestern Blotting Detection Reagent (GE Healthcare Life 
Sciences, Pittsburgh, PA) and quantified using ImageJ. All detected proteins were 
normalized to the total protein loaded per well as measured by Ponceau S staining. 
Statistical analysis of immunoblot data was performed by one-way ANOVA across 
synaptoneurosome fractions followed by Tukey’s post-hoc analysis. Fold change 
between P2 and WH was also examined. 
Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR). 
Synaptoneurosomal fractions were assayed for transcripts with known subcellular 
localizations using qRT-PCR. Three preparations were preformed to provide biological 
replicates of the fractions. Total RNA was isolated from aliquots of WH (0.5 ml) and S1 
(0.75 ml) and from P1, P2, and S2 fractions in their entirety using the 
guanidine/phenol/chloroform method (Stat-60, Tel-Test Inc., Friendswood, TX) and a 
Tekmar homogenizer as per the STAT-60 protocol. RNA concentration and quality was 
determined using the SmartSpec 3000 (Bio-Rad, Hercules, CA) and the Experion 
Automated Electrophoresis Station (Bio-Rad, Hercules, CA). All RNA samples had RNA 
quality indices (RQI) ≥ 7.9, and 260/280 ratios were between 1.86 and 2.04. cDNA was 
generated from 995 ng of total DNase-treated RNA and 5 ng of luciferase mRNA 
(Promega, Madison, WI) using Deoxyribonuclease I (Invitrogen, Carlsbad, CA) and the 
iScript cDNA kit (Bio-Rad, Hercules, CA) according to manufacturer’s instructions. qRT-
PCR was performed using the iCycler iQ system (Bio-Rad, Hercules, CA) according to
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manufacturer’s instructions for iQ SYBER Green Supermix (Bio-Rad, Hercules, CA). 
Primer sequences, annealing temperatures, amplicon sizes, and cDNA dilutions used 
for each gene are listed in Table 3.2. Relative expression was calculated by comparing 
Ct values to a standard curve produced from WH cDNA (diluted 1:5, 1:25, 1:125, 
1:625). Statistical analysis of qRT-PCR data was performed using a one-way ANOVA 
across all fractions and by Student’s t-test between P2 and S2 fractions. 
Small RNA qRT-PCR. The profile of selective small RNAs was assessed in P2 
and S2 fractions of synaptoneurosomal preparations acquired from behaviorally 
sensitized mice (refer to Chapter 4 Materials and Methods). Pre-formulated TaqMan® 
primer/probe sets for small RNA detection (Life Technologies, Carlsbad, CA) were used 
to evaluate the levels of miR-149, miR-134, and miR-9 according to manufacturer’s 
instructions. Briefly, individual reverse transcription reactions were set up using unique 
hairpinned primers that recognize a specific small RNA, MultiScribe™ reverse 
transcriptase, and 5 ng total RNA in a 15 µL reaction. cDNA was stored at -20˚C until 
the amplification reaction was prepared in triplicate using TaqMan® Universal PCR 
Master Mix II. The 5’end of the TaqMan® probes, which anneals specifically to a 
complementary sequence between the forward and reverse primer, are linked to FAM™ 
reporter dye. When DNA polymerase cleaves the probe during transcription of target, 
the reporter dye is separated from the non-fluorescent quencher dye, and detection can 
occur. Samples were analyzed using the iCycler iQ system (Bio-Rad, Hercules, CA). 
The PCR protocol was 95˚C for 10 minutes, followed by 50 cycles of 95˚C for 15 
seconds, 60˚C for 60 seconds. Statistical analysis was performed using a Student’s t-
test between fractions for each small RNA.
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Microarray Sample Preparation, Hybridization and Scanning. Genomic 
expression analysis of P2 and S2 fractions of synaptoneurosomal preparations acquired 
from behaviorally sensitized mice (refer to Chapter 4 Materials and Methods) was 
performed using microarrays. Total RNA was isolated using the 
guanidine/phenol/chloroform method (Stat-60, Tel-Test Inc., Friendswood, TX) and a 
Tekmar homogenizer as per the STAT-60 protocol. RNA concentration was determined 
by measuring absorbance at 260 nm and RNA quality was assessed by electrophoresis 
on an Experion Analyzer (Bio-Rad, Hercules, CA) and 260/280 absorbance ratios. All 
RNA samples had RQI ≥ 7.6, and 260/280 ratios were between 1.97 and 2.06. Total 
RNA (100 ng) from each sample, spiked with poly-A RNA controls (Affymetrix, Santa 
Clara, CA), was used to generate amplified sense-strand cDNA utilizing the Ambion® 
WT Expression Kit (Life Technologies, Carlsbad, CA) according to the manufacturer’s 
instructions. Using GeneChip® WT Terminal Labeling Kit (Affymetrix, Santa Clara, CA), 
purified cDNA was fragmented and biotin-labeled, followed by hybridization along with 
biotin-labeled hybridization controls to GeneChip® Mouse Gene 1.0 ST Arrays 
(Affymetrix, Santa Clara, CA) and scanning with Affymetrix GeneChip Scanner 3000 
according to standard Affymetrix protocols. To avoid non-biological experimental 
variation that arises from sample batch structure, supervised randomization of samples 
into batches prior to each processing stage (RNA extraction, cRNA synthesis, and 
hybridization) was performed.  
Microarray Data Analysis. Expression data from the S2 and P2 fractions were 
background corrected, quantile normalized, log2 transformed, and fit to a linear model 
using the robust multi-array average (RMA) expression measure (Irizarry et al., 2003).  
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Microarray quality was assessed by inspecting the frequency distributions of log-
transformed probe intensity values and by reviewing quality assessment metrics and 
graphs available from Expression Console™ software (Affymetrix, Santa Clara, CA). All 
arrays had pos_vs_neg_auc values (a metric that evaluates how well signal is 
separated from noise) greater than 0.92. Differential expression of genes across 
synaptoneurosomal fractions was assessed using linear models for microarray data 
(Limma) analysis (Smyth, 2004) using the Bioconductor package in the statistical 
platform, R (Team, 2011). For the comparison between fractions, false discovery rate 
(FDR) was set equal to 0.05. 
RNA-Seq Library Preparation and Sequencing. Total RNA isolated for microarray 
analysis was subsequently used for RNA-Seq performed by the VCU Genomics Core 
Laboratory. The preparation of cDNA libraries was conducted following standard 
protocols using TruSeq RNA Sample Preparation Kit (Illumina, San Diego, CA). Briefly, 
mRNA was isolated from total RNA using poly-T oligo-attached magnetic beads. The 
mRNA was then fragmented in the presence of divalent cations at 94˚C. The 
fragmented RNA was converted into double stranded cDNA and the ends polished 
using T4 and Klenow DNA polymerases, with an adenine base added to the 3’ ends 
followed by ligation of Illumina specific adaptors. The adaptor-ligated DNA was 
amplified with 15 cycles of PCR and purified using QIAquick PCR Purification Kit 
(Qiagen, Venlo, Netherlands). Library insert size was determined using an Agilent 
Bioanalyzer. Library quantification was performed by qRT-PCR assay using the KAPA 
Library Quant Kit (KAPA, Wilmington. MA). RNA-Seq libraries were analyzed using 
Illumina TruSeq Cluster V3 flow cells and TruSeq SBS Kit V3 (Illumina, San Diego, CA), 
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with six libraries of different indices pooled together in equal amounts loaded on to a 
single lane at a concentration of 13 pM and sequenced (2 x 100 paired end reads) on a 
Illumina HiSeq 2000. A summary of metrics that describe the RNA-Seq data can be 
found in Table 3.3. Once again, supervised randomization of samples prior to each 
processing stage (RNA extraction, library amplification, and lane assignment) was 
performed. 
RNA-Seq Alignment, Transcript Assembly, Quantification and Differential 
Expression Analysis. Fastq formatted sequences generated on the Illumina HiSeq 2000, 
were mapped to the mouse reference genome (mm10) that had been edited for single 
nucleotide polymorphism (SNPs) between the C57BL/6 (B6) and DBA2/J (D2) strains 
(Williams, University of Tennessee) using Spliced Transcripts Alignment to a Reference, 
or STAR (v2.3.0) (Dobin et al., 2013). The STAR algorithm consists of two phases: a 
seed searching phase and a clustering and scoring phase. The seed searching process 
is itself a two-part process. First, a sequential search of the reference genome is 
conducted to find the highest quality match to the read. Once this match is determined, 
a second sequential search of the reference is conducted using any unmapped portion 
of the reads if necessary. During the clustering process, STAR constructs full-length 
alignments of the reads by merging the hits detected by the first phase. BLAST-like 
local alignment scoring controls the process, which allows STAR to tolerate sequence 
mismatches as well as insertions and deletions relative to the reference.  
To assemble transcripts and estimate abundance, BAM files from STAR and the 
annotated reference genome were analyzed using Cufflinks (v2.1.1, 
http://cufflinks.cbcb.umd.edu/) (Trapnell et al., 2010). Once transcripts were assembled, 
 51 
 
 
 52 
 
their abundances were estimated by counting the number of aligned reads contained 
within a transcript, and normalizing to both the size of the transcript and to the total 
number of aligned reads in the sample (Fragments Per Kilobase of exon per Million 
fragments mapped, FPKM). It should be noted that for paired end reads a read pair was 
counted as a single fragment. Cuffmerge was then used to merge all transcriptome 
assemblies, generating common IDs for each transcript, which were then tested for 
differential expression using Cuffdiff, which calculates pairwise comparisons of gene 
expression. For the comparison between fractions, false discovery rate (FDR) was set 
equal to 0.05.  
Bioinformatics analysis. Integrative functional genomics analysis was performed 
using Gene Weaver (geneweaver.org) (Baker et al., 2012), a curated repository of 
genomic experimental results. This web-based software allows users to evaluate gene 
set interactions and facilitates the assessment of gene set similarity through 
computation of the Jaccard Coefficient (size of the interaction divided by size of the 
union of the sample set). Independence between gene lists was additionally measured 
using Fisher’s exact test in the statistical platform, R (Team, 2011) and by calculating 
the representation factor (RF) for overlap 
(http://nemates.org/MA/progs/overlap_stats.html). RF is the number of overlapping 
genes divided by the expected number of overlapping genes drawn from two 
independent groups. The expected number of overlapping genes is equal to the product 
of genes in both groups divided by the total number of genes in the genome. A RF > 1 
indicates more overlap than expected of two independent groups.  
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Functional enrichment analysis was performed using ToppFun, a functional 
enrichment application available as part of the ToppGene suite of web based 
applications (toppgene.cchmc.org) (Chen et al., 2009). Mouse gene symbols were 
submitted and analyzed for over-representation of genes that belong to Gene Ontology 
(GO) categories (molecular function, biological processes, and cellular component). To 
enhance informativeness of results, top ranked terms were filtered to remove broad and 
redundant definitions. Only categories that were comprised of greater than 3 and fewer 
than 400 genes were included, removing those that contained exactly the same query 
list as another term already listed in the displayed results. 
MicroRNA Arrays. Total RNA isolated for the purpose of genomic expression 
profiling by microarray and RNA-Seq analyses was further assayed to characterize the 
complement of microRNAs present at the synapse (P2 samples) and compare to the 
microRNAs present in the somatic-RNA containing fraction (S2 samples). Samples 
were prepared using the FlashTag™ Biotin HSR RNA Labeling Kit (Affymetrix, Santa 
Clara, CA) in accordance to manufacturer’s instructions. Total RNA (250 ng) from each 
sample, spiked with control oligos, was subjected to poly (A) tailing and biotin labeling. 
Qualitative assessment of proper target labeling was performed using an enzyme-linked 
oligosorbent assay (ELOSA). Samples were hybridized to GeneChip® miRNA 3.0 
Arrays (Affymetrix, Santa Clara, CA) and scanned with the Affymetrix GeneChip 
Scanner 3000 according to standard Affymetrix protocols. Supervised randomization of 
samples into batches for RNA labeling and hybridization was performed. Data were 
summarized using the RMA algorithm and probe sets consistently called ‘absent’ across 
all samples using Detection Above Background’ (DABG) p-values were removed 
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(McClintick & Edenberg, 2006). Differential expression between fractions was evaluated 
using the rank-based permutation method statistical analysis of microarrays (SAM) 
(Tusher et al., 2001) setting the false discovery rate (FDR) at 0.01.  
 
Results 
Molecular characterization of the synaptoneurosome preparation. 
 Before the synaptoneurosomal preparation was used to investigate response of 
the synaptic transcriptome to repeated ethanol exposure, a molecular characterization 
was undertaken to establish enrichment of synaptic elements in the P2 fraction. The 
presence and morphological integrity of synaptoneurosomal structures within the P2 
fraction was confirmed by transmission electron microscopy (TEM). The characteristic 
synaptoneurosomal profile consists of an intact presynaptic terminal with distinguishable 
synaptic vesicles and postsynaptic element with well-preserved postsynaptic density 
(Figure 3.2, a). An average (mean ± SD) of 20 ± 5 (n = 4) synaptoneurosomal structures 
was identified per 130 square micron field of the P2 fraction. Detected within the 
synaptoneurosomes were structures consistent with the size and density of 
polyribosomes (Figure 3.2, b). As suggested previously (Williams et al., 2009), the intact 
pre- and postsynaptic terminals, identified by TEM, provides for selective extraction of 
synaptic mRNAs. Aliquots of the P1 fractions were also analyzed (Figure 3.2, c). 
Prominent features included nuclei, myelin structure, and blood vessels. 
Synaptoneurosomal structures were also identified within the P1. While electron 
microscopy provides visual detection of synaptoneurosomes, it is not a suitable method 
to evaluate the purity of the preparation since unequivocal identification requires the 
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Figure 3.2 – Representative electron micrographs from P2 and P1 fractions. 
Characteristic synaptoneurosomal profiles in the P2 fraction were observed at (a) 
10,000x magnification and (b) 8,000x magnification. Postsynaptic densities are labeled 
by red arrows and presynaptic elements with synaptic vesicles can be observed 
immediately adjacent. Polyribosome structures are highlighted by red circles. The P1 
fraction (c) at 1,500x magnification contains prominent nuclei and myelin structure.   
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Figure 3.3 – DAPI staining of synaptoneurosome fractions. 4’, 6-diamidino-2-
phenylindole (DAPI) staining of DNA across the fractions indicated that most, if not all 
the nuclei were removed in the initial centrifugation step to produce the P1 pellet. All 
images were captured at 20x magnification. 
 
  
WH P1 
S1 P2 
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plane of the section to cut through both the pre- and postsynaptic elements. Enrichment 
was better ascertained through other quantitative methods. 
Presence of residual nuclei throughout synaptoneurosomal fractions was 
assessed by DAPI staining (Figure 3.3). No fluorescent signal was detected in any of 
the representative fields captured from P2 samples, and little to no DAPI staining was 
observed in the S1 supernatant from which P2 fractions were obtained. Most, if not all, 
nuclei were observed densely packed in the P1 fraction, produced during the initial 
centrifugation step. Concern over loss of synaptic elements during the first 
centrifugation prompted a change in protocol, from 1000 x g to 500 x g. To ensure that 
this modification in procedure did not result in greater nuclear contamination, 
synaptoneurosomal preparations were performed using both speeds and resulting P1 
and P2 fractions were compared (Figure 3.4). DAPI staining was not detected in P2 
fractions from either preparation. Therefore, to prevent the potential loss of synaptic 
structures, the slower centrifugation speed was chosen for subsequent preparations.   
One method used to ascertain purity of the preparation and to verify enrichment 
was immunoblotting for subcellular protein markers (Figure 3.5). Due to the fractionating 
nature of the protocol, a priori determination of a proper loading control was impossible. 
Therefore, immunoreactivity for each protein was quantitated by densitometry and 
normalization to total protein loaded in each lane as measured by Ponceau S staining. 
Histone 4 (H4), a marker for the nuclear component, was detected only in the WH and 
P1 fraction. Lactate dehydrogenase (LDH), an abundant and ubiquitous protein used as 
the maker for the cytosolic component, was detected uniformly across all fractions. 
There was a significant increase in postsynaptic density protein 95 (PSD95) in the P2   
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Figure 3.4 – Comparison of synaptoneurosomal preparation centrifugation 
speeds by DAPI staining. (a) P1, 1000 x g (b) P2, 1000 x g (c) P1, 500 x g (d) P2, 500 
x g. All images were captured at 20x magnification.  
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Figure 3.5 – Immunoblotting of subcellular protein markers across 
synaptoneurosome fractions. (a) Representative immunoblot images (b) 
quantification of H4 (F[4,10] = 125.3, *p < 0.01 compared to WH, #p < 0.01 compared to 
P1) (c) quantification of LDH (F[4,10] = 0.5492) (d) quantification of PSD95 (F[4,10] = 
11.09, *p < 0.05 compared to P2) (e) quantification of SYT (F[4,10] = 9.828, *p < 0.05 
compared to S2). Statistical analysis for each protein was performed by one-way 
ANOVA, followed by Tukey’s HSD post-hoc, n = 3.  
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fraction, with a 4.6 fold enrichment compared to the WH. This enrichment of PSD95 in 
the synaptoneurosomal fraction is greater than what has been observed in previous 
publications, including the study this present protocol was adapted from, which only 
obtained 2.3 fold enrichment. (Villasana et al., 2006; Williams et al., 2009). The level of 
presynaptic marker, synaptotagmin (SYT), was significantly greater in the P2 fraction as 
compared to the S2, but there was no significant enrichment compared to the WH. This 
might suggest some loss of presynaptic elements in the P1. Together with the DAPI 
staining results, these data indicate P2 fractions contain synaptic elements enriched for 
synaptic protein markers as compared to the complementary supernatant fraction, S2, 
and are devoid of appreciable nuclear contamination.  
To further ensure purity of the synaptoneurosomal preparation and to determine 
enrichment of known synaptically targeted transcripts, qRT-PCR was performed. 
Normalization to a cohort of endogenous control genes is currently the most accurate 
method to correct for potential biases that result from input or reaction efficiency. Ideal 
control genes are abundantly and consistently expressed across all sample types in the 
experimental design. Once again, since the objective of the synaptoneurosome 
preparation is distribution of mRNA species between the fractions based on subcellular 
location, it was assumed that typical housekeeping genes would not fulfill their intended 
purpose. Alternatively, an exogenous internal reference mRNA, luciferase, was added 
to the cDNA synthesis reaction. Detection of this reference transcript with primers 
designed by Johnson et al. (2005) was used to control for the losses and inefficiencies 
of downstream processing (Johnson et al., 2005). Transcripts known to be synaptically 
targeted, Camk2a and Arc (Burgin et al., 1990; Link et al., 1995; Lyford et al., 1995)  
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Figure 3.6 – qRT-PCR profile across synaptoneurosome fractions. (a) Camk2a 
(F[4,10] = 3.170, p = 0.0632, t[4] = 7.996, *p = 0.0013 compared to P2). (b) Arc (F[4,10] 
= 1.008, p = 0.4479, t[4] = 1.301, *p = 0.2631 compared to P2). (c) Gapdh (F[4,10] = 
2.968, p = 0.0742, t[4] = 1.301, *p = 0.0190 compared to P2). (d) Snrpn (F[4,10] = 
1.845, p = 0.1969, t[4] = 2.823, *p = 0.0477 compared to P2). (e) Gfap (F[4,10] = 3.642, 
p = 0.0443, t[4] = 4.933, *p = 0.0079 compared to P2). (f) Rn18s (F[4,10] = 3.022, p = 
0.0711, t[4] = 3.835, *p = 0.0185 compared to P2). Statistical analysis for each gene 
was performed by one-way ANOVA across all fractions and a Student’s t-test between 
P2 and S2 fractions, n = 3. 
c 
e 
d 
f 
a b 
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(Figure 3.6, a, b), as well as somatically restricted transcripts, Gapdh and Snrpn (Litman 
et al., 1994; Poon et al., 2006) (Figure 3.6, c, d) were assayed across all 
synaptoneurosomal fractions. Gfap, a prototypical astrocyte marker, and Rn18s, a 
ribosomal RNA, were also analyzed for further characterization of the preparation 
(Figure 3.6, e, f). These analyses were underpowered for detection of significant 
differences in transcript abundance when comparing all fractions. Nevertheless, the 
results produced a profile that depicted a pattern of differential expression between the 
P2 and S2 fractions. A Student’s t-test to compare these fractions alone revealed 
significant differences in the expression of all genes, except Arc, which had a high level 
of variability. These results confirmed that subsequent genomic analyses should focus 
on differences between the P2 and S2 fractions.  
 To observe the percentage of total RNA present in each fraction and determine 
the approximate yield obtained from the synaptoneurosomal protocol, the three 
preparations from the qRT-PCR analysis were analyzed. An approximate value for total 
RNA present in the initial whole homogenate was extrapolated by multiplying the mass 
of RNA obtained from an aliquot of WH by the volume of buffer added in the initial step. 
The percent yield was estimated from the sum of the total RNA measured from each 
fraction. From the three preparations performed, an average (mean ± SD) yield of 
75.8% ± 8.4 was attained. Using the sum of RNA from each fraction as an actual 
starting quantity, the percentage of total RNA present in the WH and S1 aliquots and 
P1, P2, and S2 fractions were calculated as (mean ± SD) 15.1 ± 2.2, 15.6 ± 2.7, 39.1 ± 
8.4, 6.0 ± 1.7, and 24.2 ± 3.5 %, respectively. On average (mean ± SD), the yield of 
RNA isolated from the P2 fraction was 17.5 ± 3.4 µg per 0.45 g of starting tissue wet 
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weight. This quantity was greater than the amount obtained from Williams et al. (2009), 
which achieved a yield of 10 µg synaptoneurosomal RNA from 1 g of tissue.  
 
Transcriptomic characterization of synaptoneurosome preparation.  
 Synaptoneurosomal fractions were prepared from the tissue of mice subjected to 
the ethanol behavioral sensitization paradigm (refer to Chapter 4 Materials and 
Methods) for the purpose of investigating the effect repeated ethanol exposure has on 
the synaptic transcriptome. These samples also provided the opportunity to further 
characterize the populations of RNA acquired from P2 and S2 fractions at the level of 
the entire transcriptome. Following RNA isolation and prior to preparation for microarray 
analysis, automated electrophoresis was performed to ascertain the quality of RNA from 
each sample. Figure 3.7, a, is a representative virtual gel which provides visualization of 
the molecular weight distribution of total RNA. Invariably, the P2 fractions appeared to 
be enriched for small molecular weight RNAs. Since it is known that microRNAs and 
their regulatory machinery are present in dendritic spines (Lugli et al., 2005; Lugli et al., 
2008) and the low molecular weight bands consistently observed in the P2 fractions 
corresponded to the typical distance traveled by microRNAs on the automated 
electrophoretic gels, it was hypothesized that this enrichment consisted of microRNAs 
trafficked to the synapse for the purpose of local translation regulation. To examine 
microRNA distribution between the P2 and S2 fractions, qRT-PCR was performed using 
TaqMan® primers and probes selective for mir-149, mir-134, and mir-9 (Figure 3.7, b). 
Primers for miR-134 were used because this regulatory RNA is known to be present 
and function at the synapse (Schratt et al., 2006). miR-9 was assayed since it has been  
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Figure 3.7 – Enrichment of small molecular weight RNAs in the P2 fraction (a) 
Representative virtual electrophoretic gel that shows distribution of total RNA isolated 
from synaptoneurosome fractions, P2 and S2. Lanes loaded with P2 samples are 
highlighted by the red boxes, and the enrichment of small molecular weight RNAs is 
indicated by the red arrow. (b) microRNA qRT-PCR results: miR-149 (t[6] = 5.511, p = 
0.0015); miR-134 (t[6] = 6.324, p = 0.0007); miR-9 (t[6] = 3.521, p = 0.0125). Statistical 
analysis for each microRNA was performed by a Student’s t-test between P2 and S2 
fractions, n = 4. 
    L  P2 S2 S2  S2 P2 S2  S2 P2  S2 P2  P2 S2 
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shown to be regulated by ethanol (Pietrzykowski et al., 2008). The assay for mir-149 
had previously been used and validated in the laboratory. There was a significant 
increase in the level of these microRNA species in P2 versus S2 samples. These 
results prompted a global survey of the microRNA population using Affymetrix 
GeneChip® miRNA 3.0 arrays. SAM analysis, with an FDR correction set at 1%, 
identified 693 microRNAs that were differentially expressed between the fractions. Of 
these, 383 and 310 microRNAs were found enriched for in the P2 and S2 fractions, 
respectively (Supplemental Tables S3.1, S3.2). Chi squared analysis found a deviation 
from the null hypothesis frequency of 50%, indicating a significantly greater number of 
genes enriched for in the P2 (χ2 = 7.690, df = 1, p = 0.0056).  
Once it was determined that the total RNA from P2 and S2 fractions had passed 
quality assurance measures, preparation of labeled targets for microarray analysis 
followed the protocol outlined in Figure 3.8, a. Starting with 100 ng of total RNA, each 
sample was spiked with poly-A RNA controls which permits monitoring of the entire 
target synthesis and labeling procedure. The quantity of anti-sense cRNA produced at 
an intermediary step was assessed revealing a significant reduction in the yield from S2 
samples, despite using the exact same amount of starting material for both fractions 
(Figure3.8, b). Equal quantities of cRNA (10 µg) from each sample were used for 
subsequent reactions. The final product, labeled and fragmented cDNA, was spiked 
with hybridization controls and incubated on the microarray platform, allowing for 
hybridization between targets and probes. Despite equivalent amounts of labeled cDNA 
being added to each chip, a constant dissimilarity in overall fluorescent intensity 
between P2 and S2 fractions could be observed when looking at the digital images of  
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Figure 3.8 – Distinct RNA populations between P2 and S2 fractions affect 
microarray sample preparation. (a) Schematic of the protocol for microarray sample 
preparation. Image adapted from the Ambion® WT Expression Kit manual. (b) In vitro 
transcription cRNA yields (Student’s t-test, t[30] = 14.94, p < 0.0001, n = 16) (c) 
Representative P2 and S2 sample DAT files, which store intensity calculations as pixel 
values. 
  
100 ng starting material  
+ polyA spike-in controls 
10 µg cRNA is used for 
subsequent reactions  
5.5 µg of cDNA is used 
for subsequent 
reactions  
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the microarray (Figure 3.8, c). Concern that such disparity in signal intensity was the 
result of non-hybridizable material in the P2 that would prevent proper data 
normalization prompted a reanalysis by RNA-Seq. This methodology relies on next-
generation sequencing which provides direct read counts of target RNA, ideally 
bypassing the potential bias that results from hybridization in the microarrays. The 
objectives of this analysis were: a) use RNA-Seq results to calculate a normalization 
factor that could be applied to the microarray intensity values b) compare and validate 
differential expression results obtained from the differing technologies. 
To calculate a normalization factor, RNA-Seq results were filtered to provide a 
set of genes whose expression was not dependent on fraction. Genes were removed 
that had greater than 10% fold change and p-values less than 0.50 between P2 and S2 
fractions. Additionally, low abundance genes (maximum FPKM less than 1 across all 
samples) were discarded. This provided a set of 193 genes that were stably expressed 
between the two fractions that were also present on the GeneChip® Mouse Gene 1.0 
ST Arrays. By plotting the log2 transformed RMA microarray values for P2 versus S2 for 
this gene set, linear regression would indicate the degree to which the standard 
normalization scheme was amiss and the slope of the line of best fit could be used as a 
proper normalization factor (Figure 3.9). The resulting slope equaled 1.02, indicating 
that these genes were found to be equally distributed between P2 and S2 by both RNA-
Seq and microarray analyses. This suggested that the RMA algorithm used for 
normalization of microarray data was able to properly correct for the large RNA 
population differences between P2 and S2 samples.  
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Figure 3.9 – Microarray normalization factor determination. S2 fraction RMA values 
plotted against P2 fraction RMA values for genes whose expression was found not be 
dependent on fraction by RNA-Seq. A significant correlation was found between S2 and 
P2 expression (F{1, 237] = 14520, p < 0.0001). The slope of the line of best fit suggests 
no further normalization is required for RMA values calculated from P2 and S2 samples 
together.  
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 RNA-Seq and microarrays both provide a genomic view of expression, yet their 
detection methods depend on distinct molecular principles. Calculated expression 
values for microarrays (RMA) and RNA-Seq (FPKM) for all genes can be found in 
Supplemental Tables 3.3, S3.4. Figure 3.10, a compares the number of fraction level 
significant genes as determined by the separate assays (Supplemental Table S3.5). 
The ability of RNA-Seq and microarrays to detect genes putatively enriched in the 
synaptic transcriptome was examined by looking at the number genes with greater 
expression in the P2 fraction compared to the S2 (Figure 3.10, b). Strikingly, there was 
an overlap of 1,945 genes enriched in the P2 fraction in both the microarray and RNA-
Seq analyses (Supplemental Table S3.6). This overlapping set of genes was used for 
subsequent bioinformatics analyses to determine the underlying biological function of 
P2 enriched transcripts. Significant overlap with genes found through deep sequencing 
of RNA obtained from micro-dissected rat hippocampal neuropil structure (Cajigas et al., 
2012) and gene products present in the mouse postsynaptic proteome (Collins et al., 
2006) suggests a portion of the genes contained within the P2 fraction have been 
validated to be present or functioning in the synapse (Figure 3.11). Further evidence of 
this comes from functional enrichment analysis where the top ontological categories 
overrepresented in the P2 enriched gene list relate to neurotransmission and the 
synaptic compartment (Table 3.4) which contrasts from the somatic functions of the 
genes expressed in the S2 (Table 3.5, Supplemental Table S3.7).  The complete list of 
functional enrichment categories for both the P2 fraction and S2 enriched genes can be 
found in Supplemental Tables S3.8, S3.9. The top 50 enriched genes from the P2 and  
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Figure 3.10 – Venn diagrams for P2 versus S2 fraction significant genes. (a) Total 
number of genes determined to be significantly different (q < 0.05) between P2 and S2 
fractions by microarray Limma and RNA-Seq Cuffdiff analyses. Significance of overlap 
was measured by Fisher’s exact test (p < 2.2 x 10-16, odds ratio = 0.65), Jaccard 
Coefficient (J = 0.4835, p < 0.01), and Representation Factor (RF = 2.3, p < 1.2 x 10-
238). (b) Number of genes enriched in the P2 fraction as determined by microarray 
Limma and RNA-Seq Cuffdiff analyses. Fisher’s exact test (p < 2.2 x 10-16, odds ratio = 
3.71), Jaccard Coefficient (J = 0.4833, p < 0.01), and Representation Factor (RF = 5.4, 
p < 1.2 x 10-238). 
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Figure 3.11 – Venn diagram depicting overlap between synapse related data sets. 
Significant overlap was found between the P2 enriched gene list and the postsynaptic 
proteome gene set (Collins et al., 2006) (Fisher’s exact test (p < 2.2 x 10-16, odds ratio = 
2.52), Jaccard Coefficient (J = 0.0888, p < 0.01), and Representation Factor (RF = 2.9, 
p < 1.05 x 10-53)) and the CA1 neuropil gene set (Cajigas et al., 2012) (Fisher’s exact 
test (p < 5.2 x 10-7, odds ratio = 1.38), Jaccard Coefficient (J = 0.0842, p < 0.01), and 
Representation Factor (RF = 1.7, p < 2.23 x 10-23).
 72 
 
 
  
 73 
 
 
 74 
 
S2 fractions along with their average microarray RMA expression values and fold 
change are listed in Tables 3.6 and 3.7. Interestingly, the top P2 fraction enriched genes 
contained 4 transmembrane receptor protein tyrosine kinases (GO:0004714, p = 2.44E-
5) and enrichment of genes related to neuro- and gliogenesis (GO:0022008, p = 1.45E-
5; GO:0042063 p = 2.30E-5). 
Discussion 
 In the present studies, we characterized the synaptoneurosomal preparation prior 
to subsequent analyses intended to investigate the effect of repeated ethanol on the 
synaptic transcriptome. We expected that an enrichment of synaptically localized RNA 
would allow for detection of gene expression changes potentially confined to the 
synapse that would otherwise go undetected when studying the entire transcriptome. 
Immunoblotting, qRT-PCR, microarray, and RNA-Seq analyses revealed marked 
differences in the proteins and transcripts present in the P2 and S2 fractions. A distinct 
pattern emerged indicating that a comparison of these two fractions would allow for an 
evaluation of the synaptically enriched and somatically restricted transcriptomes in 
response to an exogenously administered drug in an in vivo model.  
 The actual degree of enrichment of synaptic entities in the P2 fraction as 
compared to the whole homogenate (WH) is challenging to ascertain, as 
immunoblotting and qRT-PCR provided seemingly inconsistent results.  For previously 
published studies that have used Camk2a as a marker for known synaptically trafficked 
transcripts, there is variability in whether this gene is enriched for in the 
synaptoneurosomal fraction as compared to the whole homogenate. Similar to our 
experiment, studies performed by Rao & Steward (1993) and Lugli et al. (2008) also  
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isolated synaptoneurosomal fractions from forebrain tissue, but only the later detected 
enrichment ( > 2.0 fold) for Camk2a as compared to total homogenate (Rao & Steward, 
1993; Lugli et al., 2008). An issue with comparing results across publications is the 
number of procedural variations in synaptoneurosomal preparation. The protocol 
published by Lugli et al. (2008) performed the filtration prior to both centrifugation steps 
while Rao & Steward (1993) utilized a discontinuous Ficoll gradient to further promote 
fractionation. Both protocols used initial and final centrifugation speeds much higher 
than those used in the present study (2000 x g – 45,000 x g). Nevertheless, we did 
observe 4.3 fold enrichment of the postsynaptic protein marker, PSD95, as compared to 
the WH (Figure 3.5), and immunoblotting and qRT-PCR analyses both indicated 
enrichment of synaptic entities in the P2 fraction as compared to the S2 (Figures 3.5, 
3.6). As a result, our subsequent analyses were the first to focus on expression 
differences between these two fractions instead of between the WH and P2.    
 The objective of the synaptoneurosome preparation is enrichment, since 
obtaining a pure neuron-specific synaptic fraction from tissue as complex as brain 
through a centrifugation and filtration scheme is improbable. As such, the P2 fractions 
were not completely devoid of somatically-restricted transcripts (Figure 3.6). 
Additionally, the qRT-PCR results revealed a significant increase in the level of Gfap 
present in the P2 as compared to the S2. High levels of Gfap, an intermediate filament 
used as a protein marker for reactive astrocytes, has previously been found to 
contaminate synaptoneurosome preparations (Rao & Steward, 1993). GFAP message 
has been identified in the processes of some astrocytes (Sarthy et al., 1989; Trimmer et 
al., 1991). Furthermore, evidence for regulated trafficking of astrocytic mRNA to 
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perisynaptic processes came from studies conducted with synaptoneurosomes 
(Gerstner et al., 2012). As components of the tripartite synaptic structure, the role 
astrocytes play in regulation of neurotransmission makes them a major participant in 
brain plasticity (Halassa & Haydon, 2010). Therefore, the potential presence of glial 
processes makes the synaptoneurosomal preparation more representative of a 
comprehensive synaptic transcriptome. However, without distinguishing the populations 
of mRNA by cell type, we must evaluate our results with the knowledge that observed 
changes in expression may be non-neuronal in nature. 
 The conclusion that the P2 and S2 fractions yielded exceedingly disparate 
populations of RNA came from several lines of evidence during the characterization. 
The fact that automated electrophoresis revealed distinctive total RNA distributions 
(Figure 3.7, a) was the first indication of differences in RNA composition. The 
observation that synaptoneurosomal fractions are enriched with small molecular weight 
RNAs was previously made by Oswald Steward’s group (Rao & Steward, 1993). 
Steward also found through subfractionation by oligo-dT chromatography that these 
small molecular weight RNAs were primarily found in the poly(A)-minus fraction. Our 
microarray results did confirm significant differences in the microRNA populations 
present in the P2 and S2 fractions, and even an enrichment within the P2. However, it is 
possible that the low molecular weight banding distribution represents a variety of small 
non-coding RNAs, such as tRNAs, snoRNAs, and piRNAs that could have undiscovered 
synaptic functions. A more complete assessment of this RNA will be necessary to make 
a definitive claim as to its composition.  
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If the complement of low molecular weight transcripts found in the P2 fraction did 
consist of large quantities of non-coding RNAs, this could partially explain the 
differences perceived in overall fluorescent intensity detected from the arrays hybridized 
with P2 and S2 samples. During microarray sample preparation, the in vitro transcription 
reaction utilizes primers that target both poly(A) and non-poly(A) containing RNAs. 
However, without complementary probes to hybridize to on the array, these non-poly(A) 
transcripts would lower the pool of targets available for detection. The proprietary 
primers used in the synthesis of cRNA are also designed to exclude rRNA. Our qRT-
PCR results did show decreased levels of one particular rRNA, Rn18S, in the P2 
fraction as compared to the S2 (Figure 3.6, f). If this pattern held for other rRNAs, P2 
samples would theoretically have a larger proportion of RNAs available for reverse 
transcription and consequently for in vitro transcription, resulting in the larger yields of 
cRNA that were obtained.  
 Through our characterization of the synaptoneurosome preparation we 
determined that the P2 and S2 fractions exhibited the complementary expression 
profiles that we sought to investigate in response to repeated ethanol exposure. 
Functional enrichment analysis determined that genes enriched for in the P2, and 
therefore presumably trafficked to the synapse, are involved in the functioning of this 
subcellular compartment. However, the results of these studies indicate that further 
optimization may be required. For instance, modifications in particular centrifugation and 
filtration steps may increase the enrichment of known synaptically targeted transcripts in 
the P2 as compared to the WH. Furthermore, Johnson et al., 1997 published a protocol 
to isolate synaptoneurosomes from single rat hippocampal slices (Johnson et al., 1997). 
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In that study, no effort at isolating RNA from the small scale fractions was attempted, 
but ideally this protocol could be adapted to produce enough RNA from smaller starting 
quantities of tissue. This could permit the examination of the synaptic transcriptome of 
individual brain regions. Nevertheless, we were satisfied with the prospect of using this 
preparation to study changes to the synaptic transcriptome in response to repeated 
ethanol exposure. 
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Chapter 4 – Regulation of the Synaptic Transcriptome by Repeated Ethanol 
Administration 
 
Introduction 
Alcoholism is a chronic disease characterized by compulsive drug-seeking 
undeterred by negative consequences, as well as cravings and potential for relapse that 
persist despite years of abstinence. The endurance of these long-lived pernicious 
behaviors support the theory that addiction arises from progressive and lasting cellular 
and molecular adaptations in response to repeated drug exposure (Nestler et al., 1993; 
Nestler, 2001b). A more complete comprehension of neuronal plasticity that underlies 
the transition to compulsive drug use could lead to novel therapeutic strategies for 
alcohol use disorders. 
Previous research from our laboratory looking at ethanol regulation of gene 
expression across a variety of mouse strains has found significant enrichment of genes 
involved with synaptic functioning and plasticity, reproducibly amongst several brain 
regions (Kerns et al., 2005; Wolen et al., 2012). Preliminary data obtained during my 
rotation project also suggested that chronic ethanol consumption could alter synaptic 
RNA populations. Yet, the functionally significant changes ethanol exposure has on 
RNA localized at the synapse remains largely unexplored. By mechanically separating 
the processes in primary rat neuronal cultures, it has been shown that axons, dendrites, 
and their synaptic terminals contain only about 3.9% of the total cellular RNA (Poon et 
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al., 2006). Therefore, it would be advantageous to discriminately examine the synaptic 
transcriptome to ascertain the cellular location of ethanol’s effect on gene expression 
and potentially identify regulation that could go undetected when studying the entire 
transcriptome. 
It has been proposed that behavioral sensitization is a process that occurs 
following repeated drug exposure as the result of neuroadaptations in brain reward 
systems that contribute to such phenomenon as drug craving and relapse in alcoholics 
(Piazza et al., 1990; Robinson & Berridge, 1993). Intermittent administration of many 
drugs of abuse, including ethanol, propagates the development of long-lasting 
sensitized responses to their stimulant effects, often measured as augmented locomotor 
activation in rodent models (Shuster et al., 1975; Hirabayashi & Alam, 1981; Masur et 
al., 1986). Behavioral sensitization has been associated with neurochemical and 
molecular adaptations that effect neurotransmission (Kalivas & Stewart, 1991; White & 
Kalivas, 1998; Vanderschuren & Kalivas, 2000). There is also evidence that 
neuroadaptations to brain regions that mediate reinforcement and reward occurring in 
response to sensitizing treatments result in incentive salience of the drug. This is 
demonstrated by studies with amphetamine and cocaine where animals have increased 
propensity for self-administration after sensitization (Horger et al., 1990; Piazza et al., 
1990). Increased voluntary consumption of ethanol has also been observed following 
intermittent repeated exposure (Lessov et al., 2001; Camarini & Hodge, 2004).  
We therefore sought to determine whether ethanol-induced sensitization may 
result, at least in part, from alterations in the synaptic transcriptome, contributing to 
synaptic remodeling and plasticity. To characterize the effect of ethanol on the synaptic 
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transcriptome as opposed to global changes in cells’ expression, we utilized 
synaptoneurosomes, prepared from frontal pole tissue of sensitized DBA2/J mice, to 
enrich for synaptic mRNAs for the purpose of transcriptomic analysis. Our expression 
profile reveals that repeated ethanol exposure elicits distinctive changes to the 
complement of mRNA present at the synapse, substantiating the synaptoneurosome 
preparation as a practical technique in which to study ethanol-induced changes to gene 
expression on a subcellular basis.  
 
Materials and Methods 
Animals. Male DBA/2J (D2) mice were purchased from Jackson Laboratories 
(Bar Harbor, ME) at 8-9 weeks of age.  Animals were housed 4 per cage and had ad 
libitum access to standard rodent chow (7912, Harlan, Madison, WI) and tap water in a 
12-hour light/dark cycle (6 am on, 6 pm off). Mice were housed with Teklad corn cob 
bedding (7092, Harlan, Madison, WI) and cages were changed weekly. Subjects were 
allowed to habituate to the animal facility for one week prior to commencement of 
behavioral experiments. All behaviors were assayed during the light cycle between the 
hours of 8 am and 2 pm. All animal procedures were approved by the Institutional 
Animal Care and Use Committee of Virginia (AM10332) and carried out in accordance 
with the National Institute of Health guide for the Care and Use of Laboratory Animals. 
Ethanol-Induced Behavioral Sensitization. Ethanol (EtOH) behavioral 
sensitization was induced according to a previously established laboratory protocol 
(Costin et al., 2013a; Costin et al., 2013b). Mice were divided into one of four treatment 
groups (n = 16): saline-saline (SS), saline-EtOH (SE), EtOH-saline (ES), and EtOH-
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EtOH (EE) (Table 4.1). Mice were acclimated to the behavioral room for 1 hour prior to 
the start of the experiment on testing days. All locomotor activity was measured 
immediately following i.p. injection with either saline or ethanol during 10 minute 
sessions in sound-attenuating locomotor chambers (Med Associates, model ENV-515, 
St. Albans, VT). The system is interfaced with Med Associates software that assesses 
activity using a set of 16 infrared beam sensors along the X-Y plane. Animals received 
two days of habituating saline injections and placement in the testing apparatus. On test 
day 3, acute locomotor responses to saline (SS, SE) or 2.0 g/kg ethanol (ES, EE) were 
measured. On conditioning days 4-13, animals received daily injections in their home 
cages of either saline (SS, SE) or 2.5 g/kg ethanol (ES, EE). On final testing day 14, the 
SS and ES groups received saline and the SE and EE groups received 2.0 g/kg ethanol 
and all animals were placed in the activity chambers for 10 minutes. Statistical analysis 
for distance traveled was performed using a two-way repeated measures ANOVA 
followed by Tukey’s post-hoc analysis.  
Tissue Collection. On day 14 of the behavioral sensitization paradigm, mice were 
sacrificed by cervical dislocation 4 hours following i.p. injection. It has previously been 
shown that the 4-hour time-point captures a spectrum of early, intermediate, and late 
gene expression responses to alcohol (Kerns et al., 2005). Immediately, brains were 
extracted and chilled for one minute in ice-cold 1x phosphate buffered saline. The 
frontal pole was dissected by making a cut rostral of the optic chiasm and excluding the 
olfactory bulbs. Excised tissue was stored in a tube on ice for as short of a period as 
possible before being processed in the synaptoneurosome preparation (refer to Chapter 
3 Materials and Methods). 
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Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR). 
Synaptoneurosomal fractions, S2 and P2, prepared from mice subjected to the 
sensitization protocol were assessed for enrichment of known dendritically-trafficked 
and somatically-restricted transcripts using qRT-PCR. Total RNA was isolated using the 
guanidine/phenol/chloroform method (Stat-60, Tel-Test Inc., Friendswood, TX) and a 
Tekmar homogenizer as per the STAT-60 protocol. RNA concentration was determined 
by measuring absorbance at 260 nm and RNA quality was assessed by electrophoresis 
on an Experion Analyzer (Bio-Rad, Hercules, CA) and 260/280 absorbance ratios. All 
RNA samples had RNA quality indices (RQI) ≥ 7.6, and 260/280 ratios were between 
1.97 and 2.06. cDNA was generated from 995 ng of total DNase-treated RNA and 5 ng 
of luciferase mRNA (Promega, Madison, WI) using Deoxyribonuclease I (Invitrogen, 
Carlsbad, CA) and the iScript cDNA kit (Bio-Rad, Hercules, CA) according to 
manufacturer’s instructions. qRT-PCR was performed using the iCycler iQ system (Bio-
Rad, Hercules, CA) according to manufacturer’s instructions for iQ SYBER Green 
Supermix (Bio-Rad, Hercules, CA). Primer sequences, annealing temperatures, 
amplicon sizes, and cDNA dilutions used for each gene are listed in Table 3.1. Relative 
expression was calculated by comparing Ct values to a standard curve produced from 
S2 fraction cDNA (diluted 1:5, 1:25, 1:125, 1:625). Statistical analysis of qRT-PCR data 
was performed using a Student’s t-test between the two fractions. 
Microarray Data Analysis. For microarray sample preparation, hybridization and 
scanning refer to Chapter 3, Materials and Methods. Expression data from the S2 and 
P2 fractions were background corrected, quantile normalized, log2 transformed and fit 
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to a linear model using the robust multi-array average (RMA) expression measure 
(Irizarry et al., 2003).  Microarray quality was assessed by inspecting the distributions of 
log-transformed probe intensity values and reviewing quality assessment metrics and 
graphs available from Expression Console™ software (Affymetrix, Santa Clara, CA). All 
arrays had pos_vs_neg_auc values (a metric that evaluates how well signal is 
separated from noise) greater than 0.92. Differential expression of genes due to ethanol 
treatment was assessed in two ways. Initial examination of microarray data was 
performed on RMA values calculated separately for P2 and S2 fractions. One-way 
ANOVA was performed for each data set using TIGR Multiexperiment Viewer (MeV). P-
values were corrected for multiple testing using the Bioconductor q-value package in the 
statistical platform, R (Team, 2011). Due to the exploratory nature of the study, a less 
stringent threshold for significance was applied (FDR = 0.3). Post-hoc pattern 
recognition analysis was performed using Pavlidis Template matching (PTM) (Pavlidis & 
Noble, 2001), an algorithm based on Pearson Correlation between template and the 
data, available in MeV. For a more direct comparison of microarray data to RNA-Seq 
results, differential expression was additionally assessed using linear models for 
microarray data (Limma) analysis (Smyth, 2004) using the Bioconductor package in R. 
This analysis was performed using RMA values calculated from P2 and S2 samples 
together and provided results for each pairwise comparison. FDR = 0.20 was applied for 
multiple testing correction.   
RNA-Seq Data Analysis. For RNA-Seq library preparation, sequencing protocol, 
read alignment, transcript assembly, and quantification refer to Chapter 3 Materials and 
Methods. Only SS, SE, and EE samples were sequenced after initial microarray 
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analysis revealed little differential expression between the ES and EE ethanol treatment 
groups. Estimated abundances were reported as Fragments Per Kilobase of exon per 
Million fragments mapped (FPKM). Differential expression was performed using Cuffdiff 
(v2.1.1, http://cufflinks.cbcb.umd.edu/) (Trapnell et al., 2010) and pairwise comparisons 
of gene expression were calculated for each of the six groups (SS_S2, SE_S2, EE_S2, 
SS_P2, SE_P2, and EE_P2). For treatment comparisons within fraction, an FDR = 0.20 
was applied for multiple testing correction. 
Bioinformatics Analysis. Functional enrichment analysis was performed using 
ToppFun, a functional enrichment application available as part of the ToppGene suite of 
web based applications (toppgene.cchmc.org) (Chen et al., 2009). Mouse gene symbols 
were submitted and analyzed for over-representation of genes that belong to Gene 
Ontology (GO) categories (molecular function, biological processes, and cellular 
component). To enhance informativeness of results, top ranked terms were filtered to 
remove broad and redundant definitions. Only categories that were comprised of 
greater than 3 and fewer than 400 genes were included, removing those that contained 
exactly the same query list as another term already listed in the displayed results. 
Literature association analysis of statistically significant genes was investigated using 
Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.com/). IPA derives connections 
between genes based on their curated repository of biological interactions and 
functional annotations. Finally, the biological function of genes that adhered to specific 
patterns of regulation were independently assessed using GeneMANIA 
(genemania.org) (Mostafavi et al., 2008). GeneMANIA creates interaction networks 
based on functional association data such as protein and genetic interactions, 
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pathways, co-expression, co-localization, and protein domain similarity as well as 
identifying candidate genes not directly detected from our analysis. 
 
Results 
Synaptoneurosome preparation allows for analysis of synaptic transcriptome in 
sensitized mice. 
 DBA/2J (D2) mice were chosen for these studies due to their characteristic 
sensitivity to ethanol psychomotor stimulation and development of sensitization (Phillips 
et al., 1994). The four treatment groups (SS, SE, ES, and EE) were necessary not only 
to provide pertinent controls, but also to allow for a comprehensive examination of 
ethanol’s effect on the synaptic transcriptome during the induction of behavioral 
sensitization. The saline-saline (SS) group provided baseline activity responses and 
controlled for changes that resulted solely from the stress of injections. The saline-
ethanol (SE) group revealed synaptic responses to acute administration of ethanol. The 
ethanol-saline (ES) group exposed allostatic changes in gene expression at the 
synapse produced by repeated ethanol injections. Finally, the ethanol-ethanol (EE) 
group tested for alterations due to the induction of sensitization, following an acute 
ethanol administration. Distance traveled on test days 3 and 14 was compared, and a 
significant increase in activity on day 14 was interpreted as an induction of ethanol 
sensitization (Figure 4.1). Daily i.p. injections of 2.5 g/kg ethanol elicited an augmented 
locomotor response to 2.0 g/kg ethanol on day 14 as compared to day 3 in the EE 
treatment group. Frontal pole brain tissue obtained from mice, 4 hours following the final 
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Figure 4.1 – Repeated ethanol exposure induced behavioral sensitization in D2 
mice. On test day 3, acute ethanol elicited a significant locomotor activation compared 
to saline (#p < 0.001 compared to SS within same day; *p< 0.001 compared to SE within 
same day). One test day 14, daily injections of ethanol resulted in an augmented 
locomotor response compared to acute ethanol on day 3 ($p < 0.001 compared to same 
treatment on day 3) and acute ethanol on day 14 (&p < 0.001 compared to ES within 
same day). Repeated measures two-way ANOVA, main effect of treatment (F[3,60] = 
63.143), main effect of day (F[1,60] = 14.567), significant interaction treatment x day 
(F[3,60] = 44.763), n = 16. 
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 i.p. injection on day 14, was utilized in preparation of synaptoneurosome enriched 
samples (refer to Chapter 3 Materials and Methods). 
To ensure enrichment in experimental tissues, qRT-PCR of total RNA isolated 
from mice subjected to the ethanol behavioral sensitization paradigm evaluated the 
profile of mRNA present in S2 and P2 fractions (Figure 4.2). P2 fractions had higher 
relative expression levels of known synaptically targeted transcripts, CamK2a and Arc 
(Burgin et al., 1990; Link et al., 1995; Lyford et al., 1995), while transcripts known to be 
somatically restricted, Gapdh and Snrpn (Litman et al., 1994; Poon et al., 2006), were 
more abundant in the S2 fraction. These results established that P2 fractions acquired 
from tissue harvested from sensitized D2 mice, which were used for subsequent 
analyses, did possess an enrichment of synaptically targeted RNA as compared to the 
S2 fractions. 
 
Sensitizing ethanol treatment alters the synaptic transcriptome. 
Microarray analysis. Initial examination of the synaptoneurosomal fractions 
obtained from sensitized D2 mice was performed by microarray analysis. This 
investigation was completed prior to demonstrating the validity of RMA data 
normalization (Chapter 3), which had required RNA-Seq be performed on these same 
samples. Therefore, to bypass any potential error that could have been introduced by 
applying an inappropriate normalization scheme across disparate fractions, expression 
measures were calculated separately for P2 and S2 samples. One-way ANOVA (FDR = 
0.3) across ethanol treatments identified 214 probe sets, corresponding to 185 unique 
genes, which were significantly different within the P2 fraction (Supplemental Table 
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Figure 4.2 – qRT-PCR of S2 and P2 fractions from mice subjected to behavioral 
sensitization paradigm. RNA isolated from S2 and P2 fractions of behaviorally 
sensitized mice was assayed for transcripts of known subcellular localization to ensure 
enrichment of synaptic RNAs. Paired students t-test between fraction for each gene, 
Camk2a (t[7] = 6.941, ***p = 0.0002), Arc (t[7] = 2.646, *p = 0.0331), Gapdh (t[7] = 
4.181, **p = 0.0041), Snrpn (t[7] = 8.439, ****p < 0.0001), n = 8. 
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S4.1). A similar analysis of the S2 fraction found 264 probe sets, corresponding to 243 
unique genes that were regulated by ethanol (Supplemental Table S4.2). There were 44 
genes that were found to be in common between the S2 and P2 significant gene lists, 
which left 141 genes that were being altered by ethanol in the P2 fraction only. This 
demonstrated that we were able to detect ethanol-responsive changes that were 
potentially unique to the synaptic transcriptome. 
 Functional enrichment analysis of genes found to be regulated by ethanol in the 
P2 fraction revealed significant over-representation of gene ontology categories 
involved with protein folding and association with the endoplasmic reticulum (ER) (Table 
4.2, Supplemental Table S4.3).  S2 functional enrichment analysis indicated that 
ethanol largely affected cell signaling processes in the fraction shown largely to contain 
somatically restricted transcripts (Table 4.3, Supplemental Table S4.4). However, there 
was also an over-representation of genes associated with the ER in the S2 significant 
gene list. Literature association analysis employing IPA identified 38 and 42 canonical 
pathways that were statistically enriched for in the P2 and S2 ethanol regulated gene 
sets, respectively (Tables 4.4, 4.5). Ethanol altered expression of both ER and 
glucocorticoid receptor signaling pathways in both fractions. However, the level of 
glucocorticoid receptor signaling enrichment was greater in the P2 fraction as compared 
to the S2. Additionally, there were only 10 canonical pathways in common between P2 
and S2. This suggested that although there is overlap in the molecular processes being 
affected by ethanol in the synaptic and somatic RNA populations, there also appears to 
be differential regulation as well. 
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Visualizing expression values by heat maps allows for biologically-relevant 
patterns of gene regulation to be identified. Two interesting expression patterns that 
were further investigated by PTM are displayed in Figure 4.3, a, b. Setting threshold 
parameters at absolute R > 0.75 and p < 0.05, 20 genes were found to be altered by 
repeated ethanol (ES, EE) compared to saline treatment (SS), which were not affected 
by treatment with acute ethanol (SE). Another 39 genes were found to be acutely 
regulated by ethanol (SE), but then exhibited a blunted or no response with repeated 
administration (ES, EE). This habituating gene expression profile has previously been 
observed in response to sensitizing ethanol treatments (Costin et al., 2013a) and was 
examined further in the subsequent RNA-Seq analysis.  
   
RNA-Seq analysis. As mentioned previously, RNA-Seq was performed to 
facilitate validation of data normalization and differential expression results. An 
independent bioinformatics examination of RNA-Seq data was also performed as a 
complement to microarray analysis. Cuffdiff analysis of RNA-Seq data provided 
differential expression results for each pairwise treatment comparison in the S2 and P2 
fractions (Figure 4.4, a, b). Collapsing the significant genes across all comparisons, it 
was found that 2968 and 292 unique genes, corresponding to 2936 and 311 XLOC 
gene ids, changed with ethanol treatment in the S2 and P2 fractions, respectively 
(Figure 4.4, c, Supplemental Tables S4.5, S4.6). There were 176 genes that were found 
to be in common between the S2 and P2 significant gene lists, which left 116 genes that 
were being altered by ethanol in the P2 fraction only. Upon closer inspection of the 176 
genes that overlapped between the S2 and P2 it was determined that 43 were regulated  
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Figure 4.3 – Visual representation of gene expression patterns identified by PTM 
in the initial microarray analysis. These heatmaps depict the RMA values for genes 
found to be significantly regulated by ethanol in the P2 fraction by one-way ANOVA (q < 
0.3). Templates were defined following a cursory examination of gene expression data 
using MeV. A threshold of absolute R > 0.75 and p < 0.05 identified (a) 39 genes that 
were acutely regulated by ethanol, but whose expression habituated with repeated 
ethanol and (b) 20 genes that were regulated by repeated ethanol administration.  
  
a 
b 
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Figure 4.4 – RNA-Seq significant genes broken down by ethanol treatment and 
synaptoneurosome fraction. The number of genes found to be significantly altered 
across the behavioral sensitization treatments in the (a) S2 fraction and (b) P2 fraction. 
(c) A comparison of S2 and P2 ethanol regulated genes found 176 common genes. (d) 
A breakdown of the genes in common between the S2 and P2 fractions revealed that 43 
were found to be regulated by different ethanol treatments. Of the remaining 133 genes, 
all but 4 exhibited the same direction of regulation by ethanol, either up- or down-
regulated.  
 101 
 
by different ethanol treatments between the fractions (Figure 4.4, d). These results 
corroborated the initial microarray analysis finding that detection of ethanol-responsive 
changes unique to the synaptic transcriptome was possible.  
It was decided that it would be more informative to focus on changes that were 
localized to the synapse and compare those genes to the somatic RNA population. 
Therefore, a P2 fraction candidate gene list was compiled for subsequent bioinformatics 
analyses. For inclusion into the candidate gene list, genes were required to be 
differentially expressed only in the pairwise comparisons between the three P2 groups 
(SS_P2, SE_P2, and EE_P2) or a gene was regulated by ethanol in both the P2 and S2 
fractions, but showed overall enrichment in the P2 fractions by collapsing and 
comparing all S2 and P2 samples. 
 Application of these criteria consolidated the list to 248 genes (Supplemental 
Table S4.7). The principal gene ontology categories derived from ToppFun functional 
enrichment analysis of the P2 candidate gene list revealed over-representation of ER 
activity and components of the extracellular matrix (Table 4.6). Alternatively, the top 
categories found to be over-represented in RNA-Seq S2 ethanol regulated genes 
reflected different biological functions, including cytoskeletal regulation and Ras protein 
signal transduction (Table 4.7). Genes regulated by ethanol in the S2 fraction were also 
related to the synapse, indicating global regulation of gene expression by ethanol has 
repercussions for synaptic functioning. However, the differences in functional 
enrichment between the P2 and S2 fractions support the conclusion that ethanol’s 
regulation of gene expression is distinctive and contingent upon subcellular location. 
The complete list of functional enrichment categories for both the P2 fraction and S2 
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candidate genes can be found in the supporting information (Supplemental Tables S4.8, 
S4.9). 
A posteriori, FPKM values for P2 candidate genes were evaluated across all 
treatment comparisons for the distinct patterns of regulation observed in the initial 
microarray analysis. Thirty-nine genes were classified as being altered by repeated 
ethanol as they were found to be significant in the SS vs EE comparison, but not in the 
SS vs SE. The habituating expression profile was defined as genes determined to be 
differentially regulated between SS and SE samples, but not SS and EE. This described 
114 P2 candidate genes. Resulting gene lists were submitted to GeneMANIA to assess 
functional association across multiple independent datasets related to gene co-
expression, co-localization, protein and genetic interactions, and predicted interactions 
(Figure 4.5, a, b). GeneMANIA also populates the composite network with predicted 
candidate genes related to the input genes, but not directly identified through our RNA-
Seq analysis. The GeneMANIA algorithm predicted inclusion of Sgk1 and Mt1 into the 
habituating gene expression network. These two genes have previously been shown to 
be regulated by ethanol in the PFC of D2 mice, and are known to be glucocorticoid 
responsive (Kerns et al., 2005).  The repeated ethanol gene network was populated with 
14 ribosomal proteins, 5 of which have been previously reported to be associated with 
the molecular and behavioral responses to ethanol (Fau, Rpl26, Rpl27a, Rpl13, and 
Rpl10) (Lewohl et al., 2000; Saito et al., 2004; Rodd et al., 2008). The inclusion of these 
genes into the networks was primarily informed by co-expression relationships within 
the GeneMANIA databases. 
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Figure 4.5 – RNA-Seq P2 candidate gene list functional association networks 
using GeneMANIA. (a) Interaction network for genes that were acutely regulated and 
then habituate following repeated ethanol is predicted to include Mt1 and Sgk1. (b) 
Interaction network for genes that are regulated by repeated ethanol was populated with 
ribosomal proteins. 
  
b 
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Trafficking of mRNA to the dendrites is facilitated by multiple RNA binding 
proteins (Bramham & Wells, 2007). Ethanol regulation of these proteins could contribute 
to alterations in the synaptic transcriptome and therefore impact synaptic plasticity. 
Functional enrichment analysis of the S2 fraction RNA-Seq significant gene list 
(Supplemental Table S4.9) found the ontological category, mRNA binding 
(GO:0003729), to be significantly over-represented (p = 0.00103). The S2 ethanol-
responsive gene list was then compared to the RNA-Binding Protein DataBase’s 
(RBPDB, http://rbpdb.ccbr.utoronto.ca/) (Cook et al., 2011) collection of 413 curated 
mouse RNA-binding proteins. A significant number of genes (85) were found to overlap 
between the S2 gene set and RBPDB (Fisher’s Exact Test, p < 0.0004314, odds ratio = 
1.555425). Cpeb1, a RNA-binding protein shown to be involved in mRNA transport 
(Huang et al., 2003), was regulated by ethanol in the S2 fraction. P2 candidate genes 
were compared to a set of genes that were identified as containing the cytoplasmic 
polyadenylation element (CPE), the consensus sequence for CPEB1 binding (Zhang et 
al., 2010), and found that 32 genes were putative targets of CPEB1. One gene in 
particular, Rhou, has been determined to be regulated by ethanol under a number of 
different conditions. A survey of Gene Weaver (geneweaver.org) (Baker et al., 2012), a 
curated repository of genomic experimental results, revealed Rhou to be regulated by 
both acute (Kerns et al., 2005) and chronic administration as well as across various 
species, including mice and monkeys. Rhou was also identified in a study using gene 
expression patterns to distinguish between alcoholics and non-alcoholic controls in 
post-mortem samples (Liu et al., 2006a). 
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Comparison of Array and RNA-Seq Result. For a more direct comparison to 
RNA-Seq data, microarrays were reanalyzed using Limma, a statistical algorithm that 
also examines differential expression for each pairwise treatment comparison in the S2 
and P2 fractions. A candidate gene list was derived from Limma results in the same 
manner as the RNA-Seq analysis. 1078 genes were found to be significantly regulated 
by ethanol across all pairwise treatment comparisons in the P2, or in the S2 and P2, but 
enriched for in the P2 fraction in the microarray data (Figure 4.6, Supplemental Table 
S4.10). There was a significant overlap between the Limma and RNA-Seq data, where 
82 genes were determined to be regulated by ethanol using both methodologies (Table 
4.8). Functional enrichment analysis for the validated genes revealed over-
representation of categories related to endoplasmic reticulum and protein folding 
(Figure 4.9, Supplemental Table 4.12). Therefore, microarray and RNA-Seq produced 
comparable results, verifying regulation of the synaptic transcriptome by sensitizing 
ethanol treatment.  
This list of genes, which have been validated by two different methodologies 
dependent on distinct molecular principles, represents a starting foundation for selection 
of candidate genes from these studies. Other criteria to consider for choosing genes for 
following up experiments include synaptic localization of regulation, membership in 
significantly enriched ontological categories, high degree of connectivity to other ethanol 
responsive genes that would signify its potential as a hub gene for manipulation, and 
robustness of differential expression.  
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Figure 4.6 – Overlap of genes regulated by ethanol in the synaptic transcriptome 
between microarray and RNA-Seq analyses. Candidate genes were defined as being 
regulated by ethanol only in the P2, or in both the P2 and S2, but enriched for in the P2. 
Significance of overlap between microarray Limma and RNA-Seq Cuffdiff results was 
measured by Fisher’s exact test (p < 2.2 x 10-16, odds ratio = 7.54), Jaccard Coefficient 
(J = 0.066, p < 0.01), and Representation Factor (RF = 8.0, p < 3.795 x 10-51). 
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Discussion 
In this study, we examined the synaptic transcriptome in response to a 
behavioral sensitizing ethanol treatment in D2 mice. It was determined that by enriching 
tissue samples for synaptoneurosomal structures and then comparing somatic and 
synaptic fractions using transcriptomic analyses, we were able to distinguish ethanol’s 
effects on localized populations of RNA. Differential expression was validated by the 
use of microarrays and RNA-Seq, which provided comparable results implicating the 
synaptic transcriptome in modulation of behavior by affecting local protein populations.  
Neurons are highly specialized polarized cells, whose dendritic and axonal 
arborizations contain thousands of synapses that function and plasticize individually in 
response to stimulation (Steward & Levy, 1982; Steward et al., 1998; Wallace et al., 
1998). It has been proposed that activity-dependent synaptic plasticity requires the 
transport and translation of specific mRNA species, creating a unique complement of 
proteins that are able to function in response to a specific stimulus (Bramham & Wells, 
2007). Comparing the somatic and synaptic transcriptomes in response to sensitizing 
treatments of ethanol, we were able to detect discrete differences in ethanol regulation 
of gene expression. Through the characterization studies presented in Chapter 3, we 
were confident in the assessment that differences observed when analyzing P2 and S2 
fractions represent ethanol’s effect on gene expression in distinct subcellular locations. 
The exact means by which ethanol is exerting its regulation of the synaptic 
transcriptome has yet to be determined. Conceivably, ethanol could be affecting 
synaptic transcript abundances through overall modulation of transcription rates. This 
could have a global effect on mRNA levels within the cell, and, ultimately, through the 
mere altered availability of transcript, result in changes at the synapse. Our data 
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indicates that this is not an adequate explanation, as we were able to detect 141 genes 
by our initial microarray analysis and 116 genes by RNA-Seq, whose expression was 
changed in the P2 fraction alone and not in the somatic-RNA containing fraction, S2 
(Figure 4.4).  
Alternatively, the trafficking and localization of transcripts to the synapse offers 
another possible means of regulatory control. Synaptic tagging is a process whereby 
synaptic activation induces a transient synapse-specific change that allows the synapse 
to capture mRNA or proteins required for long-term plasticity, which has explicitly been 
studied for its role in long-term potentiation (Frey & Morris, 1997). The exact physical 
nature of the synaptic tag has not been absolutely defined, but candidate molecular tags 
that have been proposed include post-translation modifications to existing synaptic 
proteins, alterations to protein conformational states, initiation of localized translation or 
proteolysis, and reorganization of the local cytoskeleton (Martin & Kosik, 2002; Kelleher 
et al., 2004; Doyle & Kiebler, 2011). All of these mechanisms have the potential of being 
initiated by signaling events that result from membrane receptor activation. For 
instance, one pharmacological effect of ethanol is the release of dopamine in the 
nucleus accumbens which, when acting at D1-like receptors, increases activity of 
adenylyl cyclase, thereby increasing cAMP levels and PKA activity. It has been shown 
that PKA activation is required for the formation of the synaptic tag (Casadio et al., 
1999; Barco et al., 2002). The premise that signaling cascades downstream of ethanol 
could alter the ability of activated synapses to capture dendritically targeted mRNA 
requires examination.  
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In the proposed model of mRNA trafficking to the synapse, newly synthesized 
transcripts are bound by RNA-binding proteins in the nucleus and transported as part of 
large ribonucleoprotein particles (RNPs) along microtubules to the dendrites where, 
following synaptic activation, mRNA is localized to the spines by the actin cytoskeletal 
system (Bramham & Wells, 2007). Functional enrichment analysis of the RNA-Seq S2 
ethanol-responsive gene list suggested that actin cytoskeletal reorganization and 
regulation of RNA-binding proteins may contribute to the mechanisms by which ethanol 
modulates the synaptic transcriptome. In the S2 fraction, we not only found regulation of 
Cpeb1, but also Syncrip, and hnRNP-U, whose two gene products have previously 
been shown to interact with kinesin family member 5 (KIF5), a myosin motor protein 
identified as a component of RNA transport granules (Kanai et al., 2004). Ethanol’s 
regulation of genes that participate in mRNA transport in the S2 fraction but not the P2 
suggests that the synaptic plasticity elicited by repeated administration of ethanol can 
result from differential regulation of expression on a subcellular basis. 
Bioinformatics analysis of the P2 candidate gene list (as well as the initial 
microarray analysis)  indicated that transcripts altered in response to repeated ethanol 
exposure are significantly enriched for biological functions associated with endoplasmic 
reticulum function, in particular protein folding. Previously our laboratory has shown that 
ethanol regulates mRNA abundance of molecular chaperones in vitro and in vivo (Miles 
et al., 1994; Kerns et al., 2005). The present study extends these findings by providing 
evidence that this regulation may be localized or at least occurring at the synapse. In 
addition, biological network integration based upon functional annotation data using 
GeneMANIA predicted membership of 14 ribosomal proteins to the network constructed 
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from genes regulated by repeated ethanol (EE) but not acute ethanol (SE). Thus, our 
results that demonstrate ethanol regulation of genes that code for protein chaperones 
(Hspa5, Hsp90b1), co-chaperones (Fkbp5, Chordc1), and protein disulfide isomerases 
(Pdia3, Pdia4, Pdia6) suggest that repeated ethanol exposure modulate the local 
synaptic protein populations through synaptic genes involved in translation and protein 
folding. Alternatively, these changes in the P2 fraction of EE-treated animals may reflect 
increased demand for dendritic protein synthesis in response to repeated ethanol-
evoked synaptic activity. 
 We also found enrichment of genes associated with the extracellular matrix, 
which is known for its role in altering synaptic architecture that contributes to the 
processes of learning and memory (Wright & Harding, 2009). It has been suggested 
that these processes are subverted during the development of addiction (Hyman et al., 
2006) and studies have linked extracellular matrix proteins to escalation of ethanol 
consumption (Smith et al., 2011) and cocaine reward associative learning (Brown et al., 
2007). Our profiling of the synaptic transcriptome suggests that ethanol modifies 
expression of genes that participate in synaptic remodeling through regulation of 
synaptic and extracellular matrix proteins that may contribute to the induction of 
behavioral sensitization. 
Our differential expression results were validated by performing both microarray 
and RNA-Seq analyses, techniques that rely on different sets of molecular principles. 
While RNA-Seq utilizes Next Generation Sequencing technology to provide direct read 
counts of transcripts, microarrays depend on the hybridization of target RNA to probe. 
Using both of these approaches allowed for a validation of data processing schemes 
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(Chapter 3) and differential expression results. A biologically relevant gene expression 
pattern detected in the P2 fraction, by both microarrays and RNA-Seq, was habituation 
following repeated administration of ethanol. It has previously been demonstrated in the 
Miles laboratory that this pattern of expression in response to ethanol behavioral 
sensitization occurs with glucocorticoid responsive genes, Sgk1 and Fkbp5, and mimics 
the profile of the glucocorticoid, corticosterone, in response to ethanol (Costin et al., 
2013a). It also coincides with the literature that shows acute ethanol activates the 
hypothalamic-pituitary-adrenal (HPA) axis (Ellis, 1966), but that rodents and human 
alcoholics have blunted HPA responses while drinking and upon withdrawal (Wand & 
Dobs, 1991; Roberts et al., 1995; Costa et al., 1996; Rasmussen et al., 2000; 
Richardson et al., 2008). In the present study, we identified Rhou, which not only 
habituates in response to repeated ethanol, but also contains a glucocorticoid response 
element in its promoter region (http://opossum.cisreg.ca/oPOSSUM3/) and was found to 
be regulated in the P2 fraction only. This has implications for the synaptic transcriptome 
as a mediator of interactions between stress and alcoholism. 
Despite a significant overlap of differential expression results from microarrays 
and RNA-Seq, there were still a number of genes that were only found to be regulated 
by ethanol in a single assay. This inconsistency may be the result of limitations of both 
technologies. While RNA-Seq is touted as having a greater dynamic range compared to 
arrays (Wang et al., 2009; Zhao et al., 2014), the ability to detect differences in low 
abundant transcripts is limited by sequencing depth, which is often begrudgingly 
sacrificed in efforts to balance cost and analytical power. It has been estimated that a 
minimum of 80 million reads per sample is required for accurate quantification of low 
 117 
 
abundant genes (Consortium, 2011), while detection of up to 80% of differential 
expression events could possibly require as many as 300 million reads (Liu et al., 
2013). Our analysis averaged 28 million mapped reads per sample which could 
potentially prevent detection of differences in low abundant transcripts. This could 
especially be true in the complex mixed tissue sample of brain frontal pole which 
contains numerous cell types that exhibit diverse array of responses to exogenous 
stimulus. While at current sequencing depths, microarrays may still have greater 
sensitivity, they are at a disadvantage in discernable detection of differential expression 
of genes that are exceedingly abundant, resulting in over-saturation of the probe. 
Comprehensive coverage of the entire transcriptome by microarray analyses is also 
limited by representation of the genome on the chip. In the end, RNA-Seq and 
microarrays are both high-throughput approaches that can be used to complement each 
other, and analyses may benefit from investigating the union of their results as opposed 
to the intersection, with validation of individual candidate genes by other methodologies, 
such as quantitative reverse transcription PCR.  
Using expression analysis, our study is the first to show regulation of the synaptic 
transcriptome by ethanol (or any exogenous drug) in an in vivo model. With repeated 
intermittent exposure to ethanol that resulted in a sensitized response, we observed 
changes to the complement of mRNA present at the synapse that we hypothesize 
contribute to the development of the behavioral phenotype in D2 mice. The individual 
genes and functional groups (e.g. molecular chaperones) identified in these studies 
provide important new information regarding the mechanisms of ethanol-induced 
synaptic plasticity. Functional analyses will be required to further validate these results 
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with the ultimate goal of selecting a candidate gene to disrupt synaptic targeting of its 
transcript in efforts to modulate ethanol behavior. Perhaps most importantly, this model 
has now been shown capable of identifying changes to the synaptic transcriptome and 
can be used to investigate other models of neuroplasticity in response to ethanol and 
other drugs of abuse. 
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Chapter 5 – Role of Synaptically Targeted Bdnf mRNA in Ethanol-Responsive 
Behaviors 
 
Introduction 
Brain-derived neurotrophic factor (BDNF) is a member of a class of molecules 
known as neurotrophins (NTs). These proteins are responsible for the differentiation 
and survival of developing neurons and the maintenance of mature neurons. NTs have 
also been investigated for their role in modulating synaptic transmission and facilitating 
plasticity (Poo, 2001). It is proposed that addiction arises from persistent and 
progressive cellular and molecular adaptations in response to repeated drug exposure 
(Wilke et al., 1994; Nestler, 2001b), and research suggests that NTs, like BDNF, 
participate in the signaling and remodeling that contribute to the pathology (Russo et al., 
2009). 
It has been proposed that activity-dependent local translation at the synapse is a 
mechanism of synaptic plasticity (Steward & Banker, 1992). It would stand to reason 
that regulation of local protein synthesis depends, at least in part, on the complement of 
RNA trafficked to the synapse. mRNA transport to distal processes has been shown to 
occur in an activity-dependent manner (Tongiorgi et al., 1997; Steward & Worley, 2001; 
Grooms et al., 2006). Our objective in this work was to investigate how the composition 
of the synaptic transcriptome contributes to ethanol-responsive behaviors. One 
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approach was through disrupting the dendritic trafficking of a known ethanol–responsive 
gene in vivo. 
Bdnf has been identified as an ethanol-responsive gene through several of lines 
of evidence. Our lab has shown that Bdnf is up-regulated in the NAc of DBA/2J (D2) 
mice, 4 hours following a 2 g/kg i.p. injection of ethanol (Kerns et al., 2005). Studies 
from the Ron lab have shown up-regulation of Bdnf in the hippocampus and dorsal 
striatum (DS) of C57BL/6J (B6) mice following an acute injection of 2 g/kg ethanol and 
in the DS after 4 weeks of self-administration of a 10% ethanol solution (McGough et 
al., 2004). No change was observed in the expression of the closely related 
neurotrophin, nerve growth factor, following 4 weeks continuous access to ethanol. 
Interestingly, it was also demonstrated that escalating consumption of ethanol over 6 
weeks resulted in the loss of ethanol’s ability to increase Bdnf transcript levels, and that 
this was not recovered with a 2 week withdrawal period (Logrip et al., 2009). The 
authors posit that the escalation in drinking resulted from dysregulation of BDNF 
signaling, which normally acts to prevent the neuroadaptations contributing to 
alcoholism (McGough et al., 2004; Logrip et al., 2009). Human studies have indicated 
an association between BDNF and susceptibility to addiction (Uhl et al., 2001; 
Matsushita et al., 2004) along with lower plasma levels of BDNF in alcoholics, 
particularly in those with a family history of the disease (Joe et al., 2007). In animal 
studies, alterations in BDNF have been shown to modulate several behaviors 
associated with drugs of abuse (Horger et al., 1999; Hall et al., 2003; Hensler et al., 
2003). On a mixed J129ftm/1Jae/C57BL/6 background, heterozygous mice exhibited 
increased ethanol consumption as well as augmented ethanol-induced sensitization and 
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conditioned place preference as compared to their wildtype littermates (McGough et al., 
2004). Together these studies implicate Bdnf as an ethanol-responsive gene, whose 
altered expression can modify behavior.  
The mRNA for Bdnf has been identified as a synaptically targeted transcript with 
evidence indicating that its dendritic transport is enhanced in an activity-dependent 
manner (Tongiorgi et al., 1997). Using the existing Bdnfklox/klox mouse strain (Gorski et 
al., 2003) in which the long 3’ untranslated region (UTR) of this transcript was truncated, 
An et al. (2008) demonstrated that the long transcript variant was required for trafficking 
of Bdnf to dendrites (An et al., 2008). Bdnfklox/klox mice possess reduced levels of BDNF 
transcript and protein in the dendrites, yet total levels remained unchanged. These mice 
also show a significant dysmorphogenesis of dendritic spines at 8 weeks of age 
indicating a role of dendritically translated BDNF in spine maturation and pruning (An et 
al., 2008). Considering the involvement BDNF has shown in synaptic plasticity 
mediating addiction behaviors, these Bdnfklox/klox mice provide a valuable model for 
investigating whether targeting of certain transcripts to the synapse is necessary for 
ethanol response behaviors. 
The aim of this study was to characterize the function of synaptically trafficked 
Bdnf in ethanol-responsive behaviors following acute low and high dose exposure. This 
was accomplished by testing Bdnfklox/klox mice for locomotor activity, sedation, and 
anxiolysis following ethanol administration. Furthermore, animals were tested for 
ethanol consumption in a two-bottle choice paradigm and ethanol’s rewarding properties 
using conditioned placed preference (CPP). We hypothesized that Bdnf mRNA 
specifically targeted to the synapse would have a distinct function in response to 
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ethanol and that by disrupting its dendritic trafficking in vivo we would observe altered 
behavioral phenotypes as compared to wildtype littermates. Our results indicate an 
altered sensitivity to both low and high dose ethanol in Bdnfklox/klox mice, which was not 
exclusively pharmacokinetic in nature. 
 
Materials and Methods 
Animals. The Bdnfklox/klox strain of mice (Dr. Kevin Jones, University of Colorado-
Boulder, CO, USA) were re-derived and bred in the VCU Transgenic Mouse Core, 
maintaining their C57BL/6J genetic background. Heterozygote matings were used to 
procure klox/klox homozygotes and wildtype littermates for experiments. Male mice 
were singly housed between 4 and 5 weeks of age and had ad libitum access to tap 
water in a 12-hour light/dark cycle (6 am on, 6 pm off). Mice were housed with Teklad 
corn cob bedding (7092, Harlan, Madison, WI). All behaviors were assayed during the 
light cycle between the hours of 8 am and 2 pm. All animal procedures were approved 
by the Institutional Animal Care and Use Committee of Virginia (AM10332) and carried 
out in accordance with the National Institute of Health guide for the Care and Use of 
Laboratory Animals. 
 
Pair-Feeding. In a pair-feeding paradigm, daily food intake for Bdnfklox/klox mice 
was restricted to that of wildtype mice, which were given ad libitum access to Teklad 
standard rodent chow (7912, Harlan, Madison, WI). Each day, Bdnfklox/klox mice were 
provided with the average amount of food consumed by age-matched wildtype 
littermates on the previous day. Bdnfklox/klox mice were given two feedings per day: the 
first between 8 and 9 am and second between 4 and 5 pm. All mice were weighed on a 
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weekly basis to ensure Bdnfklox/klox mice were maintaining a body mass similar to 
wildtype mice. The pair-feeding protocol commenced at approximately 4 to 5 weeks of 
age, when Bdnfklox/klox mice were not obese, and continued throughout testing of the 
animals. Statistical analysis of body mass over time was performed using two-factor 
ANOVA and Bonferroni post-hoc analysis was used to compare differences between 
genotypes at each week.   
Acute Locomotor Dose Response. The locomotor activity profile across various 
doses of ethanol was assessed using Med-Associates sound-attenuating locomotor 
activity chambers (Med Associates, model ENV-515, St. Albans, VT). Chambers are 
equipped with 100 mA lights, a fan to diminish ambient noise, and 16 infrared sensor 
beams along the x and y axis. The system is interfaced with Med Associates software 
that records the number of photobeam breaks which it converts to horizontal distance 
traveled. Mice approximately 8-10 weeks of age were acclimated to the behavioral 
testing room for 1 hour prior to i.p. injections. Two days of saline administration and 10 
minutes placement in the testing apparatus allowed for habituation to injections and 
environment. On test day, mice received 1-, 1.5-, 2-, 2.5 g/kg ethanol or saline and 
distance traveled was recorded for 60 minutes. Statistical analysis for the locomotor 
dose response curves was performed using a two-way ANOVA on z-scored rank 
transformed data. Time course data across the full 60 minute testing period for each 
dose was analyzed using repeated measures two-way ANOVA. For analyses of body 
mass between genotypes and treatment groups, a two-way ANOVA was applied. 
Tukey’s post-hoc analyses were performed where appropriate for all pairwise 
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comparisons. Correlation between body mass and distance traveled was analyzed 
using linear regression.  
 Loss of Righting Reflex (LORR). The sedative-hypnotic effects of ethanol were 
measured using the loss of righting reflex assay (LORR). Mice approximately 9.5-12 
weeks of age were habituated to i.p. saline injections for 3 days. On test day mice 
received 4.0 g/kg ethanol at Time 0. Upon initial signs of intoxication, the mice were 
placed supine in a V-shaped trough. Latency for LORR, or Time 1, was recorded when 
a mouse was unable to right itself for 30 seconds. Mice taking longer than 5 minutes to 
acquire LORR were removed from the study due to possibility of improper injection. An 
animal was deemed to have regained its righting reflex, and Time 2 recorded, when it 
was able to right itself 2 times within 30 seconds. Duration of LORR was calculated by 
Time 2- Time 1. Statistical analyses of latency and duration of LORR as well as body 
mass were performed using a Student’s t-test between genotypes. Correlation between 
body mass and LORR measurements was analyzed using linear regression.  
 Ethanol Two-Bottle Choice Drinking. General avidity for ethanol was measured 
using the voluntary two-bottle choice paradigm. Mice approximately 12-17 weeks of age 
were given 24 hour access to one bottle containing 7.5% (v/v) ethanol and one bottle 
containing tap water for 7 days followed by access to one bottle 15% (v/v) ethanol and 
one bottle tap water for an additional 7 days. Bottles were constructed from 15 ml glass 
centrifuge tubes (BioExpress, Kaysville, UT) plugged with a rubber stopper containing a 
2.5 inch stainless steel sipper (Ancare, Bellmore, NY). Bottle position was varied in a 
double alternating fashion (left, left, right, right) as to account for arbitrary side 
preference. Daily fluid consumption was measured to the nearest 0.1 ml, average daily 
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intake was reported as g/kg, and preference was calculated from the ratio of ethanol 
intake divided by total amount of fluid consumed. Statistical analyses for total fluid and 
ethanol daily intake, as well as ethanol preference, were performed using repeated 
measures two-way ANOVA followed by Tukey’s HSD post-hoc at α = 0.05 to determine 
statistical significance between groups.  
 Saccharin and Quinine Taste Discrimination. Taste discrimination studies were 
performed to assess the selectivity of genotype effect on consumption. Taste 
preference for bitter or sweet solutions was measured using quinine hydrochloride 
(QHCl) or saccharin versus tap water in a two-bottle choice paradigm. Mice were cycled 
through a series of experiments: 30 µM QHCl, 2 mM saccharin, 75 µM QHCl, 0.5 mM 
saccharin. Consumption of each concentration was measured daily for 4 days with 4 
days of access to water only between each experiment. It has been shown that tests 
lasting a minimum of 4 days are sensitive enough to discriminate strain differences in 
taste preference (Tordoff & Bachmanov, 2002). Bottles were constructed as described 
previously and were alternated every other day. Average daily intake was reported as 
g/kg and preference was calculated from the ratio of tastant solution intake divided by 
total amount of fluid consumed. Statistical analyses for intake, preference, and total fluid 
consumption was performed using a Student’s t-test comparing genotype. 
 Conditioned Place Preference (CPP). Genotypic differences in the reward-like 
properties of ethanol were measured by conditioned place preference (CPP). Animals 
received cage enrichment and experimenter handling for one week prior to 
commencement of testing. The experimental apparatus (Med-Associates, ENV3013, St. 
Albans, VT) consisted of black and white chambers (20 x 20 x 20 cm each) which 
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differed in floor texture (white mesh and black rod) to help mice further differentiate 
between the two environments. Chambers were separated by a smaller intermediate 
compartment with grey walls, smooth PVC floor, and partitions that allowed access to 
the black and white chambers. On day 1 (pre-conditioning day), male mice were 
confined to the intermediate compartment for 5 minutes, partitions were lifted and mice 
were allowed to roam freely between chambers for 15 minutes. The time spent in the 
black and white chambers was used to establish baseline chamber preferences, if any. 
Mice were separated into vehicle and drug groups such that initial chamber biases were 
approximately balanced. On days 2–4 (conditioning days), twice per day, mice were 
injected (i.p.) with vehicle or drug and subsequently paired with either the black or white 
chamber, where they were allowed to roam for 15 minutes. Vehicle-treated animals 
were paired with saline in both chambers, and drug-treated animals received saline in 
one chamber and ethanol (2.0 g/kg) in the opposite chamber. Pairing of the ethanol with 
either the black or white chamber was randomized within the drug-treated group of 
mice. Daily injections were counterbalanced so that some mice received ethanol in the 
morning and others in the afternoon. On day 5 (test day), mice did not receive an 
injection. They were placed into the intermediate compartment for 5 minutes, the 
partitions were lifted and they were allowed to roam freely for 15 minutes. Locomotor 
activity counts and time spent in each chamber was recorded. For ethanol-treated mice, 
preference scores were calculated as time spent in the drug-paired side on test day 
minus time spent in drug-paired side during baseline. For saline-treated mice, 
preference scores were calculated as the average of time spent in the white side on test 
day minus the white side during baseline and the time spent in the black side on test 
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day minus the black side during baseline. Each animal was subjected to the CPP 
protocol twice, receiving the alternative conditioning treatment in the second 
experiment. There was a 6 week wash-out period between tests. Locomotor activity and 
body mass data was analyzed for the first experiment. Statistical analyses for 
preference score, locomotor activity, and body mass were performed using a two-way 
ANOVA followed by Tukey’s HSD post-hoc to test pairwise comparisons where 
appropriate.  
 Light-Dark Box (LDB). Basal anxiety-like behavior and ethanol-induced anxiolysis 
were measured in the light-dark box (LDB) assay. The LDB apparatus (Med Associates, 
model ENV-515, St. Albans, VT) consists of a transparent square box 10.75” L x 10.75” 
W x 8” H, divided into two equally sized zones by a black insert, all enclosed within a 
sound-attenuating chamber. Chambers were illuminated with 170 mA stimulating lights. 
One hour prior to behavioral testing, mice approximately 8 to 9 weeks of age were 
relocated to the behavior room and the light-dark box chambers were turned on for 
habituation to testing environment. Mice were injected with either saline or 1.5 g/kg i.p. 
ethanol, returned to their home cage for 5 minutes, and then placed into the center of 
the LDB, facing the dark side, and allowed to roam for 10 minutes. Time (seconds) 
spent in each zone and distance traveled was recorded. Animals were removed from 
the study if they never entered the light side during the entire testing period. Statistical 
analyses were performed for percent time spent (PTS) in the light, percent distance 
traveled (PDT) in the light, latency to enter the light, and total locomotor activity by two-
way ANOVA followed by Tukey’s HSD post-hoc test for pairwise comparisons where 
applicable.  
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 Ethanol Metabolism Time Course. Blood ethanol concentration (BEC) was 
measured at various time points following administration of high dose ethanol to 
determine the effect of genotype on ethanol metabolism. Male mice between 9 and 12 
weeks of age were administered 4.0 g/kg ethanol and blood was collected via 
submandibular cheek punch at 10-, 30-, 60-, 120-, and 240 minutes following i.p. 
injection. On a single day, blood was collected from an individual mouse at either one or 
two given time points. Each mouse was subjected to the procedure for 3 days, with 3 to 
5 days between ethanol administrations. Statistical analysis of the ethanol metabolism 
curve was performed using two-way ANOVA followed by Tukey’s HSD post-hoc to 
determine significance between genotypes at each time point. Linear regression was 
used to compare the slope of the metabolism curves and to correlate body mass to BEC 
at each time point. 
Tissue Collection and Preparation. As part of particular experiments, different 
tissue samples were taken for the purpose of correlating internal ethanol concentration 
to behavior. In two separate LORR experiments, blood was collected at Time 2 via 
submandibular cheek punch for the determination of BEC. In another LORR 
experiment, brain tissue was collected following cervical dislocation at Time 2 for the 
determination of brain ethanol concentration (BrEC). Blood samples procured during 
LORR and the for the ethanol metabolism time course were collected in BD microtainer 
tubes containing EDTA (Fisher Scientific, Waltham, MA) to prevent clotting. Samples 
were prepared for analysis by headspace gas chromatograph (GC) by aliquoting 20 µl 
of whole blood into 20 ml GC vials (Autosampler Guys, Alexandria, VA) containing 960 
µl deionized (DI) water and 20 µl of 0.1 mg/ml 1-propanol standard. Vials were capped 
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with steel screw-top septa and stored at -20 ˚C until processed. For BrEC, whole brain 
was collected and rinsed in ice-cold DI water and blotted with filter paper. The tissue 
was then placed in an ice-cold, pre-weighed 14 ml polypropylene tube (BD Biosciences, 
Franklin Lakes, NJ) and weighed to determine brain mass. Samples were then flash 
frozen on dry ice and stored at -80 ˚C until processing could continue. On ice, tissue 
was partially thawed in a Pyrex glass homogenizer (#7727-07) and diluted 1:4 with ice-
cold DI water. Homogenate was transferred to a GC vial and analyzed via headspace 
GC. Statistical analyses for BEC and BrEC were performed using Student’s t-test or 
one-way ANOVA followed by a Tukey’s post-hoc test where appropriate.  
 
Results 
Bdnfklox/klox mice maintained on a pair-feeding paradigm have comparable body mass to 
wildtype littermates. 
 It has been shown that Bdnfklox/klox mice’s obesity phenotype is solely the result of 
hyperphagia and can be prevented by maintaining the animals on a pair-feeding 
schedule (Liao et al., 2012). Preserving a comparable body mass between Bdnfklox/klox 
mice and their wildtype littermates was essential for the interpretation of many ethanol-
induced behaviors. After ethanol is absorbed, it is distributed throughout the various 
body tissues in direct proportion to the water content of each tissue. Since adipose 
tissue contains relatively less water, an increase would reduce the volume of distribution 
(Vd) for ethanol, resulting in higher BECs despite administration of equal doses. Figure 
5.1, a-b, demonstrates the pair-feeding paradigm’s utility to prevent Bdnfklox/klox mice 
from developing an obese phenotype. When Bdnfklox/klox mice have ad libitum access to  
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Figure 5.1 – Pair-feeding maintains comparable body mass between Bdnfklox/klox 
mice and wildtype littermates. (a) Female (and male) Bdnfklox/klox mice given ad libitum 
access to food have significantly different body masses compared to wildtype animals. 
Two-way ANOVA, Bonferroni post-hoc analysis, main effect of genotype F[1,91] = 
475.3, main effect of week F[12,91] = 62.57, and significant interaction F[12,91] = 21.84, 
*p < 0.05, n = 1-6/group. (b) Pair-fed male Bdnfklox/klox mice maintained comparable 
body masses compared to wildtype animals. Two-way ANOVA, Bonferroni post-hoc 
analysis, main effect of genotype F[1,699] = 96.44, main effect of week F[11,699] = 
176.5, but no significant interaction genotype x week, *p < 0.05, n = 16-46/group. 
a 
b 
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food, their body mass significantly differs from wildtype as early as 7 weeks of age. 
While Figure 5.1, a, depicts this phenomenon in female mice, this same trend has been 
observed in male mice (Liao et al., 2012). Restricting male Bdnfklox/klox mice to the 
quantity of food consumed by their wildtype counterparts promoted maintenance of a 
“normal” body mass throughout the time frame of experimentation (Figure 5.1, b). 
 
Bdnfklox/klox mice have an altered acute ethanol locomotor dose response profile. 
 The biphasic response to ethanol in rodent models, where relatively large doses 
are known to decrease locomotor activity while smaller doses are reported to increase 
locomotor activity, is well established (Wallgren & Barry, 1970; Pohorecky, 1997). 
However, the locomotor activating effect of low dose ethanol is strain dependent, and is 
considered virtually absent in C57BL/J6 (B6) mice (Phillips et al., 1995). Since 
Bdnfklox/klox mice are maintained on a B6 genetic background, this could explain the 
shallow locomotor dose response observed in both the 10 and 60 minute time bins for 
both genotypes (Figure 5.2, a, b). Nevertheless, wildtype littermates exhibited 
significantly augmented locomotor activity following 2.0 and 2.5 g/kg ethanol as 
compared to saline in the 10 minute time bin immediately following injection (Figure 5.2, 
a). In contrast, Bdnfklox/klox mice demonstrated locomotor activation in response to 1.0 
g/kg ethanol as compared to saline in both the 10 and 60 minute time bins and this level 
of activity was significantly different from wildtype mice when comparing the 60 minute 
time bin (Figure 5.2, a, b). Furthermore, Bdnfklox/klox mice revealed a biphasic locomotor 
response over the doses tested, displaying a reduced level of activity at 2.5 g/kg ethanol 
as compared to wildtype littermates in both 10 and 60 minute time bins (Figure 5.2, a, 
b). A time course of the data for each dose was plotted in 5 minute time bins throughout  
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Figure 5.2 – Locomotor Activity Dose Response Curves. Bdnfklox/klox and wildtype 
mice that received various ethanol doses were placed in the locomotor activity 
chambers and locomotor activity was recorded. Distance traveled is reported for (a) the 
first 10 minute time bin (two-way ANOVA, Tukey’s HSD post-hoc, main effect of dose 
F[4,82] = 3.982, significant interaction genotype x dose F[4,82] = 2.864, *p < 0.05 
between genotypes, #p < 0.05 compared to wildtype saline, $p < 0.05 compared to 
klox/klox saline, n = 8-10/group) and (b) the full 60 minute testing session (two-way 
ANOVA, Tukey’s HSD post-hoc, significant interaction genotype x dose F[4,82] = 3.004, 
*p < 0.05 between genotypes, $p < 0.05 compared to klox/klox saline, n = 8-10/group).
a 
b 
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 the 60 minute testing period (Figure 5.3, a-e). Interestingly, the locomotor activation of 
Bdnfklox/klox mice induced by 1.0 g/kg ethanol was sustained almost throughout the entire 
60 minute testing period, remaining significantly different from wildtype mice at the 5, 
10, 15, 20, 35, 50, and 60 minute time bins (Figure 5.3, b). Additionally, when 
examining the 2.5 g/kg ethanol treatment time course in Bdnfklox/klox mice, a significant 
decrease in activity below saline baseline levels was observed at the 20 minute time 
bin, with a trend at the 15 minute time bin (Figure 5.3, f). This suggests a sedative effect 
of 2.5 g/kg ethanol in the Bdnfklox/klox mice that was not observed in the wildtype 
littermates.  
 Although the Bdnfklox/klox mice used in this experiment were pair-fed, there was a 
concern that a difference in Vd as a result of dissimilar lean body mass between the 
genotypes would contribute to a shift in the locomotor dose response curve. While there 
was a main effect of genotype, no significant difference in body mass could be detected 
between the genotypes for any particular treatment group (Figure 5.4). Correlation 
between body mass and distance traveled was also examined for the ethanol doses 
that exhibited differences between the genotypes. No correlation was found between 
body mass and locomotor activity following 1.0 g/kg ethanol in the significant time bin of 
60 minutes for the Bdnfklox/klox mice alone (Figure 5.5, a) or when considering Bdnfklox/klox 
and wildtype mice (Figure 5.5, b). Similarly, no correlation was found between body 
mass and locomotor activity following 2.5 g/kg in the significant time bin of 10 minutes 
(Figure 5.5, c, d). Therefore, it was unlikely that body mass was contributing to the 
genotypic effect on locomotor dose response profile.  
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Figure 5.4 – Body mass of animals used for locomotor dose response. When 
comparing the body mass between the genotypes, broken down by treatment, there 
was a main effect of genotype (two-way ANOVA, F[1, 82] =  5.348), but no effect of 
dose and no significant interaction genotype x dose (n = 8-10/group). 
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Figure 5.5 – Correlation between body mass and locomotor activity. There was no 
significant correlation between mass and locomotor activity under any of the conditions 
examined (a) 60 minute locomotor activity after 1.0 g/kg in Bdnfklox/klox mice (F[1,6] = 
0.1640, r = 0.16, p = 0.6988) (b) 60 minute locomotor activity after 1.0 g/kg in all mice 
(F[1,6] = 0.01817, r = 0.03, p = 0.8945) (c) 10 minute locomotor activity after 2.5 g/kg in 
Bdnfklox/klox mice (F[1,6] = 0.2122, r = 0.18, p = 0.6612) (d) 10 minute locomotor activity 
after 2.5 g/kg in all mice (F[1,6] = 0.00697, r = 0.02, p = 0.9345). 
  
c 
a b 
d 
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 Bdnfklox/klox mice exhibit longer ethanol LORR sleep times. 
 Initial investigations into the sedative-hypnotic properties of ethanol using LORR 
were performed with a cohort of non-pair-fed Bdnfklox/klox mice. This experiment also 
utilized two heterozygous klox mice which exhibited no detectable phenotypic 
differences from wildtype animals in the LORR assay. The data for these two genotypes 
was collapsed for the purpose of statistical analysis and the resulting group was 
referred to “Littermates”. Animals lacking synaptically targeted Bdnf had significantly 
greater duration of LORR, sleeping 3.8x longer than “Littermate” controls (Figure 5.6, c). 
No difference in latency to LORR was observed (Figure 5.6, b).  There was an obvious 
inequality in body mass between the non-pair-fed Bdnfklox/klox and “Littermate” animals 
(Figure 5.6, d). This prompted the concurrent measurement of BEC at multiple time 
points to examine relative contributions of pharmacokinetic and pharmacodynamic 
factors to the altered phenotype (Figure 5.6, a). No difference in BEC at the time 
Bdnfklox/klox and “Littermate” animals regain righting reflex (Time 2) would suggest the 
increased duration of LORR displayed by Bdnfklox/klox was solely the result of an altered 
pharmacokinetic profile, producing an elevated BEC for an extended period of time in 
Bdnfklox/klox mice. In contrast, Bdnfklox/klox mice had a significantly lower BEC at Time 2 as 
compared to “Littermates” (Figure 5.6, e), suggesting a possible deficit in acute 
functional tolerance (AFT). The BEC of “Littermate” animals was tested at a second 
time point, which corresponded approximately to the Time 2 for Bdnfklox/klox mice. This 
was referred to as “Littermate” Time 3. No difference between Bdnfklox/klox Time 2 BEC 
and “Littermate” Time 3 BEC implied a similar pharmacokinetic profile (Figure 5.6, e).  
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Figure 5.6 – LORR in non-pair-fed Bdnfklox/klox mice. (a) Diagram of the LORR 
experimental design. (b) No significant difference in latency to LORR was detected 
between “Littermates” and non-pair-fed Bdnfklox/klox mice (Student’s t-test, t[12] = 0.1043) 
(c) A significant difference in duration of LORR between “Littermates” and non-pair-fed 
Bdnfklox/klox mice was detected (Student’s t-test, t[12] =5.384, *p < 0.0001) (d) A 
significant difference in body mass between “Littermates” and non-pair-fed Bdnfklox/klox 
mice was detected (Student’s t-test, t[12] =5.305, *p = 0.0025) (e) There was a 
significant difference in BEC between “Littermates” at Time 2 and “Littermates” at Time 
3 and non-pair-fed Bdnfklox/klox at Time 2 (one-way ANOVA, t[2,15] = 19.28, *p < 0.001) 
(n = 6-8/group). 
“Littermate” Time 3 Time 0 
“Littermate” 
Time 2  Time 1 
Bdnf klox/klox Time 2 
0hr                1hr               2hr                  3hr 4hr                                        
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To further demonstrate that the enhanced sleep time in Bdnfklox/klox mice was not 
exclusively the result of increased body mass, LORR was performed in pair-fed 
Bdnfklox/klox and wildtype mice (Figure 5.7). A significant effect of genotype was found for 
duration of LORR (Figure 5.7, b) between groups of mice that had similar body masses 
(Figure 5.7, c). The observed effect was not as robust as with non-pair-fed animals, 
suggesting that the duration of LORR in non-pair-fed Bdnfklox/klox mice was probably 
attributable to a combination of altered pharmacokinetics and pharmacodynamics. 
BECs measured at Time 2 for this cohort of mice once again indicated that Bdnfklox/klox 
mice required lower blood ethanol concentrations to regain LORR (Figure 5.8, a). To 
establish there was not an altered blood: brain ethanol ratio in Bdnfklox/klox mice that 
contributed to the phenotype, another group of mice was subjected to LORR, and whole 
brain samples were collected for the determination of BrEC. A significant decrease in 
BrEC at Time 2 confirmed that the sedative effect of ethanol persisted at lower internal 
ethanol concentrations in Bdnfklox/klox mice compared to wildtype littermates (Figure 5.8, 
b).   
 Correlation analysis was used to further determine the potential impact of body 
mass on ethanol LORR. The latency and duration data for pair-fed Bdnfklox/klox and 
wildtype mice from all experiments were collapsed and plotted against body mass. A 
moderately strong positive linear relationship was found between body mass and 
duration when both genotypes were included, but no relationship was detected for 
latency to LORR (Figure 5.9, a, b). The data was broken down to examine the 
contribution of each genotype to the relationship between body mass and LORR. 
Interestingly, no significant correlation was detected for mass and duration within the 
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Figure 5.7 – LORR in pair-fed Bdnfklox/klox mice. (a) No significant difference in latency 
to LORR was detected between wildtype and pair-fed Bdnfklox/klox mice (Student’s t-test, 
t[8] = 0.2198) (b) There was a significant difference in duration of LORR between 
wildtype and pair-fed Bdnfklox/klox mice (Student’s t-test, t[8] =5.101, *p = 0.0009) (d) 
There was no difference in body mass between wildtype and pair-fed Bdnfklox/klox mice 
(Student’s t-test, t[8] = 1.344), (n = 5/group). 
  
a 
c 
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Figure 5.8 – Internal ethanol concentration of pair-fed Bdnfklox/klox mice at LORR 
Time 2. At the relative time of regaining loss of righting reflex, Bdnfklox/klox mice have 
lower (a) BEC (Student’s t-test, t[8] = 2.49, *p = 0.0375) and (b) BrEC (Student’s t-test, 
t[17] = 4.205, *p = 0.0006) as compared to wildtype animals (n = 5-10/group).  
  
a 
b 
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Figure 5.9 – Correlation between body mass and latency and duration of LORR. 
Subjects from all pair-fed animal LORR experiments were pooled for correlation 
analysis. (a) There was no significant correlation between body mass and latency to 
LORR (F[1,33] = 0.004, r = 0.011, p = 0.9459, n = 35/group) (b) A moderately strong 
positive linear relationship was found between body mass and duration (F[1,33] = 25.63, 
r = 0.66, p < 0.0001, n = 35/group)  (c) A fairly strong positive relationship was found in 
the wildtype animals (F[1,18] = 6.549, r = 0.52, p = 0.0197, n = 20/group) (d) No 
significant correlation was detected for pair-fed Bdnfklox/klox mice (F[1,13] = 2.056, r = 
0.37, p = 0.1752, n = 15/group).  
 
 
a 
c 
b 
d 
 143 
 
pair-fed Bdnfklox/klox mice (Figure 5.9, d), while a fairly strong positive relationship was 
found in the wildtype animals (Figure 5.9, c). These results indicated that even amongst 
wildtype mice, pharmacokinetics may play a role in duration of LORR. This concept is 
compatible with data from the human literature that shows differences in lean body 
mass between males and females contributes to observed differences in impairment 
after administration of equivalent doses of alcohol adjusted for body weight 
(Mumenthaler et al., 1999). This outcome suggests the need for increased awareness 
of balancing all variables, including weight, when dividing subjects into treatment groups 
for LORR.  
 
Bdnfklox/klox mice consume more ethanol, quinine, and saccharin in two-bottle choice. 
 In the voluntary two-bottle choice paradigm, Bdnfklox/klox mice exhibited a 
concentration-dependent increase in ethanol intake, consuming significantly more 15% 
but not 7.5% ethanol as compared to wildtype littermates (Figure 5.10, a). Although not 
significant, there was an apparent trend toward increased consumption for the 7.5% 
concentration. Bdnfklox/klox mice also consumed a greater amount of 15% ethanol as 
compared to 7.5% ethanol whereas wildtype mice’s level of consumption did not change 
between concentrations. For ethanol preference there was a main effect of 
concentration, as both genotypes had a greater preference ratio for 7.5% ethanol than 
15% ethanol (Figure 5.10, b). Although there was a trend, no significant difference in 
preference between Bdnfklox/klox and wildtype mice was detected at either concentration. 
The concentration-dependent increase in ethanol intake by Bdnfklox/klox mice was not the 
result of differences in total fluid intake, as no effect of genotype or ethanol  
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Figure 5.10 – Altered ethanol consumption in Bdnfklox/klox mice. In a classical two-
bottle choice paradigm Bdnfklox/klox mice had (a) greater daily intake of 15% ethanol as 
compared to 7.5% (F[1,33] = 10.467, *p = 0.002) and greater daily intake of 15% 
ethanol as compared to wildtype (F[1,33] = 5.609, #p = 0.012). There was a trend for 
greater intake at 7.5% between genotypes (F[1,33] = 10.467, p = 0.106) (b) Both 
wildtype and Bdnfklox/klox mice exhibited decreased preference for 15% ethanol as 
compared to 7.5% (F[1,33] = 62.46, *p < 0.001), but no difference between genotype 
was detected (F[1,33] = 2.623, p = 0.115) (c) No difference in average daily fluid intake 
was detected between ethanol concentrations, but there was a trend for genotype 
(F[1,33] = 0.349, p = 0.559, F[1,33] = 3.395, p = 0.074). (Two-way, repeated measures 
ANOVA, Tukey’s HSD post-hoc, n = 15-20/genotype). 
  
a 
c 
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concentration was detected (Figure 5.10, c). Of note, ethanol intake for both wildtype 
and Bdnfklox/klox mice was substantially lower than C57BL/6J intake levels previously 
reported by this lab (~10g/kg/18hr) (Khisti et al., 2006), indicating a possible 
confounding effect of environmental factors specific to this study. 
 Ethanol is consumed orally and it has been shown that genetic manipulations 
that alter taste perception can lead to changes in ethanol preference and consumption 
(Blednov et al., 2008). Therefore, taste preference studies are typically performed to 
test altered palatability of sweet and bitter tastes that could confound genotypic 
differences in ethanol consumption. Moderate aversion to bitter taste was tested using 
30 µM QHCl, a concentration previously used in the literature (Bachmanov et al., 1996; 
Tordoff, 2007). Bdnfklox/klox mice had a significantly greater intake of 30 µM QHCl as 
compared to wildtype mice (Figure 5.11, a), with no difference in total fluid consumed, 
but a trend towards increased preference in Bdnfklox/klox mice (Figure 5.11, b, c). This 
concentration of QHCl did not result in aversion for either genotype (one-sample t-test, 
µ = 0.50, twildtype[14] = 1.7023, p = 0.1108, tklox/klox[19] = 0.2516, p = 0.8040). Therefore 
animals were retested with 75 µM QHCl, in an attempt to alter preference. Once again, 
Bdnfklox/klox mice had greater intake of 75 µM QHCL (Figure 5.11, d), this time with a 
significant increase in preference for the bitter tastant as compared to wildtype (Figure 
5.11, e). Proclivity for consumption of sweet tasting solutions was measured using 2 
mM saccharin, a concentration previously used in the literature (Tordoff, 2007). 
Bdnfklox/klox mice consumed greater quantities of 2 mM saccharin as compared to 
wildtype (Figure 5.11, g), with no difference in preference between the genotypes as a 
result of the significantly greater volume of fluid consumed by Bdnfklox/klox animals  
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Figure 5.11 – Altered quinine and saccharin consumption in Bdnfklox/klox mice. 
Taste preference studies were performed to test taste palatability of sweet and bitter 
tastants. Average daily intake, preference, and total fluid consumption was measured 
for (a-c) 30 µM QHCl (t[33] = 2.349, *p = 0.03, t[33] = 1.636, p = 0.11, t[33] = 1.479, p = 
0.11) (d-f) 75 µM QHCl (t[33] = 3.275, *p = 0.03, t[33] = 1.982, *p = 0.05, t[33] =1.791, p 
= 0.08)  (g-i) 2 mM saccharin (t[33] = 4.352, *p = 0.0001, t[33] = 1.464, p = 0.15, t[33] 
=4.479, *p < 0.0001) (j-k) 0.5 mM saccharin (t[33] = 1.335, p = 0.19, t[33] = 0.8970, p = 
0.38, t[33] =2.252, p = 0.03). Student’s t-test, n = 15-20/genotype. 
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(Figure 5.11, h, i). In an attempt to determine if a difference in preference for saccharin 
actually existed between the genotypes, animals were retested with a 0.5 mM solution. 
At this concentration, no difference in intake or preference was found (Figure 5.11, j, k), 
despite a significant preference over water for both genotypes (one-sample t-test, µ = 
0.50, twildtype[14] = 8.5988, p < 0.0001, tklox/klox[19] = 18.1594, p < 0.0001). The results of 
these taste preference experiments obfuscate the finding that Bdnfklox/klox mice had a 
concentration-dependent increase in ethanol intake. Differences in saccharin 
consumption do not necessarily negate the significance of increased ethanol intake, 
since hedonic responses to sweet tastes are considered a biomarker of predisposition 
to alcoholism in humans (Kampov-Polevoy et al., 2004). However, in conjunction with 
the QHCl results, the voluntary consumption data is difficult to interpret.  
 
Wildtype and Bdnfklox/klox mice display similar preference in ethanol CPP. 
 A previous study reported that Bdnf+/- mice exhibit enhanced preference scores 
in ethanol CPP (McGough et al., 2004). Additionally, rats injected with a lentivirus over-
expressing Bdnf in the dorsal lateral striatum had attenuated ethanol-induced 
conditioned preference (Bahi & Dreyer, 2013). A major component of the CPP paradigm 
is the learned association between conditioned stimulus and unconditioned stimulus 
(Bardo & Bevins, 2000) and synaptic plasticity is an important neurochemical foundation 
for the processes of learning and memory. It was therefore hypothesized that 
synaptically targeted Bdnf is involved in the conditioned response to ethanol, and that 
Bdnfklox/klox mice would have augmented preference scores as compared to wildtype 
animals. Following conditioning with saline-ethanol (2.0 g/kg) twice daily for 3 days,  
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Figure 5.12 – Ethanol CPP in Bdnfklox/klox mice. The rewarding properties of 2.0 g/kg 
ethanol were tested in Bdnfklox/klox and wildtype mice. (a) Both genotypes exhibited a 
significant preference for the chamber paired with ethanol (F[1,51] = 23.312, *p < 0.01, 
n = 12-14/group). However, there was no difference in preference score between 
genotypes (F[1,51] = 0.740, p = 0.394, n = 12-14/group). (b) There was no difference in 
the locomotor activity amongst any of the groups on test day (Fgenotype[1,23] = 0.0182, p 
= 0.894, Ftreatment[1,23] = 0.0600, p = 0.809, n = 6-7/group).  (c) While there was a trend, 
no significant difference in body mass was detected between genotypes (F[1,23] = 
3.739, p = 0.066). Treatment groups were equally balanced for body mass (F[1,23] = 
0.0763, p = 0.785, n = 6-7/group). (Two-way ANOVA, Tukey’s HSD post-hoc).  
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Bdnfklox/klox and wildtype mice both exhibited a place preference greater than animals 
that were paired with saline in both chambers (Figure 5.12, a). No genotypic difference 
in ethanol preference score was detected. Additionally, there was no significant 
difference in body mass or locomotor activity on test day between any of the 
experimental groups (Figure 5.12, b, c). These results suggest that a lack of 
synaptically targeted Bdnf does not alter the reward-like properties of ethanol as 
measured by CPP.  
 
Bdnfklox/klox mice have reduced basal anxiety-like behavior.  
 A pilot study to examine the function of synaptically targeted Bdnf in ethanol-
induced anxiolysis was performed utilizing the light-dark box (LDB) model of anxiety. 
Basal anxiety-like behavior was assessed with administration of 0.9% saline. Ethanol-
induced anxiolysis was evaluated using 1.5 g/kg ethanol, a dose that did not produce a 
differential locomotor response between the genotypes (Figure 5.2, 5.3, c). Previous 
dose-response studies in our laboratory had determined that a 1.8 g/kg dose of ethanol 
elicits a significant increase in PTS and PDT in the light. This dose was found to cause 
marked decreases in total distance traveled by Bdnfklox/klox mice in the LDB assay (data 
not shown). Figure 5.13 depicts the results of the present study, which found a main 
effect of genotype for both PTS and PDT in the light, with a significant increase for 
Bdnfklox/klox as compared to wildtype in saline treated animals (Figure 5.13, a, b). 
Although there was a trend, no difference was found between the genotypes when 
treated with ethanol and there was no main effect of treatment. The effect of genotype 
was not detected when looking at latency to enter the light (Figure 5.13, c). However,  
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Figure 5.13 – Light-dark box (LDB) assay for anxiety-like behavior in Bdnfklox/klox 
mice. Basal anxiety-like behavior and ethanol-induced anxiolysis were measured in 
Bdnfklox/klox and wildtype mice. Bdnfklox/klox mice had a significant increase in basal (a) 
PTS (F[1,30] = 9.131, *p = 0.008) and (b) PDT in the light (F[1,30] = 9.131, *p = 0.002). 
There was a trend for a difference between genotypes in both PTS and PDT following 
1.5 g/kg ethanol (F[1,30] = 9.131, p = 0.162, F[1,30] = 9.131, p = 0.072)  (c) There was 
no effect of genotype or treatment on latency to enter the light compartment, although 
this measure exhibited high variability ((F[1,29] = 0.394, p = 0.535, F[1,29] = 0.219, p = 
0.643). (d) Total distance traveled in the LDB assay was not affected by genotype or 
ethanol treatment (Fgenotype[1,30] = 2.009, p = 0.167, Ftreatment[1,30] = 0.215, p = 0.647). 
(Two-way ANOVA, Tukey’s HSD post-hoc, n = 5-14/group).  
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there was a trend towards increased latency in the Bdnfklox/klox mice after ethanol as 
compared to wildtype, which was in contrast to the PTS and PDT data. Overall, there 
was no significant difference in total locomotor activity amongst any of the groups 
(Figure 5.13, d). These data indicate that Bdnfklox/klox mice have a lower basal anxiety-
like behavior, and suggest no effect of 1.5 g/kg ethanol in either genotype. However, 
this was a preliminary assessment, and therefore experiments need to be repeated with 
larger sample sizes to make any definitive conclusions. Furthermore, since “anxiety” is a 
complex trait comprised of multiple phenotypic dimensions (Cryan & Holmes, 2005; 
Ramos, 2008), it may be prudent to test these mice in other anxiety-like behavior 
models, such as elevated plus maze or marble burying, to dissect the underlying factors 
contributing to the basal response in Bdnfklox/klox mice.  
 
Bdnfklox/klox mice have an altered ethanol metabolism time course. 
  Ethanol metabolism was assessed to further investigate possible alterations in 
pharmacokinetic profiles between genotypes. As expected, BEC decreased significantly 
with time (Figure 5.14, a). There was also a main effect of genotype, but post-hoc 
analysis only found a significant difference between wildtype and Bdnfklox/klox mice at the 
10 minute time point. Linear regression analysis concluded that the slopes of the 
metabolism curves were significantly different (Figure 5.14, a), suggesting a faster rate 
of metabolism in Bdnfklox/klox mice. For the mice used in this experiment, a main effect of 
genotype was detected when analyzing body mass (Figure 5.14, b). However, no 
difference was detected between animals used for any particular time point. Further  
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Figure 5.14 – Ethanol metabolism time course for Bdnfklox/klox and wildtype mice. 
(a) Analysis of the ethanol metabolism time course found a main effect of genotype and 
time, but no significant interaction of genotype x time (Fgenotype[1,34] = 10.614, p = 0.003, 
Ftime[4,34] = 59.232, p < 0.001, Finteraction[4,34] = 0.374, p = 0.825). Bdnf
klox/klox mice had 
a significantly different BEC at the 10 minute time point as compared to wildtype (*p = 
0.043). Linear regression determined that the metabolism curves for Bdnfklox/klox and 
wildtype mice had significantly different slopes, indicating a difference in rate of ethanol 
metabolism (wildtype slope = -0.009709 ± 0.0001182, Bdnfklox/klox slope = -0.01110 ± 
0.0004791, F[1,6] = 7.89, p = 0.03). (b) Statistical analysis of body mass for the 
genotypes, broken down by time point, reveals a main effect of genotype, but no 
significant difference at any given time point (Two-way ANOVA, Tukey’s HSD post-hoc, 
F[1,34] = 4.179, p = 0.049, n = 4-5/group). 
  
a 
b 
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Figure 5.15 – Correlation between body mass and BEC. Linear regression was used 
to examine the correlation between body mass and BEC for Bdnfklox/klox and wildtype 
mice at each time point. (a) 10 minute F[1,7] =1.185, r = 0.38, p = 0.31 (b) 30  minute 
F[1,6] =1.185, r = 0.04, p = 0.91 (c) 10 minute F[1,6] =0.001, r = 0.02, p = 0.9698 (d) 10 
minute F[1,7] =0.013, r = 0.04, p = 0.9109 (e) 10 minute F[1,8] =0.1379, r = 0.13, p = 
0.72). 
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examination into the relationship between body mass and BEC at each time point found 
no significant correlation (Figure 5.15, a-e). 
 
Discussion 
Bdnfklox/klox mice provided a unique model to study the implications of altered 
synaptic trafficking of an ethanol responsive gene. A behavioral characterization of 
these mice revealed the importance of proper mRNA localization in ethanol-responsive 
behaviors. In particular, ethanol-induced locomotor activation and LORR were found to 
be susceptible to changes in Bdnf transport. This series of experiments indicated that  
Bdnfklox/klox mice have an altered pharmacokinetic profile. However, evidence also 
suggests they have a greater sensitivity to both low and high dose ethanol that was the 
result of altered pharmacodynamic properties of the drug.  
The biphasic behavioral response to ethanol is thought to reflect ethanol’s action 
at multiple receptor and neurotransmitter systems (Grant, 1999; Quertemont et al., 
2003). Support for this comes from ethanol discriminative stimulus studies that show the 
substitution pattern of various receptor ligands, such as GABAA, NMDA, and 5-HT, are 
dose and time dependent (Colombo & Grant, 1992; Grant & Colombo, 1993; Grant et 
al., 1997; Green & Grant, 1998; Quertemont et al., 2003). In particular, the actions of 
low and intermediate doses of ethanol appear to be mediated by GABAA positive 
modulation and 5-HT1 agonism (Grant & Colombo, 1993; Grant et al., 1997; Green & 
Grant, 1998). At higher doses, ethanol’s antagonism of NMDA receptors appears more 
influential to the discriminative stimulus (Green & Grant, 1998). Our results showed that 
Bdnfklox/klox mice had increased sensitivity to both low dose ethanol (increased locomotor 
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activity at 1.0 g/kg ethanol, Figure 5.2) and high dose ethanol (decreased locomotor 
activity at 2.5 g/kg and enhanced duration of LORR, Figure 5.2 and Figure 5.7, b). This 
suggests that Bdnfklox/klox mice may have altered functioning of multiple receptor-
signaling cascades as a result of reduced trafficking of Bdnf to the synapse. This is not 
unfounded conjecture, as BDNF signaling has been shown to modulate several 
neurotransmitter systems; including GABA and glutamate (Tanaka et al., 1997; Levine 
et al., 1998; Lin et al., 1998; Brunig et al., 2001; Jovanovic et al., 2004). Additionally, 
Bdnf heterozygous knockouts (Korte et al., 1995) and  Bdnfklox/klox mice (An et al., 2008) 
have been shown to have altered CA1 region long-term potentiation (LTP); an NMDA 
receptor-dependent form of LTP (Tsien et al., 1996). 
Alternatively, the observed difference in metabolism between Bdnfklox/klox mice 
and wildtype littermates (Figure 5.14, a) suggests that increased ethanol sensitivity to 
low and high doses may result from a shift in the dose response curve. An examination 
of our ethanol-induced locomotor activity data indicates this is not a sufficient 
explanation. Bdnfklox/klox mice exhibited an increased level of response to 1 g/kg ethanol 
that extended for the entire 60 minute testing period (Figure 5.3, b). This protracted 
response was not observed in wildtype animals at any tested dose. Testing higher 
doses would elicit sedating effects of ethanol in wildtype mice, not an activating 
response. While a residual difference in lean body mass of the pair-fed animals cannot 
be overlooked as a potential factor, these data suggest a pharmacodynamic mechanism 
is involved.  
Our LORR data also indicates that the increased sensitivity of Bdnfklox/klox mice is 
not exclusively the consequence of an altered pharmacokinetic profile. From blood 
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collected during LORR, we observed that wildtype mice regained their righting reflex at 
a BEC of 3.39 mg/mL (Figure 5.8, a), after a period of 79.6 minutes (Figure 5.7, b). 
Even if volume of distribution was a factor, Bdnfklox/klox mice should still have regained 
their righting reflex at a similar BEC to wildtype animals, but at a later time. From the 
ethanol metabolism curve, it was determined that Bdnfklox/klox animals were reaching a 
BEC of 3.39 mg/ml at an average time of 101.4 minutes. This was not significantly 
different from the time wildtype mice reached this BEC, but was significant from the 
average time at which Bdnfklox/klox mice were regaining their righting reflex, 128.9 
minutes (one-sample, one-tailed t-test, t[4] = -2.3469, p = 0.03939). One explanation is 
that Bdnfklox/klox mice have an aberrant AFT, or a reduced capacity for the rapid 
neuroadaptations that occur during a single exposure to ethanol that result in less 
impairment during the falling phase of the BEC curve as compared to the same BEC in 
the rising phase. To confirm this hypothesis, BEC should be measured at Time 1 and a 
more accurate measurement of latency to LORR is required. The Crabbe/Ponomarev 
protocol for LORR improves detection of onset by utilizing a restraint apparatus that 
decreases the loss-of-function criterion from 30 second to 5 second intervals 
(Ponomarev & Crabbe, 2002). In conjunction with BEC determination at Time 1, this 
would increase sensitivity of AFT determination. 
While our studies were in progress, a report was published using Bdnf 
heterozygous knockout mice which were shown to exhibit enhanced duration of LORR 
(Kim et al., 2012). The authors of this paper also made use of adenylyl cyclase (AC) 5 
KO and heterozygous Camk2a mice. AC5 null mice had an up-regulation of BDNF in 
the dorsal striatum (DS), but not the NAc, and exhibited a reduced duration of LORR. In 
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contrast, Camk2a+/- mice had decreased levels of BDNF in the DS and enhanced 
duration of LORR. In addition, the AC5 KO mice had increased basal levels of p-NR2B 
in the DS, but not the NAc. Phosphorylation of NR2B by the non-receptor tyrosine 
kinase, Fyn, has been shown to modulate the acute sedative-hypnotic properties of 
alcohol, and is thought to contribute to the development of AFT (Miyakawa et al., 1997; 
Yaka et al., 2003b). BDNF signaling, through its high affinity receptor, TrkB, has been 
shown to rapidly modulate NMDA receptor function through phosphorylation by Fyn 
kinase in the hippocampus and mPFC (Levine et al., 1998; Lin et al., 1998; Xu et al., 
2006; Otis et al., 2014). This specific pathway has yet to be verified in the striatum. The 
Kim et al. (2012) study, in conjunction with our work, was the first to demonstrate a 
function of BDNF in duration of LORR following acute ethanol exposure. Together they 
suggest that BDNF, perhaps specifically through translation of its synaptically trafficked 
message, is involved in the modulation of NMDA receptors, contributing to AFT.   
While the lack of synaptically targeted Bdnf seems to alter sensitivity to both low 
and high dose ethanol, its effect on the rewarding properties of the drug is more 
ambiguous. Due to the hyperphagic nature of Bdnfklox/klox mice, the use of a pair-feeding 
paradigm was necessary to maintain body masses comparable to wildtype animals. 
This required a restriction on the amount of food these mice would naturally consume. It 
has been suggested that the rewarding effects of drugs of abuse are mediated by 
neural substrates that control the incentive-motivating effects of natural reinforcers, 
such as food (Wise, 1982; Koob, 1992). The fact that food restriction enhances the 
central rewarding effects of abused drugs is well established (Carroll et al., 1979; 
Cabeza de Vaca & Carr, 1998; Stuber et al., 2002). For instance, food restriction has 
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been shown to enhance self-administration and CPP by the psychostimulants cocaine 
and amphetamine (Carroll et al., 1979; Bell et al., 1997; Cabeza de Vaca & Carr, 1998; 
Stuber et al., 2002). There is ample evidence that the regulation occurs through 
molecular adaptations in the NAc involving the dopamine signaling pathway, particularly 
downstream of the D1 receptor (Haberny et al., 2004; Pan et al., 2006; Zhen et al., 
2006; Carr et al., 2009). Despite the pair-feeding schedule, Bdnfklox/klox mice did not 
show a difference in ethanol-induced CPP compared to wildtype (Figure 5.12, a). This 
suggests that ethanol’s rewarding properties are not altered in these mice. However, a 
more appropriate interpretation of results would require an experimental deign that uses 
both pair-fed and non-pair animals.   
Food restriction has also been shown to affect ethanol consumption, in a strain-
specific manner. Schroff, et al., (2004) showed that after a 12 day food restriction, which 
resulted in a 20% loss of body weight followed by a recovery period, B6 but not D2 mice 
had higher ethanol intake and preference in a two-bottle choice paradigm (Schroff et al., 
2004). Our two-bottle choice drinking studies do show that Bdnfklox/klox mice have an 
increased avidity for consumption of ethanol (Figure 5.10, a). However, food restriction 
cannot be eliminated as a cause. Not only is there a potential for altered brain 
chemistry, but a simple attempt to supplement caloric intake may be the underlying 
basis for the behavior. Various controls were considered for the drinking studies, 
including giving the mice access to saccharin-adulterated ethanol and isocaloric 
sucrose. These solutions would have been made equivalent in caloric value, and 
balanced for level of sweetness. Unfortunately, our taste preference studies indicated 
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differential consumption of saccharin between the genotypes (Figure 5.11, j) that would 
have confounded these studies as well.  
Evidence in the literature suggests that the increased consumption of saccharin 
in the Bdnfklox/klox mice may be the result of altered leptin signaling. Bdnfklox/klox mice lack 
the long 3’ UTR containing Bdnf transcript that is preferentially trafficked to the synapse. 
This has been shown to compromise the ability of leptin, an anorectic hormone, to 
activate hypothalamic neurons and perform its central function of inhibiting food intake, 
contributing to the hyperphagic obesity in these mice (Liao et al., 2012). Administration 
of leptin has been shown to reduce sucrose self-administration in rats through a 
centrally mediated mechanism (Figlewicz et al., 2006). It has also been shown to 
suppress responses of peripheral taste nerves to both saccharin and sucrose (Kawai et 
al., 2000). However, leptin administration did not affect response of peripheral taste 
nerves to quinine (Kawai et al., 2000). Further research will be required to determine the 
cause of altered quinine palatability in Bdnfklox/klox mice, but it could indicate disrupted 
orosensory functioning or a deficit in taste processing. 
While Bdnfklox/klox mice did provide a distinctly unique model to investigate 
disruption in mRNA trafficking of a known ethanol-responsive gene, it was not without 
its limitations. First, these mice are a traditional knock-in strain. An inherent 
disadvantage being that the missing transcript variant was not expressed throughout 
development. This is especially of concern since BDNF is particularly influential in the 
developing nervous system. However, simply because these phenotypes could be the 
result of developmental abnormalities does not diminish our findings. One could 
hypothesize that since synaptically targeted Bdnf has been shown to modulate dendritic 
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spine morphology (An et al., 2008), a developmental alteration in synaptic functioning 
could set up a neural circuitry that is differentially sensitive to ethanol. This system 
would still provide a resource for advancing the understanding of ethanol’s 
neuropharmacological actions. 
Another limitation is that these studies were not able to distinguish between the 
effects of reduced dendritic or increased somatic Bdnf on ethanol phenotypes. Evidence 
for a possible role of decreased dendritic Bdnf was established in the paper by An et al. 
(2008). Here they showed that overexpression of somatically restricted Bdnf in dorsal 
forebrain did not result in the same aberrant hippocampal dendritic spine morphology 
that was exhibited by Bdnfklox/klox mice. As a control for the present studies, a viral vector 
designed to overexpress the short 3’ UTR isoform of Bdnf into various brain regions 
could distinguish the function of the two populations of Bdnf mRNA. This would further 
test the hypothesis that synaptic trafficking of Bdnf is necessary for the synaptic 
plasticity that contributes to ethanol behavioral responses.  
Despite these limitations, this investigation was the first to show that disrupted 
mRNA localization of a known ethanol-responsive gene is sufficient to cause altered 
ethanol phenotypes. The manifestation of these behaviors was shown not to be 
completely dependent on pharmacokinetic mechanisms. The lack of synaptically 
targeted Bdnf resulted in greater ethanol sensitivity to both low and high dose ethanol 
which suggests an alteration to multiple neurotransmitter systems. In particular, loss of 
locally translated BDNF may hinder the compensatory regulation of NMDA receptors in 
response to ethanol, disrupting the development of AFT. In addition to the long 3’ UTR, 
a polymorphism, Val66Met, has also been shown to disrupt dendritic trafficking of Bdnf 
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(Chiaruttini et al., 2009). Data on the association between this variant and alcohol abuse 
disorders is inconsistent and appears dependent on ethnic population differences in 
allele frequency (Gratacos et al., 2007; Shin et al., 2010; Muschler et al., 2011; Nedic et 
al., 2013). However it suggests that further examination into genetic regulation of the 
synaptic mRNA populations and its potential effect on predisposition towards alcoholism 
is warranted.  
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Chapter 6 – Viral Vector Rescue of Bdnf klox/klox Altered Ethanol-Phenotypes 
 
Introduction 
 Local translation of the synaptic transcriptome is one mechanism by which the 
neuron achieves localized activity-dependent regulation of function at the level of the 
individual synapse (Steward & Levy, 1982). We have demonstrated through the 
research presented in  previous chapters, that not only is ethanol administration able to 
alter the complement of mRNA enriched at the synapse, but that at least some ethanol-
responsive behaviors require proper synaptic targeting of specific transcripts. In 
particular, this latter finding was shown by altering the dendritic targeting of Bdnf. 
 The Bdnfklox/klox mouse provided a unique model in which to examine the effect of 
altered dendritic trafficking of a known ethanol-responsive gene. These mice, which 
possess a truncated variant of the long 3’ UTR Bdnf isoform, were shown to have 
reduced synaptic Bdnf transcript and protein (An et al., 2008). Our studies revealed that 
Bdnfklox/klox mice exhibited altered sensitivity to both low and high dose ethanol. 
However, determining whether these behaviors resulted from diminished synaptic or 
increased somatic Bdnf was not possible from the studies presented in Chapter 5 of this 
thesis. 
Xu and colleagues, however, have previously used adeno-associated viral (AAV) 
vectors to express Bdnf constructs, compensating for loss of dendritically targeted Bdnf 
in Bdnfklox/klox mice. These vectors were designed to express Bdnf’s protein coding 
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sequence (CDS) linked to either the short 3’ UTR (AAV-BDNF-A) or the long 3’ UTR 
(AAV-BDNF-A*B) (Liao et al., 2012). AAV-BDNF-A included the sequence up to and 
including the first endogenous polyadenylation signal, while AAV-BDNF-A*B encoded 
the entire 3’ UTR, where the first polyadenylation signal was mutated. In a study of the 
effects of altered synaptic trafficking of Bdnf on obesity, AAV-BDNF-A injected 
bilaterally into the ventromedial hypothalamus of 2 week old Bdnfklox/klox pups only 
slightly reduced the body mass of the animals at 7 weeks of age (Liao et al., 2012). 
However, AAV-BDNF-A*B was able to completely ameliorated the obesity phenotype 
(Liao et al., 2012). This implicated a specific function for long 3’ UTR Bdnf required for 
development of the phenotype that could not be completely overcome with simple over-
expression of Bdnf. 
 As described in Chapter 5, Bdnfklox/klox mice had a significantly prolonged duration 
of ethanol loss of righting reflex (LORR). This was a consequence, at least in part, of 
altered pharmacodynamic actions of ethanol, and not simply the result of an altered 
pharmacokinetic profile. Through the use of Bdnf heterozygotes and siRNA knock-down 
of Bdnf, Kim et al. (2012) concluded that biochemical changes in the level of Bdnf in the 
dorsal striatum (DS) plays a critical role in ethanol-induced LORR (Kim, 2012). 
Additionally, Ron and colleagues have shown selective regulation of Bdnf expression in 
the DS, specifically the dorsolateral region, in response to ethanol (McGough et al., 
2004; Jeanblanc et al., 2009; Logrip et al., 2009). Thus, we selected the DS as a target 
area for delivery of AAV-BDNF vectors to more directly test the role of Bdnf dendritic 
targeting in the ethanol behavioral responses described in Chapter 5. 
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 It was hypothesized that injection of AAV-BDNF-A*B, but not AAV-BDNF-A, into 
the DS of Bdnfklox/klox mice would rescue the altered ethanol phenotypes exhibited as a 
result of the mutation. Furthermore, if the observed behaviors derived from lack of 
dendritic and not increased somatic Bdnf, injection of AAV-BDNF-A into the DS of 
wildtype mice was expected to have no effect on ethanol-induced LORR or locomotor 
activation. This experiment still does not explicitly identify the action of synaptically 
targeted Bdnf as the cause of the observed genotypic differences. However, discovering 
a unique function for long 3’ UTR containing Bdnf, which has been shown to be 
preferentially targeted to the dendrites, would be the first step in making this 
determination. 
 
Materials and Methods 
Plasmids. DNA for three plasmids (pAAV-BDNF-A, pAAV-BDNF-A*B, and pAAV-
GFP) were received on Whatman filter paper from Dr. Baoji Xu at Georgetown 
University Medical Center, Washington, DC, USA. The BDNF-expressing AAV 
constructs (Figure 6.1, a) were previously generated by first subcloning the 
cytomegalovirus (CMV) promoter, the mouse Bdnf coding sequence that is extended at 
its 3’ end with Myc epitope sequence, and the mouse genomic sequence encoding the 
short Bdnf 3’ UTR (A) or the long Bdnf 3’ UTR (A*B) into pBluescript II KS (-) (Liao et 
al., 2012). The entire CMV-BDNF-Myc-A and CMV-BDNF-Myc-AB were removed from 
the plasmid by NotI restriction digest. The plasmid, pAAV-MCS (Stratagene, La Jolla, 
CA) (Figure 6.1, b) was digested with NotI to remove a 1.7 kb fragment and the two NotI  
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Figure 6.1 – Plasmid diagrams. Schematic of the (a) pAAV-BDNF-A and pAAV-BDNF-
A*B plasmid constructs. Image reproduced with permission © Nature Medicine (Liao et 
al., 2012). (b) Backbone structure for the pAAV-MCS vector from Stratagene.  
  
a 
b 
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fragments, CMV-BDNF-Myc-A (1.8 kb) and CMV-BDNF-Myc-AB (4.2 kb), were 
subcloned into the pAAV-MCS (Liao et al., 2012). To extract the plasmids from the filter 
paper, a sterilized razor blade was used to cut around the outline that indicated the 
placement of DNA. The DNA-containing filter paper was then placed in a 1.5 ml 
microcentrifuge tube with 200 µL TE buffer and allowed to incubate for 2.5 hours at 
room temperature. A transformation reaction with XL-10 Gold E. Coli competent cells 
(Stratagene, La Jolla, CA) was set up for each of the three experimental plasmids, a 
positive control (pUC18), and a negative control (TE buffer) following the protocol from 
the Stratagene manual. Into a 14 ml cell culture tube, 100 µL of cells and 4 µL of 2-
mercaptoethanol were added and allowed to incubate with intermittent swirling for 10 
minutes. To each tube, either 5 µL of pAAV-BDNF-A, pAAV-BDNF-AB, pAAV-GFP or 1 
µL 0.01 ng/µL pUC18 was added. Reactions were kept on ice for 30 minutes. Cells 
were heat shocked for 30 seconds at 42˚C, and then placed on ice for 2 minutes. Pre-
warmed SOC media (900 µL) was added to each sample, which was then incubated at 
37˚C with shaking (200 rpm) for 3 hours. Transformed cells (100 µL for experimental 
plasmids, 5 µL for pUC18) were plated onto pre-warmed sterile 1.5% agar plates 
infused with100 µg/ml ampicillin. All plates were incubated at 37˚C overnight. After 13.5 
hours, single colonies were isolated and used to inoculate 5 ml of either Luria Broth (LB) 
containing NaCl and 100 µg/ml ampicillin or Terrific Broth (TB) containing 100 µg/ml 
ampicillin in 14 ml cell culture tubes. Cultures were allowed to grow for 8 hours at 37˚C 
while shaking. Bacterial glycerol stocks were made for each experimental plasmid from 
a 0.5 ml aliquot of culture and 0.5 ml 50% glycerol stock. Cryopreservation tubes were 
flash frozen on dry ice and then stored at -80˚C for long term storage. Remaining liquid 
 167 
 
cultures were centrifuged at 6000 rpm at 4˚C for 10 minutes and bacterial pellets were 
stored at -80˚C until further processing. Lysis, cleanup and DNA precipitation were 
performed using the QIAquick Spin Miniprep Kit (Qiagen, Venlo, Netherlands) according 
to the manufacturer’s instructions. This DNA was used to evaluate the purity and 
integrity of the plasmids by UV spectroscopy (NanoDrop 2000, Thermo Scientific, 
Rockford, IL), restriction enzyme digest/agarose gel electrophoresis, and sequencing. 
To prepare enough plasmid for AAV production, the same process was repeated using 
the bacterial glycerol stocks. However, after the 8 hour incubation, the liquid starter 
cultures (3 ml) were added to 500 ml of LB containing 100 µg/ml ampicillin in a 1 L 
Erlenmeyer flask. The flasks were incubated for no more than 16 hours at 37˚C at 200 
rpm. Once again cells were pelleted and lysis and DNA precipitation was performed 
using the endotoxin-free Qiagen Megaprep Kit according to manufacturer’s instructions. 
Plasmid DNA was diluted to 1 µg/uL in TE and 300 µL of each was sent to the 
University of North Carolina (UNC) – Chapel Hill Vector Core for AAV production.  
In vitro Viral Transduction. As per recommendation from Stratagene, a human 
fibrosarcoma cell line, AAV-HT1080 (Agilent Technologies, Santa Clara, CA) 
maintained in high-glucose DMEM containing 10% FBS, 2 mM L-glutamine and 50 U/ml 
penicillin/streptomycin, was used for all transduction experiments. For subsequent qRT-
PCR, immunoblotting, or immunocytochemistry assays, 0.25x106, 0.20x106, or 0.12x106 
cells respectively, were plated in 6-well dishes on the afternoon prior to transduction. 
The morning of transduction, media was removed from each well and replaced with 1 ml 
of fresh media containing viruses at a concentration sufficient for a multiplicity of 
infection (MOI) of 12,400 (this MOI had been previously determined to transduce an 
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adequate number of cells in an experiment using AAV-GFP). According to SignaGen® 
Laboratories (a supplier of AAV viruses) a range of 2,000 – 10,000 MOI for AAV is used 
for most cell lines; however some cells can require an MOI up to 500,000. Controls with 
no virus were also prepared. Plates were incubated with intermittent swirling for 6 hours 
in a humidified 37˚C/5% CO2 environment. Virus containing media was then removed 
from each well and replaced with 3 ml of DMEM (for cells to be used in qRT-PCR 18% 
FBS DMEM was used rather than 10% FBS DMEM). Cells were either harvested or 
fixed, depending on the downstream analysis, 48 hours following transduction.  
Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR). 
AAV-HT1080 cells transduced with AAV-BDNF-A, AAV-BDNF-A*B, AAV-GFP, or no 
virus, were pelleted, washed three times with 1x sterile PBS, and stored at -80˚C until 
further processing. Cells were lysed using Buffer RLT and RNA was extracted following 
the cell culture protocol from the RNeasy Mini Kit (Qiagen, Venlo, Netherlands). RNA 
concentration and purity was assessed using a NanoDrop 2000 (Thermo Scientific, 
Rockford, IL). All RNA samples had 260/280 ratio between 2.07 and 2.09. Total RNA 
from each sample (2 µg) was treated with Deoxyribonuclease I (Invitrogen, Carlsbad, 
CA). DNase-treated RNA (1 µg) was used to generate cDNA using the iScript cDNA kit 
(Bio-Rad, Hercules, CA) according to manufacturer’s instructions. A balanced amount of 
DNase-treated RNA from each sample was used as a control for viral DNA 
contamination. qRT-PCR was performed using the CFX Connect™ system (Bio-Rad, 
Hercules, CA) according to manufacturer’s instructions for iQ SYBER Green Supermix 
(Bio-Rad, Hercules, CA). Primer sequences, annealing temperatures, amplicon sizes, 
and cDNA dilutions used for each gene are listed in Table 6.1. Expression was 
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calculated by comparing Ct values to a standard curve created from cDNA (diluted 1:5, 
1:25, 1:125, 1:625) produced from RNA obtained from AAV-BDNF-A*B transduced 
cells. Statistical analysis of Bdnf expression was performed by one-way ANOVA across 
all treatment groups, followed by Tukey’s HSD post-hoc for all pairwise comparisons.   
Immunoblotting. AAV-HT1080 cells transduced with virus were pelleted, washed 
three times with 1x sterile PBS, and stored at -80˚C until further processing. To each 
pellet, 100 µL of 1x RIPA buffer (1% NP40, 0.5% Na deoxycholate, 0.1% SDS, 150 mM 
NaCl, 50 mM Tris) with added protease inhibitor cocktail (Halt, Thermo Scientific, 
Rockford, IL) was added. Samples were triturated using a pipette and then stored on ice 
for 30 minutes. Lysates were passed through a 28g syringe five times and then stored 
at -80˚C. Protein concentrations were determined using the BCA assay (Thermo 
Scientific, Rockford, IL). Sample concentrations were balanced using 1x RIPA, 10x 
dithiothreitol (Fisher Scientific, Waltham, MA), and 2x stop solution (29.35 g Tris-HCl, 
300 ml 10% w/v SDS, 150 ml glycerol, QS H20), boiled for 10 minutes, and then placed 
on ice for 30 minutes. For each sample, 10 or 20 µg of protein was loaded per lane on a 
4% - 12% NuPAGE bis-tris gel (Life Technologies, Carlsbad, CA). Mouse PFC and 
entorhinal cortex (EC) samples lysed with 1x LDS buffer were used as positive controls 
for BDNF detection. Electrophoresis was performed at 150V followed by transfer to 0.20 
µm nitrocellulose or PVDF membrane for 1.5 hours at 30V on ice. Coomassie blue stain 
was used to ensure complete transfer of protein to membrane. Prior to primary antibody 
incubation, the membranes were blocked with 5% non-fat dried milk in 1x TBST for 45 
minutes. Immunoblots were visualized on GeneMate Blue Autoradiography film 
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(BioExpress, Kaysville, UT) using the Amersham ECL Western Blotting Detection 
Reagent (GE Healthcare Life Sciences, Pittsburgh, PA). 
Immunocytochemistry. Cells were washed three times for 15 minutes with 1X 
Dulbecco’s PBS (DPBS) containing calcium and magnesium (Life Technologies, 
Carlsbad, CA). All incubations in this protocol took place at room temperature and the 
plate was protected from light using tin foil. For fixation, cells were incubated with 4% 
paraformaldehyde in 1X PBS for 20 minutes. Following another three – 15 minute 
washes with DPBS, cells were blocked and permeablized with 10% goat serum, 0.5% 
Triton X-100 in 1x PBS for 30 minutes. For detection of the Myc epitope that should be 
expressed by AAV-BDNF-A and AAV-BDNF-A*B, cells were incubated at room 
temperature for 60 minutes with anti-Myc tag antibody (ab9106, Abcam, Cambridge, 
England) diluted 1:2000 and 1:5000 in 3% goat serum/1X PBST. After being washed 
(3X – 15 minutes) with DPBS, goat-α-rabbit secondary antibody (Alexa Fluor 488, Life 
Technologies, Carlsbad, CA) diluted 1:2000 in 3% goat serum/1X PBST was applied to 
cells for 2 hour incubation. Cells were washed a final three times in DPBS, followed by 
imaging using a fluorescent microscope measuring green channel emission (Zeiss 
Microscope, Q Imaging Camera).   
Enzyme-Linked Immunosorbent Assay (ELISA). Dorsal striatum (DS) tissue from 
Bdnfklox/klox and wildtype mice was lysed using a modified protein extraction protocol 
shown to significant increase yield of BDNF from brain (Szapacs et al., 2004). Frozen 
tissue was weighed and 400 µL of lysis buffer was added to each sample. Lysis buffer 
consisted of 100 mM PIPES, pH 7.0 (Boston Bioproducts, Ashland, MA), 500 mM NaCl 
(Fisher Scientific, Waltham, MA), 0.2% Triton X-100 (Fisher Scientific, Waltham, MA), 
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0.1% NaN3 (Fisher Scientific, Waltham, MA), 2% BSA (Fisher Scientific, Waltham, MA), 
2 mM EDTA · Na2 · 2H2O (Fisher Scientific, Waltham, MA), and 1x protease inhibitor 
cocktail (Halt, Thermo Scientific, Rockford, IL), which was added immediately before 
use. Samples were homogenized with a Polytron® (Kinematica AG, Germany), and 
then placed on ice until being centrifuged for 30 minutes at 16,000 x g at 4˚C. 
Supernatant was removed and stored at -80˚C until the assay was performed. The 
Promega BDNF Emax® ImmunoAssay System (Promega, Madison, WI) was employed 
to measure BDNF levels for each sample. Each well of a 96-well Nunc® Immobilizer™, 
flat bottom, amino plate (Thermo Scientific, Rockford, IL), was incubated overnight at 
4˚C with 100 µL anti-BDNF monoclonal antibody (mAb) diluted 1:1000 in carbonate 
coating buffer (25 mM sodium bicarbonate and 25 mM sodium carbonate, pH 9.7). 
Unadsorbed mAb was removed and plate was vigorously washed once with TBST wash 
buffer, which was made from 20 mM Tris (Bio-Rad, Hercules, CA), 150 mM NaCl 
(Fisher Scientific, Waltham, MA), and 0.05% (v/v) Tween 20 (Fisher Scientific, Waltham, 
MA). Just prior to blocking, lysed tissue extracts were allowed to come to room 
temperature (RT). The plate was blocked using 200 µL 1X Promega Block and Sample 
buffer followed by incubation for 1 hour at RT. The plate was then vigorously washed 
once with TBST. One hundred µL of each sample or standard (500, 250, 125, 62.5, 
31.3, 15.6, 7.8, 0 pg/ml) were added in triplicate to the plate and incubated for 2 hours 
at RT with shaking. The plate was then washed five times with TBST. One hundred µL 
of anti-human BDNF polyclonal antibody (pAb) diluted 1:500 in 1X Block and Sample 
buffer was added to each well and the plate was once again incubated for 2 hours at RT 
with shaking. After the plate was washed five times with TBST, 100 µL of anti-Igγ 
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horseradish peroxidase conjugate diluted 1:200 in 1X Block and Sample buffer was 
added to each well and the plate was incubated for 1 hour at RT with shaking. The plate 
was washed again five times with TBST. Finally, the plate was developed using 100 µL 
of room temperature Promega TMB One Solution which was allowed to incubate for 10 
minutes with shaking. The reaction was stopped using 100 µL of 1N HCl and 
absorbance was measured at 450 nm. BDNF levels were normalized to wet tissue 
weight and reported as ng/g. Statistical analysis of DS BDNF levels was performed by 
Student’s t-test between the two genotypes.  
Animals. Bdnfklox/klox and wildtype mice were bred in the VCU Transgenic Mouse 
Core. Male mice were singly housed between 4 and 5 weeks of age and kept on a 12-
hour light/dark cycle (6 am on, 6 pm off) in the out-of-vivarium animal room located on 
the 6th floor of Kontos Medical Sciences Building. Mice were housed with Teklad corn 
cob bedding (7092, Harlan, Madison, WI). All animals had ad libitum access to tap 
water, and Bdnfklox/klox mice were subjected to the pair-feeding paradigm from the time 
they were singly housed until the experiment ended. In brief, Bdnfklox/klox mice were 
restricted to the amount of standard rodent chow (7912, Harlan, Madison, WI) that was 
consumed by age-matched wildtype littermates on the previous day. All behaviors were 
assayed during the light cycle between the hours of 8 am and 2 pm. All animal 
procedures were approved by the Institutional Animal Care and Use Committee of 
Virginia (AM10332) and carried out in accordance with the National Institute of Health 
guide for the Care and Use of Laboratory Animals. 
Stereotaxic Microinjection. Surgeries were staggered over time as animals 
became available from the transgenic core. Bdnfklox/klox and wildtype mice, 9.5 to 11.5 
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weeks of age, received ad libitum access to 0.188 mg/ml cherry-flavored children’s 
ibuprofen in their drinking water from 24 hours prior to surgery until 72 hours after 
surgery. Induction of anesthesia was performed with 5% isoflurane and 7 L O2 per 
minute. Sedation was maintained with 2-3% isoflurane/7 L O2 per minute. In preparation 
for surgery ophthalmic ointment (Henry Schein) was applied to the eyes, the scalp was 
shaved and wiped with isopropanol, and the animal was placed in the stereotaxic rig 
(myNeuroLab, St Louis, MO). After ear bars were inserted to immobilize the head and 
adjusted for levelness, the incision site was cleaned with ethanol, betadine, and ethanol 
and numbed with an injection of 0.1 ml of 0.25% bupivacaine. An anterioposterior (AP) 
incision was made to expose the skull and needles were centered at bregma. If 
necessary, adjustments to the animal’s head were made to be within the same AP and 
mediolateral (ML) planes as bregma. AP and ML coordinates from bregma were 
recorded. DS coordinates (AP: + 0.10 mm, ML: + 0.22 mm, DV: -0.31 mm, with needles 
at a 10% angle) were added/subtracted from those recorded at bregma and AP and ML 
coordinates adjusted. Needles were lowered to the skull surface, where marks were 
made with a fine-point sharpie for drilling. Holes were drilled (Dremel, Mount Prospect, 
IL) into the skull with a 3/64” bit, needles rinsed with autoclaved water, 100% ethanol, 
and autoclaved water before being loaded with one of three viruses: AAV-BDNF-A, 
AAV-BDNF-A*B, or AAV-GFP. Needles were placed at the edge of the skull and 
dorsoventral (DV) readings were taken. DV coordinates were subtracted and the 
needles were lowered into the DS. One tenth of a µL of virus (0.1 µL) was injected 
bilaterally over a two minute period, for a total of 1 µL of virus. Needles were allowed to 
sit at the injection site for 10 minutes and then slowly removed and cleaned. Incisions 
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were sealed with VetBond (3M, St. Paul, MN) and mice were placed in a clean cage on 
a heating pad until coming out from anesthesia. Sterile technique was maintained 
throughout surgery and absence of toe pinch reflex and breathing was assessed and 
recorded at least every 15 minutes. The number of animals that received each AAV 
treatment was as follows: 2 wildtype, GFP; 2 wildtype, BDNF-A; 3 wildtype, BDNF-AB; 3 
Bdnfklox/klox, GFP; 5 Bdnfklox/klox, BDNF-A; 5 Bdnfklox/klox, BDNF-AB. Mice were allowed 3 
weeks for recovery and viral expression before behavioral testing commenced.   
Loss of Righting Reflex (LORR). The sedative-hypnotic effects of ethanol were 
measured using the loss of righting reflex assay (LORR). Three to four weeks following 
stereotaxic injection of AAV-BDNF-A, AAV-BDNF-A*B, or AAV-GFP, mice were 
habituated to i.p. saline injections for 3 days. On test day mice received 4.0 g/kg ethanol 
and were placed supine in a V-shaped trough after losing righting reflex. Latency for 
LORR, or Time 1, was recorded when a mouse was unable to right itself for 30 
seconds. Mice taking longer than 5 minutes to acquire LORR were removed from the 
study due to possibility of improper injection. An animal was deemed to have regained 
its righting reflex, and Time 2 recorded, when it was able to right itself 2 times within 30 
seconds. Duration of LORR was calculated by Time 2- Time 1. Statistical analyses of 
latency and duration of LORR was performed using a two-way ANOVA followed by 
Tukey’s HSD post-hoc to test pairwise comparisons where appropriate. 
Locomotor Activity Assay. Locomotor activity in response to acute low-dose 
ethanol was assessed using Med-Associates sound-attenuating locomotor activity 
chambers (Med Associates, model ENV-515, St. Albans, VT). Chambers are equipped 
with 100 mA lights, a fan to diminish ambient noise, and 16 infrared sensor beams 
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along the x and y axis. The system is interfaced with Med Associates software that 
records the number of photobeam breaks which it converts to horizontal distance 
traveled. Nine weeks following AAV injections, mice were acclimated to the behavioral 
testing room for 1 hour prior to i.p. injections. Two days of saline administration and 10 
minutes placement in the testing apparatus allowed for habituation to injections and 
environment. On test day, mice received 1.0 g/kg ethanol and distance traveled was 
recorded for 60 minutes. Preliminary statistics were performed due to the limited 
number of animals. Analysis for locomotor activity measured in the 10 and 60 minute 
time bins was performed using a two-way ANOVA. Analysis of time course data for 
AAV-treated Bdnfklox/klox mice and time course data collapsed across genotypes for the 
full 60 minute testing period was analyzed using a repeated measures two-way ANOVA. 
Tukey’s HSD post-hoc analyses were performed where appropriate for all pairwise 
comparisons.  
 
Results 
In vitro transduction of AAV containing BDNF-A and BDNF-A*B into AAV-HT1080 cells 
resulted in expression of Bdnf mRNA.  
To verify that the viruses made by the UNC Vector Core were capable of 
overexpressing Bdnf, they were first tested in vitro. DNase treated RNA from cells 
transduced with AAV-BDNF-A, AAV-BDNF-A*B, AAV-GFP and a no virus control was 
used to produce cDNA for analysis by qRT-PCR. A no-reverse transcription control was 
also run to detect any viral DNA contamination. Primers designed to test for all isoforms 
of Bdnf transcript (primers directed proximal to the initial polyadenylation site) and for  
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Figure 6.2 – qRT-PCR of AAV transduced HT1080 cells. HT1080 cells were 
transduced with AAV-BDNF-A (A), AAV-BDNF-A*B (AB), AAV-GFP (GFP), or no virus 
as a negative control (NC). qRT-PCR using primers designed to target the proximal 3’ 
UTR and detect total Bdnf levels (a) determined that both virus A and A*B were able to 
produce Bdnf transcript (one-way ANOVA, F[7,16] = 62.74, *p < 0.001, n =3). Reactions 
using DNase treated RNA as starting material confirmed that amplified product did not 
result from viral DNA contamination. (b) Using primers directed towards the distal 3’ 
UTR, it was determined that only virus A*B could produce the long 3’ UTR transcript 
isoform (one-way ANOVA, F[3,8] = 10.72, *p < 0.01, n =3). 
a 
b 
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long 3’ UTR isoforms only (primers that target distal to the initial polyadenylation site) 
were used to capture the profile of Bdnf mRNA transcribed by each virus. AAV-HT1080 
cells do not express Bdnf, therefore no Bdnf was detected in cells transduced with AAV-
GFP or no virus (Figure 6.2, a, b). Transduction with both AAV-BDNF-A and AAV-
BDNF-A*B resulted in expression that could be detected when using primers designed 
to test for Bdnf total transcript levels (Figure 6.2, a). This was not due to DNA 
contamination, as no Bdnf was detected in the samples that used DNase treated RNA 
as template. Equally as important, we were able to demonstrate that long 3’ UTR Bdnf 
was only expressed by AAV-BDNF-A*B and not AAV-BDNF-A. Thus, AAV-BDNF-A and 
AAV-BDNF-A*B expressed the appropriate Bdnf transcript isoforms in vitro.  
 
Results of in vitro BDNF protein expression by transduction of AAV into AAV-HT1080 
cells were inconclusive. 
To confirm that expression of Bdnf mRNA by AAV-BDNF-A and AAV-BDNF-A*B 
resulted in production of BDNF protein in vitro, immunocytochemical (ICC) studies of 
transduced AAV-HT1080 cells were undertaken. An antibody directed at the Myc 
epitope tag whose sequence was in frame with the BDNF CDS was used to qualitatively 
detect protein levels. Initial examination of cells transduced with AAV-BDNF-A and 
AAV-BDNF-A*B indicated a low level of fluorescent signal that was not detected in the 
no primary control cells (Figure 6.3, a-d). However, a similar level of fluorescence was 
detected in cells that had been treated with no virus (Figure 6.3, e, f). This suggested 
that the observed signal was likely background fluorescence from the primary antibody 
binding non-specific target. Robust GFP signal was detected from cells transduced with  
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Figure 6.3 – In vitro expression of BDNF protein by AAV. HT1080 cells were 
transduced with AAV-GFP, AAV-BDNF-A, AAV-BDNF-A*B, and no virus as a negative 
control. Detection of in vitro BDNF protein expression was attempted by 
immunocytochemical studies using anti-myc tag antibody (a) AAV-Bndf-A, 1:2000 anti-
myc tag, 2000 msec exposure (b) AAV-Bdnf-A , No 1˚, 2000 msec exposure (c) AAV-
Bdnf-AB, 1:2000 anti-myc tag, 2000 msec exposure (d) AAV-Bdnf-AB, No 1˚, 2000 
msec exposure (e) No virus, 1:2000 anti-myc tag, 2000 msec exposure (f) No virus, No 
1˚, 2000 msec exposure (g) AAV-GFP, 1:2000 anti-myc tag, 2000 msec exposure (h) 
AAV-GFP, No 1˚, 2000 msec exposure.  
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AAV-GFP, which indicated that this virus was able to produce its gene product as 
expected (Figure 6.3, g, h).  
 Since the design of the ICC experiment provided no positive control to compare 
results to, immunoblotting was performed on protein isolated from cells that had been 
transduced with AAV-BDNF-A, AAV-BDNF-A*B, AAV-GFP and a no virus control. For a 
positive control, protein isolated from mouse PFC and EC were also analyzed. No 
protein was detected at the expected molecular weight for BDNF (~18 kDa for 
monomers) in either the transduced AAV-HT1080 cells or the animal tissue lysates 
when probing with anti-Myc-tag antibody (data not shown). Surprisingly, two anti-BDNF 
antibodies not only failed to detect BDNF in transduced AAV-HT1080 cells, but were 
also unsuccessful in detecting BDNF in the positive controls. The results of these 
studies are inconclusive until conditions can be worked out to definitely demonstrate the 
presence or absence of BDNF protein. 
 
In vivo pilot study using AAV to express BDNF-A and BDNF-A*B in to the dorsal 
striatum of Bdnfklox/klox mice did not rescue altered LORR or locomotor phenotypes.  
Due to time constraints and limited availability of Bdnfklox/klox mice, it was 
determined that the best course of action would be to proceed with an in vivo pilot study 
while preliminary cell culture work was still ongoing. To confirm that wildtype and 
Bdnfklox/klox mice possessed similar global expression of BDNF in the DS, an ELISA 
assay was performed. No significant difference in BDNF protein was detected between 
the two genotypes (Figure 6.4), indicating that the observed phenotypic differences 
described in Chapter 5 were not the result of altered BDNF levels in the DS. 
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Figure 6.4 – BDNF protein levels in the dorsal striatum of Bdnfklox/klox mice. 
Subsequent studies into the role of synaptically targeted Bdnf required conformation 
that Bdnfklox/klox mice possessed similar global levels of BDNF protein in the dorsal 
striatum (DS) as compared to wildtype animals. No genotypic difference in DS BDNF 
expression was detected by ELISA (Student’s t-test, t[8] = 1.381, p = 0.2045). 
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 Beginning 3 weeks after viral injection, animals were tested for LORR and 
ethanol-induced locomotor activity; the two behaviors in which Bdnfklox/klox mice exhibited 
the most robust phenotypic differences. A significant main effect of genotype was found 
for duration of LORR, however no effect of viral treatment was observed (Figure 6.5, b). 
Since the sample size was low and the data variable for AAV treated wildtype mice, a 
one-way ANOVA of Bdnfklox/klox animals was performed to evaluate effect of viral 
treatment. Once again, no difference was detected in duration of LORR between 
Bdnfklox/klox mice that received AAV-GFP, AAV-BDNF-A, or AAV-BDNF-A*B. 
Interestingly, there was a main effect of genotype, but not viral treatment, for latency to 
LORR (Figure 6.5, a).  
Within 48 hours of receiving 4.0 g/kg ethanol for the LORR assay, the two 
wildtype mice that had been previously injected with AAV-GFP died. This adversely 
affected the ability to interpret data regarding viral treatment in wildtype animals going 
forward. However, as a pilot study, testing the remaining animals still permitted 
information to be gathered about the efficacy of viral treatment in Bdnfklox/klox mice. 
Locomotor activity was assessed in response to 1.0 g/kg ethanol. This dose had been 
shown to elicit an activated response in Bdnfklox/klox mice not observed in wildtype 
animals. This activation was found to persist for almost the entire 60 minutes testing 
period (reference Figure 5.3, b). In the AAV-injected animals, this genotypic difference 
in activation was detected when comparing the sum of activity for the full 60 minutes 
(Figure 6.6, b), but not when analyzing the first 10 minute time bin (Figure 6.6, a). A 
time course of the data was plotted in 5 minute time bins throughout the 60 minute  
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Figure 6.5 – LORR in AAV injected mice. Mice injected with AAV-GFP, AAV-BDNF-A, 
and AAV-BDNF-A*B into the DS were subjected to LORR. (a) For latency (Fgenotype[1,14] 
= 14.108, *p = 0.002) and (b) duration of LORR (Fgenotype[1,14] = 24.269, *p < 0.001)  
there was a main effect of genotype, but not viral treatment. 
a 
b 
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testing period (Figure 6.6, c). A three-factor ANOVA to analyze AAV-treatment, time, 
and genotype could not be performed due to the lack of AAV-GFP treated wildtype 
mice. Therefore, statistical analysis focused on AAV-treatment within Bdnfklox/klox mice. A 
main effect of time and a significant interaction between time and AAV treatment were 
detected. Post-hoc analysis revealed a significant difference in distance traveled during 
the first 5 minute time bin between AAV-GFP and AAV-BDNF-A treated Bdnfklox/klox 
mice. There was also a trend towards significance when comparing AAV-GFP and AAV-
BDNF-A*B treatments. When the locomotor activity data was collapsed across 
genotypes, the previously identified pattern of protracted activation was observed. 
Bdnfklox/klox mice remained significantly different from wildtype mice at the 10, 15, 20, 25, 
and 45 minute time bins (Figure 6.6, d). Together, these behavioral analyses suggest 
that injection of AAV-BDNF-A*B into the DS of Bdnfklox/klox mice did not rescue the 
altered phenotypes. 
 
Discussion 
The objective of this series of experiments was to confirm that altered ethanol 
phenotypes exhibited by Bdnfklox/klox mice were due to loss of a distinctive function by 
long 3’ UTR Bdnf, theoretically performed at the synapse. In order to test this 
hypothesis, AAV-BDNF-A and AAV-BDNF-A*B were injected into the DS of Bdnfklox/klox 
and wildtype mice. The intended outcome was a behavioral profile that could be 
interpreted to determine the unique actions of short and long 3’ UTR Bdnf in expression 
of ethanol-induced LORR and locomotor activation. However, a lack of significant 
behavioral findings in this pilot study could be the result of various limitations. 
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Of primary concern was the inability to detect BDNF protein expression in an in 
vitro system. The 48 hour post transduction time point appears to be appropriate, as 
Bdnf transcript (Figure 6.2, a, b) and GFP protein (Figure 6.3, g, h) expression were 
detectable. For absolute conformation that AAV-BDNF-A and AAV-BDNF-A*B are 
incapable of producing BDNF, a validated BDNF or Myc epitope antibody will be 
required. In an ongoing attempt to evaluate antibody efficacy, a BDNF protein standard 
has been purchased to test the two BDNF antibodies that failed to detect BDNF by 
immunoblotting. In the qRT-PCR analysis, primers were designed to detect short and 
long 3’ UTR isoforms, but gave no indication as to the presence of Bdnf CDS. 
Therefore, as an additional control, DNA sequencing of the BDNF CDS is also 
underway to ensure that this sequence is intact. 
If AAV-BDNF-A and AAV-BDNF-A*B are capable of producing BDNF protein in 
vitro and in vivo, there are other factors that could contribute to a lack of effect. This 
includes location and timing of injections. First, the DS was chosen for the site of viral 
injection based upon findings in the literature that suggest BDNF signaling in the DS is 
important for mediating ethanol-responsive behaviors, particularly LORR (Jeanblanc et 
al., 2009; Logrip et al., 2009; Kim et al., 2012). However there is evidence that other 
neural substrates are associated with this ethanol action, including cortex (Harris et al., 
1995) and hippocampus (Proctor et al., 2003). The hippocampus and isocortex happen 
to be the brain regions with the greatest BDNF expression levels (Wetmore et al., 
1994). Although there is no direct evidence that BDNF’s effect on ethanol LORR is 
mediated by these regions, it does not exclude the possibility.  
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As mentioned previously, an inherent limitation of the Bdnfklox/klox model is the fact 
that Bdnf is not expressed throughout development. This makes it unclear as to whether 
BDNF regulates neuronal development or neuronal function to affect ethanol-induced 
phenotypes (Liao et al., 2012). Bdnf expression is fairly low prenatally, and significantly 
rises postnatally, peaking at around 3 weeks of age in mice (Qiao et al., 1996; Gorski et 
al., 2003).Therefore, injection of Bdnf-containing AAV into mouse pups would allow for 
overexpression of BDNF to have an effect on synaptic development, synaptic function, 
or both, thereby bypassing the confounding variable (Liao et al., 2012).   
Even though injections of AAV-BDNF-A*B did not reverse ethanol phenotypes in 
Bdnfklox/klox mice as hypothesized, there were interesting findings in this pilot study that 
should be addressed. First, although not affected by AAV treatment, there was an 
apparent genotypic difference in latency to LORR (Figure 6.6, a). This prompted a post-
hoc analysis of all previous LORR data from experiments that used pair-fed Bdnfklox/klox 
mice. When the data was collapsed there was a trend, although not significant, for 
decreased latency to LORR in Bdnfklox/klox mice as compared to wildtype (unpaired, two-
tailed t-test, t[27] = 1.7208, p = 0.0967). Since the interpretation of LORR results 
depends on the accuracy of latency determination, a more in-depth analysis may be 
warranted in Bdnfklox/klox mice and wildtype littermates.  
Another relevant outcome from this pilot study was confirmation that Bdnfklox/klox 
mice exhibit protracted activation to 1.0 g/kg ethanol (Figure 6.6, d). This result did 
come with the caveat of an AAV-treatment dependent reduction in activation during the 
first 5 minute time bin for Bdnfklox/klox mice treated with AAV-BDNF-A and a trend for 
AAV-BDNF-A*B  (Figure 6.6, c). If these two viruses are able to express BDNF protein 
 188 
 
in vivo, this result would necessitate further investigation as it could suggest that 
general overexpression of BDNF could alter initial activation. However, without AAV-
GFP wildtype treated mice for comparison, this is simply conjecture.  
For any insightful interpretation to come from this pilot study, unequivocal 
determination of the efficacy of AAV-BDNF-A and AAV-BDNF-AB to express BDNF 
protein is essential. However, moving forward with this line of investigation may require 
that new viral constructs be designed and characterized, and modifications to the 
experimental design may be necessary.  
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Chapter 7 – Concluding Discussion and Future Directions 
 
Discussion 
It is generally accepted that alcoholism is a disease that develops over time as a 
consequence of genetic make-up, environmental factors, and cumulative exposure to 
the drug. The latter of which results in neuroadaptations that lead to long-lasting 
alterations in neuronal activity, which are proposed to underlie the development of 
behaviors associated with addiction.  Of particular focus in this dissertation was how 
specifically the synaptic transcriptome contributes to the molecular mechanisms 
underlying addiction. The long term objective is to have a more complete understanding 
of the mechanisms of alcohol-induced neuronal plasticity to facilitate the development of 
novel therapeutic treatments for addiction. Through a two-pronged approach, we have 
demonstrated the importance of the synaptic transcriptome in mediating ethanol-
responsive behaviors and have identified potential synaptic candidate genes that 
warrant further investigation.  
 Ever since Steward’s influential work showing that synapses possess the 
capacity for local translation (Steward & Levy, 1982), the importance of synapses as the 
effector, as opposed to merely the target, of long-term change has become abundantly 
clear. It therefore would make sense that regulation of the synaptic transcriptome would 
be an inherent mechanism by which to mediate changes in synaptic structure and 
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function. Synaptic plasticity has been studied extensively for its role in learning and 
memory (Kandel, 2001); neuronal processes that are suggested to be subverted during 
the development of addiction (Hyman et al., 2006). A large body of literature exists 
describing the role of learning in ethanol-induced behavioral sensitization (Trujillo & Akil, 
1995; Quadros et al., 2003; Brebner et al., 2005), the model of neuronal plasticity that 
was utilized for these investigations. Sensitized responses to psychostimulant effects of 
drugs also appear to be affected by stress. Cross-sensitization between stress and 
ethanol suggests a potential role for HPA axis associated changes in ethanol 
sensitization (Phillips et al., 1997). Glucocorticoid hormones are the final step in 
activation of the HPA axis and have been shown to have acutely positive and 
chronically negative effects on learning and memory (Tasker et al., 2006). 
Glucocorticoid effects on memory appear to result from regulation of gene expression 
(Tasker et al., 2006). Upon binding and activation, the glucocorticoid receptor 
translocates to the nucleus and acts as a transcription factor, where it mediates the 
transcription of a number of genes including, Sgk1 and Fkbp5 (Webster et al., 1993; 
Binder, 2009). The Miles laboratory has previously identified glucocorticoid-responsive 
gene expression changes that potentially contribute to the development of behavioral 
sensitization (Kerns et al., 2005; Costin et al., 2013a). In the present work, we found 
that a number of synaptically targeted genes conform to the gene expression pattern 
elicited by the dysregulation of the HPA access that occurs with repeated ethanol 
exposure (Figure 4.3). This suggests that local synaptic function may be a chief target 
for the interaction between ethanol and glucocorticoid signaling. 
 191 
 
 If the development of ethanol-responsive behaviors exploits the same molecular 
mechanisms as learning and memory, BDNF would be an ideal candidate for initiating 
an examination into the interaction between ethanol and the synaptic transcriptome. 
BDNF signaling has been shown to be intimately involved in the facilitation of NMDA 
receptor-dependent hippocampal LTP and LTD (Patterson et al., 1996; Woo et al., 
2005) and the trafficking of its mRNA to the synapse suggests a localized role for BDNF 
function (An et al., 2008). BDNF, and other NTs, have also been shown to modulate 
functional tolerance following ethanol withdrawal (Szabo & Hoffman, 1995). It has been 
proposed that functional tolerance is a CNS adaptation, like learning and memory, 
which depends on changes in synaptic efficacy (Hoffman et al., 1978). Potential 
adaptive mechanisms contributing to functional tolerance following chronic alcohol 
include selective targeting of NR2B-contianing NMDA receptors to the synapse 
(Carpenter-Hyland et al., 2004) and increases in F-actin and PSD95 co-localization 
promoting dendritic spine enlargement (Carpenter-Hyland & Chandler, 2006). BDNF 
could conceivably contribute to these phenomena, since it has been shown that BDNF 
application to hippocampal neuronal cultures increases NMDA receptor subunit levels 
and trafficking to the membrane (Caldeira et al., 2007). Additionally, BDNF increases 
phosphorylation of the NR2B subunit of NMDA receptors via Fyn kinase, thereby 
increasing receptor activity (Lin et al., 1998). This same molecular adaptation occurs in 
response to acute ethanol administration, and is thought to contribute to AFT (Miyakawa 
et al., 1997; Yaka et al., 2003b). Acute ethanol has also been shown to increase BDNF 
expression in the hippocampus and dorsal striatum (McGough et al., 2004). It is 
suggested that the dorsal striatum (DS) is the neuronal center that regulates duration of 
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LORR (Kim et al., 2012). Therefore, if the enhanced duration of LORR exhibited by 
Bdnfklox/klox mice (Figure 5.7) is in fact the result of a deficit in AFT, one could 
hypothesize that development of ethanol AFT requires signaling pathways initiated 
specifically by locally translated Bdnf in the DS. Overall, the studies presented in this 
dissertation suggest that ethanol alters the synaptic transcriptome, appropriating the 
processes that contribute to normal synaptic functioning, and leading to the neuronal 
and behavioral adaptations that occur during the development of addiction. Our studies 
on Bdnfklox/klox mice highlight how synaptic targeting of specific mRNA can modulate 
ethanol behavioral responses. 
   
Future Directions 
Investigations into the synaptic transcriptome were enabled through the use of a 
synaptic enrichment protocol known as the synaptoneurosome preparation. A portion of 
the studies presented here demonstrated the utility of this method to examine in vivo 
alterations to the synaptic transcriptome as a result of systemic drug administration. A 
significant outcome of this work was the establishment of the synaptoneurosome 
protocol in our laboratory, which can now be utilized to further probe the effect of 
ethanol on localized mRNA and protein populations. It was determined that sensitizing 
treatments of ethanol in D2 mice perturbed the synaptic transcriptome of the frontal pole 
(Chapter 4). This heterogeneous brain region was initially chosen for this series of 
experiments due to its inclusion of brain regions believed to mediate the rewarding and 
reinforcing properties of ethanol, such as NAc, DS, and PFC (Robinson & Berridge, 
1993). However, numerous studies have indicated brain region specific differences that 
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contribute to ethanol behavioral phenotypes (Kerns et al., 2005; Mulligan et al., 2011; 
Wolstenholme et al., 2011). Regional expression profiles may be dampened by 
examining the frontal pole synaptic transcriptome as a whole, obscuring the actual 
mechanism underlying behavioral sensitization. Furthermore, taking a systems network 
approach to examine brain-region specific synaptic transcriptomes could provide insight 
into how the brain’s circuity adapts in concert to repeated drug administration (Mulligan 
et al., 2011).  
Selection of the frontal pole region also allowed sufficient quantities of RNA to be 
obtained for subsequent analyses. Therefore, an impediment to examining brain-
regional differences in synaptic expression patterns associated with behavioral 
sensitization is the large amount of tissue necessary. While an obvious solution is to 
increase the number of test subjects, this needs to be balanced by the time and cost of 
preforming such an experiment. A conservative estimate for a brain region the size of 
the DS would require a minimum of 60 mice per sensitization treatment groups, in order 
to obtain biological replicates. Alternatively, optimization of the synaptoneurosome 
preparation could significantly lessen the starting tissue requirements. A protocol by 
Johnson et al. (1997) was able to obtain fractions enriched for intact 
synaptoneurosomes from 400 µm slices of individual rat hippocampi (Johnson et al., 
1997). No attempts at RNA isolation from these samples were made. Thus, in order to 
be useful in expression profiling studies this protocol would need to be characterized 
and optimized for RNA yield.   
As mentioned previously, the propensity for development of alcohol dependence 
arises from a combination of genetics, environmental factors, and prior history of drug 
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use. The identification of a cohort of genes regulated by ethanol exclusively at the 
synapse (Figure 4.4, Table 4.8) raised the question as to whether there could also be 
genetic regulation that occurs on the subcellular level contributing to behavioral 
responses. B6 and D2 mice are two inbred strains that have highly polymorphic 
genomes (Walter et al., 2007) and show divergent phenotypic responses to ethanol 
(McClearn & Rodgers, 1959; Goldstein, 1973; Phillips et al., 1994; Metten et al., 1998). 
Therefore, the B6 and D2 strains were used as progenitors for the BXD recombinant 
inbred panel often used for genetic mapping of quantitative traits related to ethanol. The 
breeding of these two inbred stains, followed by intercrossing of their obligate 
heterozygote F1 offspring, results in random recombinational events across the 
genomes. Further inbreeding of the F2 generation creates a mosaic of B6 and D2 
haplotypes along every chromosome, uniquely apt for genetic mapping studies.   
Examining ethanol sensitization responses across a subset of the BXD panel, along 
with the B6 and D2 progenitors, indicates that this behavior is a heritable phenotype that 
varies substantially with genotype (Figure 7.1). The synaptoneurosome preparation 
could therefore be used to profile the synaptic transcriptome of specific BXD strains 
subjected to the sensitization paradigm in efforts to identify synaptic expression 
quantitative trait loci (eQTL). An eQTL is a genomic loci that contributes to the variability 
in expression of a particular transcript. The hypothesis being that a genetical genomics 
approach could identify novel loci that contribute to transcript levels in the synapse, 
contributing to the synaptic plasticity underlying behavioral sensitization. 
A list of candidate genes was derived from analysis of RNA isolated from the 
synaptoneurosomal fraction, P2, indicating that repeated ethanol exposure is able to  
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Figure 7.1 – Ethanol behavioral sensitization across the BXD line. The heritable 
nature of the ethanol sensitization response can be observed when testing the BXD 
recombinant inbred line of mice. In response to 2.0 g/kg ethanol, the difference in 
locomotor activity between the fifth and first ethanol treatment, 1-5 minutes after 
injection in female BXD mice is graphed (Phillips et al., 1995). Plot was obtained from 
GeneNetwork (www.genenetwork.org), record ID 10484. 
  
 196 
 
regulate the synaptic transcriptome (Supplemental Table S4.7). Rhou, which encodes 
for a small G protein of the Rho family of GTPases, fulfills the majority of criteria 
established to select candidates for additional investigation.  Nothing is known regarding 
the function of Rhou in brain, but it has been previously identified as regulated by 
ethanol under various experimental conditions (Unpublished-Data; Kerns et al., 2005). 
In the present study, results indicated that Rhou expression was significantly altered in 
the P2 fraction only (Supplemental Table S4.7). This suggests that Rhou’s function in 
response to ethanol may be localized to the synapse. Additionally, Rhou exhibited the 
habituating gene expression profile characteristic of glucocorticoid responsive genes 
following repeated ethanol exposure (Figure 4.3). The gene structure of Rhou contains 
a glucocorticoid responsive element (GRE), implicating that Rhou could be involved in 
glucocorticoid regulation of the interaction between stress and alcohol dependence 
(Costin et al., 2013a). Rhou is also a putative target for the CPEB1 RNA-binding protein 
(Zhang et al., 2010). This makes Rhou amenable for experiments to test the effect of 
altering dendritic trafficking of a known ethanol responsive gene. Mutating the putative 
CPEB1 binding site would theoretically alter synaptic levels of Rhou transcript which, if 
done in vivo, would offer a unique model for examining the role of the synaptic 
transcriptome in glucocorticoid regulation of ethanol behavioral sensitization. 
This approach is not without precedence, as the second line of investigation 
presented herein demonstrated that disrupted trafficking of a known ethanol-responsive 
gene, Bdnf, results in altered behavioral phenotypes. Bdnfklox/klox mice, which have a 
truncated long 3’ UTR variant of the Bdnf mRNA and reduced levels of BDNF protein 
and transcript at the synapse, exhibited a prolonged duration of LORR (Figure 5.7). As 
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mentioned previously, I hypothesize that AFT to the sedative effects of ethanol tested in 
LORR may be mediated by signaling cascades initiated by locally translated BDNF. 
This remains contingent on validation studies required to confirm that Bdnfklox/klox mice 
have a deficit in AFT. Alternatively, since Bdnfklox/klox mice exhibited increased sensitivity 
to both 1.0 and 2.5 g/kg ethanol, the fact that Bdnfklox/klox mice also regained righting 
reflex at a lower BEC may simply reflect an increased sensitivity to 4.0 g/kg ethanol. 
Our latency measurement may not be sensitive enough to detect the altered initial 
sensitivity at this high dose of ethanol. However, if Bdnfklox/klox mice do have a deficit in 
AFT, this could also be detected through a series of experiments to test the molecular 
events that underlie the behavior. For instance, I would predict that ethanol-induced 
phosphorylation of NR2B would be lower in Bdnfklox/klox mice as compared to wildtype 
mice. It has been shown that brain-region selective compartmentalization of NR2B and 
Fyn kinase by RACK1 confers region specificity to the effects of ethanol (Yaka et al., 
2003a). Upon ethanol administration, RACK1 dissociates from the NR2B/Fyn/RACK 
complex (Yaka et al., 2003a). This allows for Fyn to phosphorylate NR2B and RACK1 to 
translocate the nucleus, where it alters the transcription of BDNF (Yaka et al., 2003a). 
BDNF signaling through TrkB, negatively regulates ethanol-induced behavioral effects 
by altering levels of neuropeptide Y, dopamine receptor 3 and dynorphin (Jeanblanc et 
al., 2006; Logrip et al., 2008). This establishes a parallel signaling mechanism to protect 
against ethanol induced neuroadaptations (Jeanblanc et al., 2009). Therefore the level 
of RACK1 nuclear translocation and subsequent effects on transcription in response to 
ethanol should be altered in Bdnfklox/klox mice. Mice selectively bred for their acquisition 
of AFT to ethanol (Erwin & Deitrich, 1996) could be used in a complementary study to 
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determine the role of synaptic Bdnf. qRT-PCR on total RNA isolated from 
synaptoneurosomes prepared from the tissue of High-AFT (HAFT) and Low-AFT 
(LAFT) mice may reveal differential targeting of Bdnf to the synapse, contributing to 
expression of the selected trait.  
Bdnfklox/klox mice also exhibited an altered behavioral response to low dose 
ethanol, wherein we observed increased locomotor activity following a 1.0 g/kg dose of 
ethanol (Figure 5.2, 5.3). Acute, ethanol has been shown to dose-dependently activate 
DAergic neuronal firing (Gessa et al., 1985), which results in an increase of DA released 
in the NAc shell (Pontieri et al., 1995). Midbrain A10 DA neurons have been 
characterized as the neurochemical substrate of reinforcement (Wise & Rompre, 1989; 
Wise, 2004), and have been shown to underlie spontaneous and psychomotor-induced 
locomotor activity (Fink & Smith, 1980; Koob et al., 1981). Therefore, one might predict 
that the increased ethanol-induced locomotor response of Bdnfklox/klox mice may result 
from altered dopamine release from mesolimbic DA neurons. Dopamine, as measured 
by microdialysis, should reveal an augmented release in the NAc shell of Bdnfklox/klox 
mice as compared to wildtype. This increased DA level would theoretically remain 
elevated for an extended period of time, contributing to the protracted activation that 
was observed to last at least 60 minutes (Figure 5.3). 
The lengthy duration of LORR displayed by non-pair-fed Bdnfklox/klox mice 
suggested a combination of pharmacokinetic and pharmacodynamic effects underlying 
the phenotype (Figure 5.6). Despite being maintained at a body mass comparable to 
wildtype animals, pair-fed Bdnfklox/klox mice still had an altered ethanol metabolism profile 
(Figure 5.14). Therefore, follow up studies to investigate the potential pharmacokinetic 
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contributions should be undertaken. Lean body mass determination through chemical 
analysis or NMR spectrometry (Tinsley et al., 2004) could determine if a discrepancy in 
Vd still exists between pair-fed Bdnf
klox/klox mice and wildtype littermates. Although, 
decreased volume of distribution in Bdnfklox/klox mice would not explain the apparent 
increased ethanol metabolism rate (Figure 5.14). An examination into the level or 
activity of ethanol metabolic enzymes, such as alcohol and aldehyde dehydrogenase, 
CYP2E1, and catalase, may be warranted.  
Expression profiling could be used as an initial examination for altered neuronal 
and metabolic systems in Bdnfklox/klox mice. Transcriptomic analyses measure steady 
state mRNA abundance, a composite of transcription and degradation rates. 
Differences between naïve Bdnfklox/klox and wildtype mice could therefore be informative 
as to the basally perturbed pathways that could contribute to altered ethanol responses. 
This has been demonstrated in Fyn-/- mice, which showed a coordinate basal decrease 
in myelin-associated gene expression that was an underlying factor in enhanced 
sensitivity to high dose ethanol (Farris & Miles, 2013). Microarray analysis of Bdnfklox/klox 
DS has been initiated, prompted by our LORR findings. Future microarray studies could 
be performed on the PFC or NAc to determine if reduced dendritic Bdnf alters basal 
myelin-associated genes, as observed in the Fyn-/- mice (Farris & Miles, 2013). Analysis 
of the liver would contribute to an overall comparison of pharmacokinetic profiles 
between Bdnfklox/klox and wildtype mice. Proper controls will be essential to these studies 
to ensure that observed differences in expression are the result of altered dendritic 
trafficking of Bdnf and not due to food restriction. As such, microarray studies will 
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require samples to be run from not only wildtype and pair-fed animals, but non-pair-fed 
animals as well.  
Overall, the studies presented in this dissertation highlight the importance of the 
synaptic transcriptome in ethanol-responsive behaviors. As the capability to positively 
identify targeted transcripts and the regulatory mechanisms that control RNA trafficking 
advances, I expect that the true extent of the synaptic transcriptome’s effect on 
localized activity-dependent plasticity will become apparent. In particular, the concept 
that dendritic transcripts act as a template for proteins that have a distinct function as 
compared to their somatically translated counterparts may reveal unconventional 
functions for otherwise well characterized proteins. In conclusion, the synaptic 
transcriptome provides a new frontier for investigating the molecular and cellular 
mechanisms that contribute to the development of alcoholism, with the ultimate goal of 
identifying novel and more effective therapeutic interventions.    
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